title,datetime,link
J&J seals $30B deal for Actelion,2017-01-26 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam5qLWFjdGVsaW9uLWFjcXVpcmUtZGVhbC0zMC1iaWxsaW9uLVBBSC80MzQ4Mzkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
The top 15 best-selling cancer drugs in 2022,2017-01-17 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvc3BlY2lhbC1yZXBvcnQtdG9wLTE1LWJlc3Qtc2VsbGluZy1jYW5jZXItZHJ1Z3MtMjAyMtIBAA?hl=en-US&gl=US&ceid=US%3Aen
"Mallinckrodt denies wrongdoing, but pays $100M fine",2017-01-19 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFsbGluY2tyb2R0LTEwMG0tZnRjLXNldHRsZW1lbnQtcXVlc3Rjb3IvNDM0MzQ3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
McKesson Corp. pays $150M in record settlement with DOJ,2017-01-19 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWNrZXNzb24tc2V0dGxlbWVudC0xNTAtZG9qLWRlYS1vcGlvaWRzLzQzNDMyNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Amgen's Humira biosim clears EMA regulatory hurdle,2017-01-30 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvQ0hNUC1Ob3ZhcnRpcy1BbWdlbi1BbWpldml0YS1aaW94dGVuem8vNDM1MDU2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Lilly shuffles management as new CEO signs on,2017-01-06 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktc2h1ZmZsZXMtbWFuYWdlbWVudC1hcy1uZXctY2VvLXNpZ25zLW9uLzQzMzQ5Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Takeda, Maverick join to drive T-cell therapeutics for cancer",2017-01-12 00:00:00,https://news.google.com/./articles/CBMiRmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGFrZWRhLW1hdmVyaWNrLWNhbmNlci1kZWFsLzQzMzkyOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Payers balk at price of EpiPen rival,2017-01-25 00:00:00,https://news.google.com/./articles/CBMiQWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2FsZW8tYXV2aS1xLXBheWVyLXBibS80MzQ3NjUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Industry limits price increases as debate continues,2017-01-03 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhcm1hLWRydWctcHJpY2UtaW5jcmVhc2VzLTIwMTcvNDMzMjI1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA to drugmakers: Don't let manufacturing lead to rejection,2017-01-05 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXRvLWRydWdtYWtlcnMtZG9udC1sZXQtbWFudWZhY3R1cmluZy1sZWFkLXRvLXJlamVjdGlvbi80MzM0Mzgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca taps APT in latest deal,2017-01-05 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtdGFwcy1hcHQtaW4tbGF0ZXN0LWRlYWwvNDMzMzkyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Report: Oncology, profitable drugs move to market faster, patent ...",2017-01-09 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvUXVpbnRpbGVzSU1TLWlubm92YXRpb24tbGlmZWN5Y2xlLXBhdGVudC1zYWxlcy80MzM2NDYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Actelion misses goal in study, but takeover talks likely unaffected",2017-01-23 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWN0ZWxpb24tb3BzdW1pdC10cmlhbC1mYWlsdXJlLUpOSi10YWtlb3Zlci80MzQ1Mzgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Gates Foundation invests $50M in Intarcia for anti-HIV work,2017-01-03 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2F0ZXMtZm91bmRhdGlvbi1pbnZlc3RzLTUwbS1pbi1pbnRhcmNpYS1mb3ItYW50aS1oaXYtd29yay80MzMyMjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Endo shakes up marketing, with former Sanofi exec in, recently hired ...",2017-01-04 00:00:00,https://news.google.com/./articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2VuZG8tbWFya2V0aW5nLXNoYWtlLXVwLWZvcm1lci1zYW5vZmktZXhlYy1oaXJlZC10by1oZWFkLWJyYW5kaW5nLXJlY2VudGx5LWhpcmVkLWJyYW5k0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA gives go-ahead to Synergy's constipation drug,2017-01-22 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWdpdmVzLWdvLWFoZWFkLXRvLXN5bmVyZ3lzLWNvbnN0aXBhdGlvbi1kcnVnLzQzNDQ5Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J to launch newest JLABS incubator in NYC,2017-01-11 00:00:00,https://news.google.com/./articles/CBMiQWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotaW5jdWJhdG9yLUpMQUJTLU5ZQy80MzM4MTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Tesaro plans speedy response to CRL for nausea drug,2017-01-13 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGVzYXJvLWNybC1mZGEtcm9sYXBpdGFudC1WYXJ1YmkvNDMzOTkyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Merck KGaA inks big data deal,2017-01-18 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2sta2dhYS1pbmtzLWJpZy1kYXRhLWRlYWwvNDM0MjQ0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Sarepta signals strong start for Exondys 51,2017-01-11 00:00:00,https://news.google.com/./articles/CBMiR2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2FyZXB0YS1leG9keXMtNTEtcTQtcmV2ZW51ZS80MzM4NDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer set to move C. diff vaccine into Phase 3,2017-01-27 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLWMtZGlmZi12YWNjaW5lLXBoYXNlLTMvNDM0OTQ0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Teva wraps up Cipro pay-for-delay suit inherited with Barr buy,2017-01-27 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RldmEtd3JhcHMtdXAtY2lwcm8tYW50aXRydXN0LXN1aXQtc2V0dGxlbWVudC1hZ3JlZW1lbnTSAQA?hl=en-US&gl=US&ceid=US%3Aen
JPM: Illumina shares surge on new gene sequencing tech,2017-01-11 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvanBtLWlsbHVtaW5hLWdlbmUtc2VxdWVuY2luZy1Ob3ZvU2VxLzQzMzgwNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Cytori hooks Azaya, acquires delivery platform",2017-01-20 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY3l0b3JpLWhvb2tzLWF6YXlhLWFjcXVpcmVzLWRlbGl2ZXJ5LXBsYXRmb3JtLzQzNDQyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Regeneron CEO: Amgen's disruptive Praluent-blocking patent move ...,2017-01-10 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JlZ2VuZXJvbi1jZW8tYW1nZW4tcy1wcmFsdWVudC1ibG9ja2luZy1tb3ZlLWlzbi10LXBhdGllbnRzLWludGVyZXN00gEA?hl=en-US&gl=US&ceid=US%3Aen
Health IT startups working to secure pharma supply chains?,2017-01-03 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDEvZHJ1Zy1zdXBwbHktY2hhaW4tc2VjdXJpdHktYW5kLXRlY2hub2xvZ3kv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Alexion admits employees were pressured to boost sales of key drug,2017-01-05 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS9waGFybWFsb3QvMjAxNy8wMS8wNS9hbGV4aW9uLXNvbGlyaXMtYWNjb3VudGluZy1zY2FuZGFsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Trial failure deals harsh blow to Alcobra,2017-01-17 00:00:00,https://news.google.com/./articles/CBMiQmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxjb2JyYS1hZGhkLXRyaWFsLWZhaWwvNDM0MTYyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Jet-setting CAR-Ts: Kite details commercialization plans at #JPM17,2017-01-12 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDEvamV0LXNldHRpbmctY2FyLXRzLWtpdGUtZGV0YWlscy1jb21tZXJjaWFsaXphdGlvbi1wbGFucy1qcG0xNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Biotech IPOs off to better start in 2017,2017-02-03 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvSVBPLW1hcmtldC0yMDE3LWJpb3RlY2gtc3RvY2svNDM1Mzc4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Gilead snaps up Sarepta's priority review voucher for $125M,2017-02-21 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2FyZXB0YS1wcmlvcml0eS1yZXZpZXctdm91Y2hlci1naWxlYWQtc2FsZS0xMjUvNDM2NTcyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Perrigo restructures board in deal with activist investor,2017-02-07 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGVycmlnby1yZXN0cnVjdHVyZXMtYm9hcmQtaW4tZGVhbC13aXRoLWFjdGl2aXN0LWludmVzdG9yLzQzNTY1Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi sells off OTC products to Ipsen,2017-02-14 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaXBzZW4tc2Fub2ZpLWRpdmVzdC1jb25zdW1lci1oZWFsdGhjYXJlLXNhbGUvNDM2MTM2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Baxalta pushes Shire to record revenues,2017-02-16 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmF4YWx0YS1wdXNoZXMtc2hpcmUtdG8tcmVjb3JkLXJldmVudWVzLzQzNjM3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
EMA reviews Actelion PAH drug after patient deaths,2017-02-15 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW1hLXJldmlld3MtYWN0ZWxpb24tcGFoLWRydWctYWZ0ZXItcGF0aWVudC1kZWF0aHMvNDM2MjI2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Merck unveils new Keytruda DTC ad,2017-02-01 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stdW52ZWlscy1uZXcta2V5dHJ1ZGEtZHRjLWFkLzQzNTI3MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer, Celltrion pushing for interchangeability with Inflectra",2017-02-22 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5mbGVjdHJhLXJlbWljYWRlLWludGVyY2hhbmdlYWJsZS1QZml6ZXItSk5KLXJlc3VsdHMvNDM2NjgxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Cytokinetics pulls in Royalty Pharma to secure $100M,2017-02-02 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY3l0b2tpbmV0aWNzLXB1bGxzLWluLXJveWFsdHktcGhhcm1hLXRvLXNlY3VyZS0xMDBtLzQzNTM1NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Why drug pricing seems so complicated,2017-02-27 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2h5LWRydWctcHJpY2luZy1zZWVtcy1zby1jb21wbGljYXRlZC80MzY4MDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Biomarkers: What you need to know,2017-02-15 00:00:00,https://news.google.com/./articles/CBMiRmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvbWFya2Vycy1kcnVnLWRldmVsb3BtZW50LzQzNjI3NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
5 trends being impacted by biomarkers,2017-02-13 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvbWFya2Vycy10cmVuZHMtcHJlY2lzaW9uLW1lZGljaW5lLWRpYWdub3N0aWNzLzQzNTk1Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Aveo's tivozanib finally moving forward after 4-year delay,2017-02-24 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXZlb3MtdGl2b3phbmliLWZpbmFsbHktbW92aW5nLWZvcndhcmQtYWZ0ZXItNC15ZWFyLWRlbGF5LzQzNjg2MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer plant hit with warning letter has history of FDA problems,2017-02-22 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9wZml6ZXItcGxhbnQtaGl0LXdhcm5pbmctbGV0dGVyLWhhcy1oaXN0b3J5LWZkYS1wcm9ibGVtc9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca's latest Kondo-izing move: A $250M-plus deal for ...,2017-02-21 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2FzdHJhemVuZWNhLXMtbGF0ZXN0LWtvbmRvLWl6aW5nLW1vdmUtYS0yNTBtLXBsdXMtZGVhbC1mb3ItY2FuY2VyLW1lZC16b2xhZGV40gEA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer's Xeljanz falls short in match-up with Humira,2017-02-17 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVycy14ZWxqYW56LWZhbGxzLXNob3J0LWluLW1hdGNoLXVwLXdpdGgtaHVtaXJhLzQzNjQ3NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Liquid biopsies: The next frontier in cancer?,2017-02-13 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlxdWlkLWJpb3BzeS1jYW5jZXItc2NyZWVuaW5nLWJsb29kLXRlc3QvNDM1ODg2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Teva CEO stands down during troubled times,2017-02-06 00:00:00,https://news.google.com/./articles/CBMiP2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDIvdGV2YS1jZW8tc3RhbmRzLXRyb3VibGVkLXRpbWVzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
5 companies mixing medicine and marijuana,2017-02-06 00:00:00,https://news.google.com/./articles/CBMiQmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDIvZml2ZS1jb21wYW5pZXMtbWVkaWNpbmUtbWFyaWp1YW5hL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Nine months of rheumatoid arthritis suppression with one stem cell ...,2017-02-17 00:00:00,https://news.google.com/./articles/CBMiQ2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDIvOS1tb250aHMtcmEtc3VwcHJlc3Npb24tc3RlbS1jZWxscy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Takeda teams up with venture firm on drug discovery unit,2017-03-16 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGFrZWRhLWpvaW50LXZlbnR1cmUtc2NvaGlhLXBoYXJtYS1yZXN0cnVjdHVyaW5nLzQzODI3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"'1984' Isn't Coming True In Real Life, Right?",2017-03-11 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy8xOTg0LWlzbnQtY29taW5nLXRydWUtcmVhbC0xNDQ3MzM1MzYuaHRtbNIBUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzLzE5ODQtaXNudC1jb21pbmctdHJ1ZS1yZWFsLTE0NDczMzUzNi5odG1s?hl=en-US&gl=US&ceid=US%3Aen
Daré hoping to turn Cerulean from blue to black,2017-03-21 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGFyZS1ob3BpbmctdG8tdHVybi1jZXJ1bGVhbi1mcm9tLWJsdWUtdG8tYmxhY2svNDM4NTg2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Depomed appoints new CEO, board members at activist investor's ...",2017-03-29 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGVwb21lZC1zdGFyYm9hcmQtYWN0aXZpc3QtaW52ZXN0b3ItY2VvLzQzOTI2Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Alexion taps ex-Baxalta chief as new CEO,2017-03-27 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi1uZXctY2VvLWx1ZHdpZy1oYW50c29uLXNvbGlyaXMvNDM5MDM4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Novartis locks up Kisqali approval, eyes Pfizer's lead",2017-03-13 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtbG9ja3MtdXAta2lzcWFsaS1hcHByb3ZhbC1leWVzLXBmaXplcnMtbGVhZC80Mzc5ODIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
JAMA confirms DTC drove 'Low-T' craze,2017-03-23 00:00:00,https://news.google.com/./articles/CBMiRGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamFtYS1kdGMtdGVzdG9zdGVyb25lLWFkcy80Mzg3ODYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
20000 leagues for biotech to explore,2017-03-27 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvMjAwMDAtbGVhZ3Vlcy1mb3ItYmlvdGVjaC10by1leHBsb3JlLzQzODk1NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Trial restart approval brings back DMD hope for Akashi,2017-03-23 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdHJpYWwtcmVzdGFydC1hcHByb3ZhbC1icmluZ3MtYmFjay1kbWQtaG9wZS1mb3ItYWthc2hpLzQzODc0Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
$5B in Humira sales at stake with Amgen EU approval,2017-03-24 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvNWItaW4taHVtaXJhLXNhbGVzLWF0LXN0YWtlLXdpdGgtYW1nZW4tZXUtYXBwcm92YWwvNDM4ODc1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Prescribed Reading: More backlash to drug pricing,2017-03-10 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHJlc2NyaWJlZC1yZWFkaW5nLW1vcmUtYmFja2xhc2gtdG8tZHJ1Zy1wcmljaW5nLzQzNzg3NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"5 biotech CEOs on payers, investors and big bets",2017-03-09 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvNS1iaW90ZWNoLWNlb3Mtb24tcGF5ZXJzLWludmVzdG9ycy1hbmQtYmlnLWJldHMvNDM3NzcxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Phase 3 win moves Lilly's breast cancer drug closer to market,2017-03-20 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhc2UtMy13aW4tbW92ZXMtbGlsbHlzLWJyZWFzdC1jYW5jZXItZHJ1Zy1jbG9zZXItdG8tbWFya2V0LzQzODQ3Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Seres rekindles once-failed microbiome study,2017-03-17 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2VyZXMtcmVraW5kbGVzLW9uY2UtZmFpbGVkLW1pY3JvYmlvbWUtc3R1ZHkvNDM4MzY2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"AstraZeneca, Sanofi partner on infant respiratory drug",2017-03-03 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvU2Fub2ZpLUFzdHJhemVuZWNhLW1lZGltbXVuZS1wYXN0ZXVyLXJlc3BpcmF0b3J5LWRlYWwvNDM3MzgxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA gives go-ahead to Lexicon's rare disease drug,2017-03-01 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGV4aWNvbnMtcmFyZS1kaXNlYXNlLWZkYS1hcHByb3ZhbC80MzcxNzkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Investors have high expectations for cannabinoids,2017-03-13 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2FubmFiaW5vaWQtbWFya2V0LXBoYXJtYS1mZGEtaW52ZXN0b3IvNDM3ODA3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Sanofi to be a leader in MS, but not yet",2017-03-21 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLWxlYWRlci1tdWx0aXBsZS1zY2xlcm9zaXMvNDM4NTkxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Immunomedics and VenBio battle goes on,2017-03-03 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW1tdW5vbWVkaWNzLWFuZC12ZW5iaW8tYmF0dGxlLWdvZXMtb24vNDM3MzU0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor",2017-03-23 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLW1lcmNrLWtnYWEtYXZlbHVtYWItZmRhLWFwcHJvdmFsLzQzODgyMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Ex-Valeant skipper Pearson claims he's owed $30M-plus in unpaid ...,2017-03-28 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Zvcm1lci12YWxlYW50LXNraXBwZXItcGVhcnNvbi1zdWVzLW92ZXItd2l0aGhlbGQtc3RvY2stYXdhcmQtY29uc3VsdGluZy1mZWVz0gEA?hl=en-US&gl=US&ceid=US%3Aen
Biogen staves off patent challenge to blockbuster MS drug,2017-03-22 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2VuLXBhdGVudC1jaGFsbGVuZ2UtYmxvY2tidXN0ZXItdGVjZmlkZXJhLzQzODY5MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
NEJM: Lyrica ineffective in sciatica,2017-03-24 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3R1ZHktbHlyaWNhLWluZWZmZWN0aXZlLXNjaWF0aWNhLXByZWdhYmFsaW4tdHJpYWwvNDM4ODczL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Merck faces growing legal headache over Zostavax: report,2017-03-15 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stc2hpbmdlcy12YWNjaW5lLWxhd3N1aXRzLXpvc3RhdmF4LzQzODEyNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Did Amgen's Repatha cut CV risks enough to make it cost-effective ...,2017-03-17 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLXBsb3RzLW5ldy1wYXllci1hc3NhdWx0LWFmdGVyLXJlcGF0aGEtc2xhc2hlcy1oZWFydC1hdHRhY2stcmlza3MtYnktMjfSAQA?hl=en-US&gl=US&ceid=US%3Aen
Optimizing clinical trials: What you need to know,2017-03-16 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb3B0aW1pemluZy1jbGluaWNhbC10cmlhbHMtd2hhdC15b3UtbmVlZC10by1rbm93LzQzNzUwMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
CARB-X dishes out $48M in grants to antimicrobial startups,2017-03-30 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDMvY2FyYi14LTQ4bS1ncmFudHMtYW50aW1pY3JvYmlhbC1zdGFydHVwcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"In dash to NASH, Immuron targets the gut not the liver",2017-03-28 00:00:00,https://news.google.com/./articles/CBMiQWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDMvZGFzaC10by1uYXNoLWltbXVyb24tdGFyZ2V0cy1ndXQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
RedHill acquires rights to medical food from Entera Health,2017-04-05 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvUmVkSGlsbC1FbnRlcmEtZGVhbC1tZWRpY2FsLWZvb2QvNDM5ODE3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
OncoMed hit with another mid-stage failure,2017-04-17 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb25jb21lZC1oaXQtd2l0aC1hbm90aGVyLW1pZC1zdGFnZS1mYWlsdXJlLzQ0MDU3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi missed out on EpiPen and it's not happy,2017-04-26 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXlsYW4ta2FsZW8tc2Fub2ZpLWF1dmlxLWVwaXBlbi1sYXdzdWl0LzQ0MTMyNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Corbus pushes toward Phase 3 after positive meeting with FDA,2017-04-05 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY29yYnVzLXB1c2hlcy10b3dhcmQtcGhhc2UtMy1hZnRlci1wb3NpdGl2ZS1tZWV0aW5nLXdpdGgtZmRhLzQzOTc5OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
CytRx set to file cancer drug NDA,2017-04-19 00:00:00,https://news.google.com/./articles/CBMiRmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvQ3l0UngtTkRBLUZEQS1hbGRveG9ydWJpY2luLzQ0MDc5Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Study shows FDA speedier than EU counterpart in reviewing drugs,2017-04-07 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWVtYS1kcnVnLXJldmlldy1jb21wYXJpc29uLWZhc3Rlci1zdHVkeS80Mzk5OTMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Former Dendreon CEO debuts new public company in reverse merger,2017-04-19 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxwaW5lLWltbXVuZS1uaXZhbGlzLW1lcmdlci1taXRjaC1nb2xkLzQ0MDYxMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Prescribed Reading: Rough start for pharma, but optimism abounds",2017-04-28 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHJlc2NyaWJlZC1yZWFkaW5nLWVhcm5pbmdzLWNlbGdlbmUtc2Fub2ZpLW15bGFuLWFzbGFuLUdvdHRsaWViLzQ0MTUzOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Amgen optimistic despite sales saying otherwise,2017-04-27 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tZW5icmVsLWRlY2xpbmUtcXVhcnRlci1lYXJuaW5ncy1yZXBhdGhhLzQ0MTQwNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Alexion's earnings signal a turnaround, but how will that pan out?",2017-04-28 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi1yZXZlbnVlcy10dXJuYXJvdW5kLXNvbGlyaXMtcmFyZS1kaXNlYXNlLzQ0MTU1Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Lonza cites issues at MD plant for 'softer' Q1 performance,2017-04-27 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbG9uemEtd2FybmluZy1sZXR0ZXItYmlvc2NpZW5jZS1tYXJ5bGFuZC80NDE0NTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Stada backs $5.6 billion takeover offer from Bain, Cinven",2017-04-11 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3RhZGEtdGFrZW92ZXItYmFpbi1jaW52ZW4tYWN0aXZpc3QtaW52ZXN0b3IvNDQwMjE5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Cel-Sci withdraws 2016 study protocol amendment,2017-04-25 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsLXNjaS13aXRoZHJhd3MtMjAxNi1zdHVkeS1wcm90b2NvbC1hbWVuZG1lbnQvNDQxMTU2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Biogen, Roche ink deals with Bristol for rare disease drugs",2017-04-13 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpc3RvbC1yb2NoZS1iaW9nZW4tbGljZW5zaW5nLWRlYWxzLWFsemhlaW1lcnMvNDQwNDY0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Scott Gottlieb commits to defend FDA's 'gold standard' for drug reviews,2017-04-05 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2NvdHQtZ290dGxpZWItY29tbWl0cy10by1kZWZlbmQtZmRhcy1nb2xkLXN0YW5kYXJkLWZvci1kcnVnLXJldmlld3MvNDM5ODI1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Mallinckrodt to settle oxycodone diversion case for $35M with ...,2017-04-03 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbGVnYWwvbWFsbGluY2tyb2R0LXNldC10by1zZXR0bGUtb3h5Y29kb25lLWRpdmVyc2lvbi1jYXNlLWRvai13YXNoaW5ndG9uLXBvc3TSAQA?hl=en-US&gl=US&ceid=US%3Aen
Rebiotix gut bug knocks out C. diff. in PUNCH study,2017-04-12 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmViaW90aXgtZ3V0LWJ1Zy1rbm9ja3Mtb3V0LWMtZGlmZi1pbi1wdW5jaC1zdHVkeS80NDAzMTMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"The March for Science: politics, puns, and plenty of numbers",2017-04-23 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDQvbWFyY2gtZm9yLXNjaWVuY2UtcG9saXRpY3MtcHVucy1udW1iZXJzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"InVentiv Health, INC Research merger creates top 3 CRO",2017-05-11 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW52ZW50aXYtaGVhbHRoLWluYy1tZXJnZXItY3JvLW1hbnVmYWN0dXJpbmcvNDQyNTUwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Thermo Fisher to buy Patheon in $7.2B deal, accelerating CDMO ...",2017-05-18 00:00:00,https://news.google.com/./articles/CBMic2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGhlcm1vLWZpc2hlci10by1idXktcGF0aGVvbi1pbi03MmItZGVhbC1hY2NlbGVyYXRpbmctY2Rtby1jb25zb2xpZGF0aW9uLzQ0MzA2Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Express Scripts, GoodRx roll out cost savings program",2017-05-08 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXhwcmVzcy1zY3JpcHRzLWdvb2RyeC1yb2xsLW91dC1jb3N0LXNhdmluZ3MtcHJvZ3JhbS80NDIxOTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Horizon dives into eye treatments with River Visions acquisition,2017-05-12 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaG9yaXpvbi1yaXZlci12aXNpb25zLWFjcXVpc2l0aW9uLWV5ZS1yYXJlLzQ0MjY0NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis pushes further into pain with Durect deal,2017-05-08 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtcHVzaGVzLWZ1cnRoZXItaW50by1wYWluLXdpdGgtZHVyZWN0LWRlYWwvNDQyMTc1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Novartis cutting up to 500 jobs, but adding 350 more in high-tech ...",2017-05-19 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtam9iLWN1dHMtNTAwLXN3aXR6ZXJsYW5kLWJpb2xvZ2ljcy80NDMxMTkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novartis axing 250 US positions in data operations move,2017-05-25 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtYXhpbmctMjUwLXVzLXBvc2l0aW9ucy1pbi1kYXRhLW9wZXJhdGlvbnMtbW92ZS80NDM1ODQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Consolidation in the CRO space a plus for biopharma,2017-05-24 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY3JvLWNkbW8tY29uc29saWRhdGlvbi1jb250cmFjdC1zZXJ2aWNlcy1waGFybWEtYmlvdGVjaC80NDM0OTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Scynexis stock slumps as clinical hold continues,2017-05-10 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2N5bmV4aXMtc3RvY2stY2xpbmljYWwtaG9sZC1mZGEtbWVldGluZy80NDIzNzIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Merck sees Keytruda gains, offsetting generic hits to sales",2017-05-02 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2sta2V5dHJ1ZGEtbHVuZy1jYW5jZXItZWFybmluZ3MtZmlyc3QtcXVhcnRlci80NDE3NjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
EMA recommends 11 drugs for approval in May meeting,2017-05-22 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2htcC1wb3NpdGl2ZS1vcGluaW9uLXp5a2FkaWEtYnJvZGFsdW1hYi80NDMyNjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
PTC to launch DMD drug with still-high price tag,2017-05-09 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHRjLXRvLWxhdW5jaC1kbWQtZHJ1Zy13aXRoLXN0aWxsLWhpZ2gtcHJpY2UtdGFnLzQ0MjI4Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Weak Xtandi sales spur questions on Pfizer's $14B Medivation ...,2017-05-03 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXh0YW5kaS1zbG93LXNhbGVzLXBhdGllbnQtYXNzaXN0YW5jZS80NDE4OTMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer making progress on Hospira manufacturing issues, execs say",2017-05-04 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLWhvc3BpcmEtbWFudWZhY3R1cmluZy1wcm9ncmVzcy80NDE5OTkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
J&J claims higher R&D productivity than peers,2017-05-17 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotY2xhaW1zLWhpZ2hlci1yZC1wcm9kdWN0aXZpdHktdGhhbi1wZWVycy80NDI5NDcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Safety signal derails expected approval of Amgen bone drug,2017-05-22 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tcm9tb3N1enVtYWItc2FmZXR5LXNpZ25hbC1kZXJhaWwtYXBwcm92YWwtcmFkaXVzLzQ0MzI0OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Vertex bumps sales guidance on new Kalydeco approval,2017-05-18 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LWtheWxkZWNvLWFwcHJvdmFsLW11dGF0aW9uLWluY3JlYXNlLWd1aWRhbmNlLzQ0MzAxNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA casts doubts on Intra-Cellular safety data,2017-05-02 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWNhc3RzLWRvdWJ0cy1vbi1pbnRyYS1jZWxsdWxhci1zYWZldHktZGF0YS80NDE3NjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Regulators order AB Science to halt trial work on PhIII ALS drug ...,2017-05-12 00:00:00,https://news.google.com/./articles/CBMimQFodHRwczovL2VuZHB0cy5jb20vcmVndWxhdG9ycy1vcmRlci1hYi1zY2llbmNlLXRvLWhhbHQtdHJpYWwtd29yay1vbi1waC1paWktYWxzLWRydWctZGVtYW5kaW5nLXByb29mLWl0cy1sb25nLXJ1bm5pbmctY2xpbmljYWwtcHJvYmxlbXMtaGF2ZS1iZWVuLXNvbHZlZC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis wins US approval of Rydapt for rare type of AML,2017-05-01 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtZmRhLWFwcHJvdmFsLXJ5ZGFwdC1BTUwvNDQxNjQ0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Kite discloses patient death in CAR-T trial, sparking safety worries",2017-05-08 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2l0ZS1wYXRpZW50LWRlYXRoLWNlcmVicmFsLWVkZW1hLWNhci10LzQ0MjE5My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Shire commits up to $535M for Parion's dry eye drug,2017-05-01 00:00:00,https://news.google.com/./articles/CBMiRGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2hpcmUtcGFyaW9uLWRyeS1leWUtZGVhbC80NDE2ODIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Overcoming delay, Sanofi, Regeneron win US approval for RA drug",2017-05-23 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2V2emFyYS1zYXJpbHVtYWItZmRhLWFwcHJvdmFsLXNhbm9maS1yZWdlbmVyb24vNDQzMzA4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Ge Li melds WuXi VC with Frontline, creating an $800M trans-Pacific ...",2017-05-30 00:00:00,https://news.google.com/./articles/CBMifGh0dHBzOi8vZW5kcHRzLmNvbS9nZS1saS1tZWxkcy13dXhpLXZjLXdpdGgtZnJvbnRsaW5lLWNyZWF0aW5nLWFuLTgwMG0tdHJhbnMtcGFjaWZpYy1iaW90ZWNoLWZ1bmQtbm93LWh1bnRpbmctZnJlc2gtY2FwaXRhbC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
New partnership will advance novel platform for I/O,2017-05-10 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmV3LXBhcnRuZXJzaGlwLXdpbGwtYWR2YW5jZS1ub3ZlbC1wbGF0Zm9ybS1mb3ItaW8vNDQyNDAwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Court reaffirms Tecfidera decision in Biogen's favor,2017-05-17 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY291cnQtcmVhZmZpcm1zLXRlY2ZpZGVyYS1kZWNpc2lvbi1pbi1iaW9nZW5zLWZhdm9yLzQ0MjkyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Patient centricity is important, but customer centricity is imperative",2017-05-18 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3BhdGllbnQtY2VudHJpY2l0eS1pcy1pbXBvcnRhbnQtYnV0LWN1c3RvbWVyLWNlbnRyaWNpdHktaXMtaW1wZXJhdGl2ZS80NDE5MDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amgen puts Repatha outcomes data to work in refund deal with ...,2017-05-03 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLWlua3MtcmVwYXRoYS1yZWZ1bmQtYXJyYW5nZW1lbnQtaGFydmFyZC1waWxncmlt0gEA?hl=en-US&gl=US&ceid=US%3Aen
Merck snags access to alternative Alzheimer's approach,2017-05-26 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stc25hZ3MtYWNjZXNzLXRvLWFsdGVybmF0aXZlLWFsemhlaW1lcnMtYXBwcm9hY2gvNDQzNjQwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
GSK invests $139M to boost lupus drug production,2017-05-04 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2xheG9zbWl0aGtsaW5lLWJlbmx5c3RhLW1hbnVmYWN0dXJpbmctZXhwYW5zaW9uLTEzOS1taWxsaW9uLzQ0MTk3My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Revenues surge for Incyte, but baricitinib rejection clouds future",2017-05-05 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5jeXRlLWVhcm5pbmdzLWJhcmljaXRpbmliLWZkYS1yZWplY3Rpb24tZ3VpZGFuY2UvNDQyMDY0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA clears new ALS drug for US market,2017-05-08 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmFkaWNhdmEtYWxzLW1pdHN1YmlzaGktdGFuYWJlLWZkYS1hcHByb3ZhbC80NDIxNzcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Feds descend on Perrigo offices with search warrants,2017-05-03 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbGVnYWwvZmVkcy1zaG93LXVwLWF0LXBlcnJpZ28tb2ZmaWNlcy1zZWFyY2gtd2FycmFudHPSAQA?hl=en-US&gl=US&ceid=US%3Aen
Medeor gets FDA go-ahead for Phase 3,2017-05-01 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVkZW9yLWdldHMtZmRhLWdvLWFoZWFkLWZvci1waGFzZS0zLzQ0MTYxNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Roche looks into PML report for Ocrevus patient,2017-05-25 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtcG1sLW9jcmV2dXMtbXVsdGlwbGUtc2NsZXJvc2lzLzQ0MzU2OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Roche's Tecentriq fails trial, raising questions about approval",2017-05-10 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGVzLXRlY2VudHJpcS1ibGFkZGVyLWNhbmNlci1mYWlsdXJlLzQ0MjQyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Steri-Pharma expanding antibiotics plant in New York,2017-05-18 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9zdGVyaS1waGFybWEtZXhwYW5kaW5nLWFudGliaW90aWNzLXBsYW50LW5ldy15b3Jr0gEA?hl=en-US&gl=US&ceid=US%3Aen
China's latest Western-style FDA tweak puts orphan drug approvals ...,2017-05-15 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvY2hpbmEtcy1mZGEtYWRvcHRzLXVzLXN0eWxlLXNwZWVkLXVwLWZvci1saWZlc2F2aW5nLWRydWctYXBwcm92YWxz0gEA?hl=en-US&gl=US&ceid=US%3Aen
Julphar Saudi Arabia opens 75000-square-meter plant in Saudi ...,2017-05-02 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9qdWxwaGFyLXNhdWRpLWFyYWJpYS1vcGVucy03NS0wMDAtc3F1YXJlLW1ldGVyLXBsYW50LXNhdWRpLWFyYWJpYdIBAA?hl=en-US&gl=US&ceid=US%3Aen
Larger-than-life biotech figure Henri Termeer dies at 71,2017-05-14 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDUvYmlvdGVjaC1maWd1cmUtaGVucmktdGVybWVlci1kaWVzLWF0LTcxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AMRI scooped up in $920M deal as contract manufacturing M&A ...,2017-06-06 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9jZG1vLWFtcmktc2Nvb3BlZC11cC05MjBtLWRlYWwtYnktcHJpdmF0ZS1lcXVpdHktZ3JvdXBz0gEA?hl=en-US&gl=US&ceid=US%3Aen
CDMO Particle Sciences making leap from clinical to commercial ...,2017-06-14 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9jZG1vLXBhcnRpY2xlcy1zY2llbmNlcy1tYWtpbmctbGVhcC1mcm9tLWNsaW5pY2FsLXRvLWNvbW1lcmNpYWwtcHJvZHVjdGlvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen
Building A Biotech Rebound,2017-06-05 00:00:00,https://news.google.com/./articles/CBMiQmh0dHBzOi8vYnVzaW5lc3NmYWNpbGl0aWVzLmNvbS8yMDE3LzA2L2J1aWxkaW5nLWEtYmlvdGVjaC1yZWJvdW5kL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AMRI valued at $930M in takeout offer,2017-06-08 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1yaS12YWx1ZWQtYXQtOTMwbS1pbi10YWtlb3V0LW9mZmVyLzQ0NDU4OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Regulus reports a trio of pipeline setbacks,2017-06-12 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVndWx1cy1wcm9ncmFtLXRlcm1pbmF0ZS1lbmQtbGVhZC1hc3RyYXplbmVjYS80NDQ3ODUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Hospira recalls add to drug shortages,2017-06-19 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaG9zcGlyYS1wZml6ZXItc2hvcnRhZ2VzLXNhZmV0eS1wcm9ibGVtcy1mZGEvNDQ1MjgzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
EpiPen alternative Symjepi gets FDA OK,2017-06-16 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWRhbWlzLWZkYS1hcHByb3ZhbC1lcGlwZW4tYWx0ZXJuYXRpdmUtc3ltamVwaS80NDUyMTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Sanofi continues biologics push, building on recent approvals",2017-06-15 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLWJpb2xvZ2ljcy1tYW51ZmFjdHVyaW5nLXByb2R1Y3Rpb24tNjAwLW1pbGxpb24vNDQ1MTIxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Celgene-backed CRISPR company emerges with $68M Series A,2017-06-23 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1iYWNrZWQtY3Jpc3ByLWNvbXBhbnktZW1lcmdlcy13aXRoLTY4bS1zZXJpZXMtYS80NDU2OTYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Exelixis clears debt, turning eye to future growth",2017-06-29 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXhlbGV4aXMtcmVwYXltZW50LWRlYnQtZGVlcmZpZWxkLWNhYm9tZXR5eC0vNDQ2MTU0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novartis' CAR-T stacks up to Kite in lymphoma,2017-06-07 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY2FyLXQtanVsaWV0LWx5bXBob21hLWN0bC0wMTkvNDQ0NDQ3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer builds out anti-infective reach with Basilea deal,2017-06-16 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLWJhc2lsZWEtY3Jlc2VtYmEtYW50aWZ1bmdhbC1ldXJvcGUtbWFya2V0aW5nLXJpZ2h0cy80NDUyMDgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
ASCO17: CAR-Ts steal the show,2017-06-06 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmx1ZWJpcmQtbGVnZW5kLWNhci10LWJjbWEtbXVsdGlwbGUtbXllbG9tYS1hc2NvLzQ0NDI3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Clovis soars on strong results for PARP inhibitor,2017-06-19 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2xvdmlzLXJ1Y2FwYXJpYi1wYXJwLWluaGliaXRvci1vdmFyaWFuLWFyaWVsLzQ0NTMwMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Rebates not to blame for rising drug costs, says PBM trade group",2017-06-14 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHJ1Zy1wcmljZS1yZWJhdGUtcGNtYS1yZXBvcnQtcGF5ZXJzLXBoYXJtYS80NDQ5OTgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Coherus cuts staff after FDA red light,2017-06-28 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY29oZXJ1cy1zdGFmZi1sYXlvZmYtcmVzdHJ1Y3R1cmUtYmlvc2ltaWxhci1yZWplY3Rpb24vNDQ2MDgyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Despite setbacks, Portola snags FDA OK for Bevyxxa",2017-06-26 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGVzcGl0ZS1zZXRiYWNrcy1wb3J0b2xhLXNuYWdzLWZkYS1vay1mb3ItYmV2eXh4YS80NDU4MjMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
ASCO17: Roche's Alecensa bests Xalkori in lung study,2017-06-05 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXNjbzE3LXJvY2hlcy1hbGVjZW5zYS1iZXN0cy14YWxrb3JpLWluLWx1bmctc3R1ZHkvNDQ0MTc2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Prescribed Reading: ADA, Mylan, and an executive order?",2017-06-16 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHJlc2NyaWJlZC1yZWFkaW5nLWFkYS1teWxhbi10cnVtcC1leGVjdXRpdmUtb3JkZXIvNDQ1MjA3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novartis scores second biosimilar approval in two weeks,2017-06-28 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtYmlvc2ltaWxhci1lbmJyZWwtZXVyb3BlLWVyZWx6aS1zYW5kb3ovNDQ2MDc2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Humira shows its staying power,2017-06-19 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXhlbGphbnotaHVtaXJhLWhlYWQtdG8taGVhZC1hcnRocml0aXMvNDQ1MzA3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
DOJ paying closer attention to compliance in foreign countries,2017-06-02 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZG9qLXBheWluZy1jbG9zZXItYXR0ZW50aW9uLXRvLWNvbXBsaWFuY2UtaW4tZm9yZWlnbi1jb3VudHJpZXMvNDQ0MDMxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
#BIO2017 Day 2 roundup: A dearth of deals and Hung on Alzheimer's,2017-06-20 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvLWNvbmZlcmVuY2UtZGF5LTItaHVuZy1hbHpoZWltZXJzLW1hLWRlYWxzLzQ0NTQyMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Failure to warn: Hundreds died while taking an arthritis drug, but ...",2017-06-05 00:00:00,https://news.google.com/./articles/CBMiRWh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE3LzA2LzA1L2FjdGVtcmEtcmhldW1hdG9pZC1hcnRocml0aXMtZmRhL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA warning slams drugmaker that made teething tablets containing ...,2017-06-27 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcmVndWxhdG9yeS9mZGEtd2FybmluZy1zbGFtcy1kcnVnbWFrZXItbWFkZS10ZWV0aGluZy10YWJsZXRzLWNvbnRhaW5pbmctYmVsbGFkb25uYdIBAA?hl=en-US&gl=US&ceid=US%3Aen
5 of the best juror excuses in the Martin Shkreli case thus far,2017-06-28 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDYvNS1iZXN0LWp1cm9yLWV4Y3VzZXMtbWFydGluLXNoa3JlbGktY2FzZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Eli Lilly's CEO on the good, the bad… and the beautiful?",2017-06-21 00:00:00,https://news.google.com/./articles/CBMiQmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDYvZWxpLWxpbGx5cy1jZW8tZ29vZC1iYWQtYmVhdXRpZnVsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Mitsubishi Tanabe to acquire NeuroDerm for $1.1B,2017-07-24 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWl0c3ViaXNoaS10YW5hYmUtdG8tYWNxdWlyZS1uZXVyb2Rlcm0tZm9yLTExYi80NDc3MzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Arena pumps out positive results for hypertension drug,2017-07-10 00:00:00,https://news.google.com/./articles/CBMiRmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJlbmEtUEFILXJhbGluZXBhZy1QaGFzZS0yLzQ0NjczMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
PhRMA finally talks drug pricing in new campaign,2017-07-19 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhybWEtZmluYWxseS10YWxrcy1kcnVnLXByaWNpbmctaW4tbmV3LWNhbXBhaWduLzQ0NzQ2Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
GSK looks to exit rare diseases,2017-07-27 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2xheG9zbWl0aGtsaW5lLWdzay1yYXJlLWRpc2Vhc2Utc2VsbC1kaXZlc3Qtc3RyaW12ZWxpcy80NDgwODcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Endo closes plant, cuts hundreds of jobs",2017-07-27 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW5kby1hbGFiYW1hLWZhY2lsaXR5LWNsb3NlLTg3NS1qb2ItbG9zcy80NDgwNTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Generic drug association sues to stop state price-gouging law,2017-07-07 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2VuZXJpYy1hc3NvY2lhdGlvbi1sYXdzdWl0LW1hcnlsYW5kLWRydWctcHJpY2UtbGF3LWFhbS80NDY2MTUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Valeant unloads Obagi in latest sell-off,2017-07-17 00:00:00,https://news.google.com/./articles/CBMiQ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmFsZWFudC1vYmFnaS1zZWxsLWFzc2V0LzQ0NzIzMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Safety issues for Novartis CAR-T therapy main focus of FDA,2017-07-10 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY2FyLXQtZmRhLWFkY29tbS1hZHZpc29yeS1jb21taXR0ZWUtY3RsMDE5LzQ0NjcwNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Quark wins in Phase 2, raising the stakes for RNAi",2017-07-27 00:00:00,https://news.google.com/./articles/CBMiRWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcXVhcmstYWtpLXJlc3VsdHMtcG9zaXRpdmUvNDQ4MDE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Roche drug sales rise on back of Tecentriq, Ocrevus",2017-07-27 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtcTItZWFybmluZ3MtdGVjZW50cmlxLW9jcmV2dXMtbmV3LWRydWctbGF1bmNoZXMvNDQ4MDMyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
A hit and a miss for Daiichi Sankyo's pain drug,2017-07-05 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGFpaWNoaS1zYW5reW8tcGFpbi1kcnVnLXBobi1maWJyb215YWxnaWEtbWl4ZWQtcmVzdWx0cy80NDYzNDcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"After MYSTIC miss, AstraZeneca taps Merck in $8.5B cancer deal",2017-07-27 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtbWVyY2stYmlsbGlvbi1jYW5jZXItZGVhbC1seW5wYXJ6YS1teXN0aWMtbWlzcy80NDc5OTgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novartis upbeat on I/O despite lagging behind competitors,2017-07-18 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtdXBiZWF0LW9uLWlvLWRlc3BpdGUtbGFnZ2luZy1iZWhpbmQtY29tcGV0aXRvcnMvNDQ3MzMzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Abeona set to fly into Phase 3 after FDA chat,2017-07-19 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJlb25hLXNldC10by1mbHktaW50by1waGFzZS0zLWFmdGVyLWZkYS1jaGF0LzQ0NzQyMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J: Remicade holding up better than expected,2017-07-18 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam9obnNvbi1xMi1lYXJuaW5ncy1yZW1pY2FkZS1iaW9zaW1pbGFyLzQ0NzM0NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Sarepta, BioMarin iron out Exondys 51 patent terms",2017-07-18 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2FyZXB0YS1iaW9tYXJpbi1pcm9uLW91dC1leG9uZHlzLTUxLXBhdGVudC10ZXJtcy80NDczNjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Lilly extends patent runway for Cialis,2017-07-13 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktY2lhbGlzLXBhdGVudC1nZW5lcmljLWNvcHljYXQtc2V0dGxlbWVudC0yMDE4LzQ0NzAyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
GSK to ax hundreds of jobs through manufacturing shuffle,2017-07-20 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ3NrLXRvLWF4LWh1bmRyZWRzLW9mLWpvYnMtdGhyb3VnaC1tYW51ZmFjdHVyaW5nLXNodWZmbGUvNDQ3NTYzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Kadmon ROCKing some positive results,2017-07-12 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2FkbW9uLXJvY2tpbmctc29tZS1wb3NpdGl2ZS1yZXN1bHRzLzQ0NjkwNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
MYSTIC flop a major blow to AstraZeneca's I/O hopes,2017-07-27 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtbXlzdGljLWZhaWx1cmUtaW1maW56aS1wZnMtc2V0YmFjay1taXNzLzQ0ODAxMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Konica Minolta buys US genetic test maker in $1B deal,2017-07-07 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva29uaWNhLW1pbm9sdGEtYW1icnktZ2VuZXRpY3MtYWNxdWlzaXRpb24tMS1iaWxsaW9uLWRlYWwvNDQ2NTY3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Endo caves to FDA pressure, removes Opana from market",2017-07-06 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW5kby1vcGFuYS1lci1yZW1vdmUtcHVsbHMtbWFya2V0LWZkYS80NDY1MjMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amgen confident about CGRP market position,2017-07-26 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tY29uZmlkZW50LWFib3V0LWNncnAtbWFya2V0LXBvc2l0aW9uLzQ0NzkwNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi inks immunology deal to expand pipeline,2017-07-20 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLWFibHlueC1pbW11bm9sb2d5LWRlYWwtcGlwZWxpbmUvNDQ3NTQ1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Further support for Opdivo as it beats out Yervoy,2017-07-06 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZnVydGhlci1zdXBwb3J0LWZvci1vcGRpdm8tYXMtaXQtYmVhdHMtb3V0LXllcnZveS80NDY0NTgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
GSK gets go-ahead for new Benlysta formulation,2017-07-26 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2xheG9zbWl0aGtsaW5lLWdzay1iZW5seXN0YS1zdWJjdXRhbmVvdXMtYXBwcm92YWwvNDQ3OTUxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"J&J's Tremfya approved, further crowding IL-inhibitor market",2017-07-14 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam9obnNvbi10cmVtZnlhLWFwcHJvdmFsLUlMLWluaGliaXRvci1tYXJrZXQvNDQ3MTQ5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Drug spending in U.S. tops the world. Translation: No pricing ...,2017-07-24 00:00:00,https://news.google.com/./articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2RydWctc3BlbmRpbmctdS1zLXRvcHMtd29ybGQtcmVwb3J0LXNheXMtdHJhbnNsYXRpb24tcGhhcm1hLXByaWNpbmctaGVhZGFjaGUtbm90LWdvaW5n0gEA?hl=en-US&gl=US&ceid=US%3Aen
"We're not done with chemotherapy, so why not improve it?",2017-07-06 00:00:00,https://news.google.com/./articles/CBMiQGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDcvd2VyZS1ub3QtZG9uZS13aXRoLWNoZW1vdGhlcmFweS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Apellis sets up another phase 3 program for lead drug APL-2,2017-08-25 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYXBlbGxpcy1zZXRzLXVwLWFub3RoZXItcGhhc2UtMy1wcm9ncmFtLWZvci1sZWFkLWRydWctYXBsLTLSAQA?hl=en-US&gl=US&ceid=US%3Aen
CDMO Avara snaps up former Hospira sterile plant from Pfizer,2017-08-10 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9jZG1vLWF2YXJhLXNuYXBzLXVwLWZvcm1lci1ob3NwaXJhLXN0ZXJpbGUtcGxhbnQtZnJvbS1wZml6ZXLSAQA?hl=en-US&gl=US&ceid=US%3Aen
Gilead and GSK are sizing up PAH specialist United Therapeutics ...,2017-08-04 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbS1hL2dpbGVhZC1hbmQtZ3NrLWFyZS1zaXppbmctdXAtcGFoLXNwZWNpYWxpc3QtdW5pdGVkLXRoZXJhcGV1dGljcy1yZXBvcnQtc2F5c9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Alnylam review turns up no clear answers on revusiran deaths,2017-08-10 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxueWxhbS1yZXZ1c2lyYW4taW52ZXN0aWdhdGlvbi1wYXRpZW50LWRlYXRocy1pbWJhbGFuY2UvNDQ5MDY3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Current law and practices related to medical use claim in South Korea,2017-08-08 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9jdXJyZW50LWxhdy1hbmQtcHJhY3RpY2VzLXJlbGF0ZWQtdG8tbWVkaWNhbC11c2UtY2xhaW0taW4ta29yZWHSAQA?hl=en-US&gl=US&ceid=US%3Aen
Valeant says FDA to reclassify troubled Tampa plant,2017-08-17 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmFsZWFudC10YW1wYS1mYWNpbGl0eS1mZGEtdmFpLXJlc29sdmUtc3VibWlzc2lvbi1hZXJpZS80NDk1Nzcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Zynerba shares up in smoke after trial failure,2017-08-07 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvenluZXJiYS1jbGluaWNhbC10cmlhbC1mYWlsdXJlLWNhbm5hYmlub2lkLXNoYXJlcy1kcm9wLzQ0ODc3MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Alexion bolsters Soliris patent defense,2017-08-16 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi1ib2xzdGVycy1zb2xpcmlzLXBhdGVudC1kZWZlbnNlLzQ0OTQ3Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Idhifa approval furthers Celgene's diversification goals,2017-08-01 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1pZGhpZmEtYXBwcm92YWwtYWdpb3MtYW1sLzQ0ODM4MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Adamas Parkinson's drug gains FDA approval,2017-08-25 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWRhbWFzLXBhcmtpbnNvbnMtZHJ1Zy1nYWlucy1mZGEtYXBwcm92YWwvNTAzNTE0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Ultragenyx shelves genetic disease drug after trial failure,2017-08-23 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdWx0cmFnZW55eC1zaGVsdmVzLWdlbmV0aWMtZGlzZWFzZS1kcnVnLWFmdGVyLXRyaWFsLWZhaWx1cmUvNTAzMzE2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
5 Trends influencing drug pricing,2017-08-14 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdHJlbmRzLWRydWctcHJpY2luZy1waGFybWEtcGF5ZXJzLWNvc3QvNDQ4Nzc5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Zynerba burned by second trial failure,2017-08-14 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvenluZXJiYS1zZWNvbmQtdHJpYWwtZmFpbHVyZS1zZWl6dXJlLVpZTjAwMi80NDkyMzUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Melinta grows pipeline through reverse merger with Cempra,2017-08-09 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VtcHJhLW1lbGludGEtbWVyZ2VyLWRlYWwtcGlwZWxpbmUvNDQ4OTY5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Roche sells off dermatitis drug to Dermira,2017-08-08 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGVybWlyYS1yb2NoZS1sZWJyaWtpenVtYWItYXRvcGljLWRlcm1hdGl0aXMtc2VsbC1kaXZlc3QtZGVhbC80NDg4NzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"As Roche wades biosimilar waters, more competitors circle Herceptin",2017-08-02 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvUm9jaGUtaGVyY2VwdGluLWJpb3NpbWlsYXItbXlsYW4tYmlvY29uLzQ0ODQ3Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"In cost debate, Amgen stands by Repatha's value",2017-08-23 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tcmVwYXRoYS1zdHVkeS1wY3NrOS12YWx1ZS1jb3N0LXByaWNlLzUwMzMwMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"PCSK9 inhibitors still too pricey, study finds",2017-08-22 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tcmVwYXRoYS1wY3NrOS1jb3N0LWVmZmVjdGl2ZW5lc3MtamFtYS1zdHVkeS81MDMyMDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Samsung Bioepis partners with Takeda to break into novel biologics,2017-08-21 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Ftc3VuZy1iaW9lcGlzLW5ldy1iaW9sb2dpY3MtdGFrZWRhLXBhcnRuZXJzaGlwLWJpb3NpbWlsYXJzLzUwMzA0OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Esperion hits a homer with new cholesterol data,2017-08-08 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXNwZXJpb24tYmVtcGVkb2ljLWFjaWQtY29tYm8tc3RhdGluLWRhdGEvNDQ4ODc2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novogen irons out Phase 2 plans for brain cancer candidate,2017-08-22 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92b2dlbi1pcm9ucy1vdXQtcGhhc2UtMi1wbGFucy1mb3ItYnJhaW4tY2FuY2VyLWNhbmRpZGF0ZS81MDMyMzcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Cardiome shaken by FDA no-go on heart drug refiling,2017-08-22 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2FyZGlvbWUtc2hha2VuLWJ5LWZkYS1uby1nby1vbi1oZWFydC1kcnVnLXJlZmlsaW5nLzUwMzIxNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"In historic first, FDA approves Novartis CAR-T therapy",2017-08-30 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY2FydC1mZGEtYXBwcm92YWwta3ltcmlhaC1nZW5lLXRoZXJhcHkvNTAzODg4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Lilly speeds up timeline for refiling of baricitinib,2017-08-30 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpLWxpbGx5LWJhcmljaXRpbmliLWVhcmxpZXItcmVzdWJtaXNzaW9uLTIwMTgtZmRhLzUwMzg3Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Troubled Galena swallowed by Sellas,2017-08-09 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2VsbGFzLWdhbGVuYS1yZXZlcnNlLW1lcmdlci1nby1wdWJsaWMvNDQ4OTUwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Puma's early Nerlynx launch raises doubts of a takeover,2017-08-01 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHVtYXMtZWFybHktbmVybHlueC1sYXVuY2gtcmFpc2VzLWRvdWJ0cy1vZi1hLXRha2VvdmVyLzQ0ODM1OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca strikes $400M deal with Takeda for Parkinson's drug,2017-08-29 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtdGFrZWRhLXBhcmtpbm9ucy1leHRlcm5hbGl6YXRpb24tZGVhbC81MDM3NjQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Expanded label boosts AstraZeneca and Merck's Lynparza,2017-08-18 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtbHlucGFyemEtYXBwcm92YWwtYnJvYWRlci1sYWJlbC1tYWludGVuYW5jZS80NDk2NTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Vernalis hit with second CRL this year,2017-08-07 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVybmFsaXMtZmRhLWNybC1jb3VnaC1jb2xkLWRydWctcmVqZWN0ZWQvNDQ4NzM5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Evotec snaps up Aptuit in further CRO consolidation,2017-08-01 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXZvdGVjLXNuYXBzLXVwLWFwdHVpdC1pbi1mdXJ0aGVyLWNyby1jb25zb2xpZGF0aW9uLzQ0ODMyOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Merck CEO resigns from Trump's manufacturing council,2017-08-14 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stY2VvLXJlc2lnbnMtZnJvbS10cnVtcHMtbWFudWZhY3R1cmluZy1jb3VuY2lsLzQ0OTI1My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"MedCo gets FDA OK on antibacterial, boosting sale potential",2017-08-30 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVkaW5jaW5lcy1jb21wYW55LWFudGliYWN0ZXJpYWwtZmRhLWFwcHJvdmFsLzUwMzg4Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
The value of the embedded-CMO model,2017-08-24 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3RoZS12YWx1ZS1vZi10aGUtZW1iZWRkZWQtY21vLW1vZGVsLzQ0NjcyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Otonomy stock crumbles as the company sidelines a key pipeline ...,2017-08-30 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb3Rvbm9teS1zdG9jay1kcnVnLWZhaWx1cmUtc3VzcGVuZC81MDM4OTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
J&J deal gives Cerecor much-needed cash infusion,2017-08-16 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VyZWNvci1jZW8tcmV0aXJlLWpvaG5zb24tam9obnNvbi1kZWFsLXNhbGUvNDQ5NDY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Bristol-Myers, Pfizer continue to build case for Eliquis",2017-08-28 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpcXVpcy1lbWFuYXRlLWJyaXN0b2wtbXllcnMtcGZpemVyLWNhcmRpb3ZlcnNpb24tYWZpYi81MDM2NzMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca taps Ethris in RNA deal,2017-08-22 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtdGFwcy1ldGhyaXMtaW4tcm5hLWRlYWwvNTAzMTc4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Galapagos' new data is good, but how much weight does it carry?",2017-08-10 00:00:00,https://news.google.com/./articles/CBMiRWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2FsYXBhZ29zLWlwZi1waGFzZS0yLWRhdGEvNDQ5MDc4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer still mum on BD, frustrated by biosimilar market",2017-08-01 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLWVhcm5pbmdzLXEyLWJpb3NpbWlsYXJzLWJ1c2luZXNzLWRldmVsb3BtZW50LW1hLzQ0ODM1MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Ardelyx cuts 28% of staff in pipeline shake-up,2017-08-09 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJkZWx5eC1yZXN0cnVjdHVyaW5nLWxheW9mZnMtcGlwZWxpbmUtc2hha2UtdXAvNDQ4OTYxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
ALK readies Odactra launch after Merck exit,2017-08-22 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxrLXJlYWRpZXMtb2RhY3RyYS1sYXVuY2gtYWZ0ZXItbWVyY2stZXhpdC81MDMyMDcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Allergan's Saunders 'cautiously optimistic' on healthcare reform,2017-08-03 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tc2F1bmRlcnMtaGVhbHRoY2FyZS1yZWZvcm0tcHJpY2luZy1XYXNoaW5ndG9uLzQ0ODU2MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Chiesi hands back gene therapy to uniQure,2017-08-01 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2hpZXNpLWhhbmRzLWJhY2stZ2VuZS10aGVyYXB5LXRvLXVuaXF1cmUvNDQ4Mzc5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Location-based marketing drives real-time, real-world engagement ...",2017-08-29 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL2xvY2F0aW9uLWJhc2VkLW1hcmtldGluZy1kcml2ZXMtcmVhbC10aW1lLXJlYWwtd29ybGQtZW5nYWdlbWVudC13aXRoLWhlYWx0LzUwMzQzOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Xoma clears debt with Novartis licensing deal,2017-08-28 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MveG9tYS1jbGVhcnMtZGVidC13aXRoLW5vdmFydGlzLWxpY2Vuc2luZy1kZWFsLzUwMzY2MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Tesaro's Zejula quickly gaining in PARP market,2017-08-10 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGVzYXJvcy16ZWp1bGEtcXVpY2tseS1nYWluaW5nLWluLXBhcnAtbWFya2V0LzQ0OTA1Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Feds pull Mylan, a small-time opioid drugmaker, into industrywide ...",2017-08-10 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbGVnYWwvbXlsYW4tZGlzY2xvc2VzLWRlcGFydG1lbnQtanVzdGljZS1zdWJwb2VuYS1mb3Itb3Bpb2lkLXNhbGVz0gEA?hl=en-US&gl=US&ceid=US%3Aen
"FiercePharmaAsia—Zai Lab's $115M IPO, Takeda-Stanford R&D ...",2017-08-18 00:00:00,https://news.google.com/./articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvZmllcmNlcGhhcm1hYXNpYS16YWktbGFiLXMtMTE1bS1pcG8tdGFrZWRhLXN0YW5mb3JkLXItZC1kZWFsLWNoaW5lc2UtZmlybXMtYmlkcy1mb3LSAQA?hl=en-US&gl=US&ceid=US%3Aen
Stada takeover inches closer,2017-08-22 00:00:00,https://news.google.com/./articles/CBMiR2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3RhZGEtdGFrZW92ZXItaW5jaGVzLWNsb3Nlci81MDMxOTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Dermatology faces big changes, but pharma can help ease ...",2017-08-03 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2Rlcm1hdG9sb2d5LWZhY2VzLWJpZy1jaGFuZ2VzLWJ1dC1waGFybWEtY2FuLWhlbHAtZWFzZS10cmFuc2l0aW9uLXNheXMtYWdlbmN50gEA?hl=en-US&gl=US&ceid=US%3Aen
Jazz nabs early FDA nod for AML med Vyxeos. Is diversifying M&A ...,2017-08-03 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2phenotbmFicy1lYXJseS1mZGEtbm9kLWZvci1hbWwtbWVkLXZ5eGVvcy1kaXZlcnNpZnlpbmctbS1hLW5leHTSAQA?hl=en-US&gl=US&ceid=US%3Aen
How Boston has transformed itself into a powerful digital health ...,2017-08-03 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDgvYm9zdG9uLXRyYW5zZm9ybWVkLXBvd2VyZnVsLWRpZ2l0YWwtaGVhbHRoLWVjb3N5c3RlbS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Alnylam soars on trial win for RNAi drug,2017-09-20 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxueWxhbS1zb2Fycy1hcG9sbG8tdHJpYWwtc3VjY2Vzcy1wYXRpc2lyYW4tcm5haS81MDUzMDgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Alnylam pauses clinical trials of hemophilia drug after patient death,2017-09-07 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxueWxhbS1wYXVzZXMtY2xpbmljYWwtdHJpYWxzLW9mLWhlbW9waGlsaWEtZHJ1Zy1hZnRlci1wYXRpZW50LWRlYXRoLzUwNDQ2Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Intellipharmaceutics receives painful FDA rejection,2017-09-25 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW50ZWxsaXBoYXJtYWNldXRpY3MtZmRhLXJlamVjdGlvbi1yZXhpc3RhLWNybC81MDU3NDQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Acer jumps on 7-year-old data,2017-09-25 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvQWNlci1zdG9jay1jZWxpcHJvbG9sLUVkc2l2by1zdHVkeS81MDU3NjQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Smaller sales forces get the job done in rare disease,2017-09-18 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc21hbGxlci1zYWxlcy1mb3JjZXMtZ2V0LXRoZS1qb2ItZG9uZS1pbi1yYXJlLWRpc2Vhc2UvNTA0ODA5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Amicus drops wound drug after trial miss,2017-09-13 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1pY3VzLXRyaWFsLWZhaWx1cmUtYnV0dGVyZmx5LWRpc2Vhc2UtZXBpZGVybW9seXNpcy1idWxsb3NhLzUwNDgzOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Industry Pulse: 10 charts on M&A, I/O and biosimilar threats",2017-09-01 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5kdXN0cnktcHVsc2UtMTAtY2hhcnRzLW9uLW1hLWlvLWFuZC1iaW9zaW1pbGFyLXRocmVhdHMvNTA0MTE1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Teva teams up with Nuvelution in Tourette,2017-09-20 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS10ZWFtcy11cC13aXRoLW51dmVsdXRpb24taW4tdG91cmV0dGUvNTA1MzI1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Bristol, Roche tap Halozyme for tech platform",2017-09-14 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpc3RvbC1yb2NoZS10YXAtaGFsb3p5bWUtZm9yLXRlY2gtcGxhdGZvcm0vNTA0OTU4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Ultragenyx trying to snag Regenxbio's takeover target,2017-09-18 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdWx0cmFnZW55eC10cnlpbmctdG8tc25hZy1yZWdlbnhiaW9zLXRha2VvdmVyLXRhcmdldC81MDUxNDgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Acorda builds its defense against potential takeover,2017-09-01 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWNvcmRhLWJ1aWxkcy1pdHMtZGVmZW5zZS1hZ2FpbnN0LXBvdGVudGlhbC10YWtlb3Zlci81MDQxMDAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Lilly's abema gets FDA OK, setting it up for blockbuster status",2017-09-29 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHlzLWFiZW1hLWdldHMtZmRhLW9rLXNldHRpbmctaXQtdXAtZm9yLWJsb2NrYnVzdGVyLXN0YXR1cy81MDYxNDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Premium price for Novartis' CAR-T sparks pushback from top PBM,2017-09-25 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2FyLXQtcHJpY2Uta3ltcmlhaC1leHByZXNzLXNjcmlwdHMtbmV3LXBheW1lbnQtbW9kZWwvNTA1NzMyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AmerisourceBergen hands over $260M for a decade of illegal drug ...,2017-09-28 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1lcmlzb3VyY2ViZXJnZW4taGFuZHMtb3Zlci0yNjBtLWZvci1hLWRlY2FkZS1vZi1pbGxlZ2FsLWRydWctbWFudWZhY3R1cmkvNTA2MDU4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca sees first-in-class potential for asthma biologic,2017-09-07 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2Etc2Vlcy1maXJzdC1pbi1jbGFzcy1wb3RlbnRpYWwtZm9yLWFzdGhtYS1iaW9sb2dpYy81MDQ0NTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Janssen drops MacroGenics cancer candidate over safety concerns,2017-09-01 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFjcm9nZW5pY3MtamFuc3Nlbi10ZXJtaW5hdGVzLWRldmVsb3BtZW50LWRlYWwtbWdkMDExLzUwNDA4OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Samsung Bioepis first to secure EMA backing for Herceptin biosimilar,2017-09-15 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Ftc3VuZy1iaW9lcGlzLWZpcnN0LWVtYS1iYWNraW5nLWhlcmNlcHRpbi1iaW9zaW1pbGFyLzUwNTA1Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Pharma tackles the ever-present problem of unmet need,2017-09-27 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhcm1hLXRhY2tsZXMtdGhlLWV2ZXItcHJlc2VudC1wcm9ibGVtLW9mLXVubWV0LW5lZWQvNTA1OTY3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Intarcia loses some of its sparkle with FDA rejection,2017-09-28 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW50YXJjaWEtZmRhLXJlamVjdGlvbi1jcmwtZGlhYmV0ZXMtZGV2aWNlLWNvbWJvLzUwNjAzMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"AbbVie, Amgen reach a deal on Humira biosimilar",2017-09-28 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLWFtZ2VuLXJlYWNoLWEtZGVhbC1vbi1odW1pcmEtYmlvc2ltaWxhci81MDYwNDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Amgen, Allergan win first approval of cancer biosimilar in US",2017-09-14 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tYmlvc2ltaWxhci1hdmFzdGluLXdpbi1mZGEtYXBwcm92YWwtZmlyc3QtY2FuY2VyLXVzLzUwNDk5MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"ESMO: Lilly breast cancer drug keeps pace with Pfizer, Novartis rivals",2017-09-09 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpLWxpbGx5LWFiZW1hY2ljbGliLW1vbmFyY2gtMy1lc21vLXJlc3VsdHMtaWJyYW5jZS1raXNxYWxpLzUwNDU5NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
What you need to know: The evolving pharma sales force,2017-09-26 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2hhdC15b3UtbmVlZC10by1rbm93LXRoZS1ldm9sdmluZy1waGFybWEtc2FsZXMtZm9yY2UvNTA1NzMxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer's Mylotarg gets a second shot at market,2017-09-01 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVycy1teWxvdGFyZy1nZXRzLWEtc2Vjb25kLXNob3QtYXQtbWFya2V0LzUwNDEwOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
EMA backs approval for J&J's Tremfya,2017-09-18 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW1hLWJhY2tzLWFwcHJvdmFsLWZvci1qanMtdHJlbWZ5YS81MDUxMDkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Catalent adds biologics manufacturing with $950M Cook Pharmica ...,2017-09-19 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2F0YWxlbnQtY29vay1waGFybWljYS1kZWFsLWNvbnNvbGlkYXRpb24vNTA1MjMyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Insmed soars on strong results for inhaled antibiotic,2017-09-05 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5zbWVkLXNvYXJzLW9uLXN0cm9uZy1yZXN1bHRzLWZvci1pbmhhbGVkLWFudGliaW90aWMvNTA0MjA0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Lilly cuts 3500 jobs in restructuring,2017-09-07 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktY3V0cy0zNTAwLWpvYnMtaW4tcmVzdHJ1Y3R1cmluZy81MDQ0NzQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
3SBio snaps up Therapure CDMO for $290M,2017-09-05 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvM3NiaW8tc25hcHMtdXAtdGhlcmFwdXJlLWNkbW8tZm9yLTI5MG0vNTA0MTc2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novo Nordisk settles claims related to Victoza marketing,2017-09-06 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by1ub3JkaXNrLXNldHRsZXMtY2xhaW1zLXJlbGF0ZWQtdG8tdmljdG96YS1tYXJrZXRpbmcvNTA0MzQwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Teva lures Lundbeck chief Schultz with $52M package that makes ...,2017-09-12 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RldmEtcG9hY2hlcy1sdW5kYmVjay1jaGllZi1zY2h1bHR6LTUybS1wYWNrYWdl0gEA?hl=en-US&gl=US&ceid=US%3Aen
Aegerion to pay $36M to settle claims it risked safety with Juxtapid ...,2017-09-25 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbGVnYWwvYWVnZXJpb24taW5rcy0zNW0tZGVhbC10by1zZXR0bGUtanV4dGFwaWQtbWlzbWFya2V0aW5nLWNsYWltc9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca's Bydureon falls short in heart study,2017-09-14 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2FzLWJ5ZHVyZW9uLWZhbGxzLXNob3J0LWluLWhlYXJ0LXN0dWR5LzUwNDk4OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Lilly's baricitinib fails to outshine Sanofi's Dupixent,2017-09-14 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHlzLWJhcmljaXRpbmliLXBoYXNlLTItZHVwaXhlbnQtc2Fub2ZpLWF0b3BpYy1kZXJtYXRpdGlzLzUwNDk2MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Arcturus to go public through merger with Alcobra,2017-09-29 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJjdHVydXMtdG8tZ28tcHVibGljLXRocm91Z2gtbWVyZ2VyLXdpdGgtYWxjb2JyYS81MDYwOTgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Allergan hit with FDA refusal to file letter,2017-09-25 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4taGl0LXdpdGgtZmRhLXJlZnVzYWwtdG8tZmlsZS1sZXR0ZXIvNTA1NzI2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
DOJ looking closer at charity named in Aegerion kickback plea deal,2017-09-26 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Rvai1sb29raW5nLWNsb3Nlci1hdC1jaGFyaXR5LW5hbWVkLWFlZ2VyaW9uLWtpY2tiYWNrLXBsZWEtZGVhbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
"Concerned with abuse of orphan drug program, FDA is rethinking ...",2017-09-13 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMDkvY29uY2VybmVkLWFidXNlLW9ycGhhbi1kcnVnLXByb2dyYW0tZmRhLXJldGhpbmtpbmctYXBwcm92ZXMtbWVkaWNhdGlvbnMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Amneal, Impax combine amid generics crunch",2017-10-17 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1uZWFsLWltcGF4LWNvbWJpbmUtYW1pZC1nZW5lcmljcy1jcnVuY2gvNTA3NDY0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
30 Under 40: Young Leaders in Biotech and Pharmaceutical ...,2017-10-09 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vMzAtdW5kZXItNDAtbGVhZGVycy1pbi1iaW90ZWNoLXBoYXJtYS0yMDE3LTEw0gEA?hl=en-US&gl=US&ceid=US%3Aen
An In-Depth Look At Alexion's Competition And Upcoming Catalysts ...,2017-10-10 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQxMTI2NzUtaW4tZGVwdGgtbG9vay1hbGV4aW9ucy1jb21wZXRpdGlvbi1hbmQtdXBjb21pbmctY2F0YWx5c3Rz0gEA?hl=en-US&gl=US&ceid=US%3Aen
Vertex grows CF franchise as combos move forward,2017-10-26 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LWJvb3N0cy1zYWxlcy1mb3JlY2FzdHMtY3lzdGljLWZpYnJvc2lzLWRydWdzLW91dHBlcmZvcm0vNTA4MjI3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
MassBio: Massachusetts edges out California as #1 biotech hub,2017-10-17 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFzc2FjaHVzZXR0cy1iaW9waGFybWEtdmVudHVyZS1jYXBpdGFsLWpvYnMtcmVzZWFyY2gvNTA3NDY2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Scangos' new biotech tackling infectious disease,2017-10-19 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Nhbmdvcy12aXItYWxueWxhbS12aXN0ZXJhLWluZmVjdGlvdXMtZGlzZWFzZS81MDc2OTUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Arcturus expands partnership with J&J into hepatitis B,2017-10-20 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJjdHVydXMtZXhwYW5kLWphbnNzZW4tcGFydG5lcnNoaXAtaGVwYXRpdGlzLWIvNTA3NzY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Arbutus boosted by $116M investment from Roivant,2017-10-02 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJidXR1cy1yb2l2YW50LWludmVzdC0xMTYtbWlsbGlvbi1oZXBhdGl0aXMtYi1sbnAvNTA2MjY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Expanded label opens new market for Alexion's Soliris,2017-10-24 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi1zb2xpcmlzLW15YXN0aGVuaWEtZ3JhdmlzLWZkYS1hcHByb3ZhbC81MDgwNzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Gilead wins US approval for CAR-T cancer therapy,2017-10-18 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2lsZWFkLWNhci10LWFwcHJvdmFsLWtpdGUteWVzY2FydGEtZmRhLzUwNzYyMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Amgen digs deeper in I/O with CytomX deal,2017-10-04 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tY3l0b214LWRlYWwtaW1tdW5vLW9uY29sb2d5LzUwNjQ2Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Biocon manufacturing problems stall another one of its biosimilars,2017-10-12 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvY29uLW15bGFuLWhlcmNlcHRpbi1iaW9zaW1pbGFyLXJlamVjdC1tYW51ZmFjdHVyaW5nLzUwNzE2NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Rigel blood drug hits mark in mid-stage study,2017-10-03 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmlnZWwtYmxvb2QtZHJ1Zy1mb3N0YW1hdGluaWItaGl0cy1tYXJrLXN0dWR5LWFpaGEvNTA2MzU3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Lupin expands US presence with $150M Symbiomix deal,2017-10-11 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbHVwaW4tc3ltYmlvbWl4LWV4cGFuZHMtdXMtYnVzaW5lc3MtZGVhbC81MDcwMjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Merck invests in diabetes through KalVista deal,2017-10-11 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2staW52ZXN0cy1pbi1kaWFiZXRlcy10aHJvdWdoLWthbHZpc3RhLWRlYWwvNTA3MDQyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Flexion secures US approval for osteoarthritis drug,2017-10-09 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmxleGlvbi1vc3Rlb2FydGhyaXRpcy1GREEtYXBwcm92YWwtemlscmV0dGEvNTA2ODEwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"In RARE news, Dimension dumps Regenxbio for better offer",2017-10-03 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW4tcmFyZS1uZXdzLWRpbWVuc2lvbi1kdW1wcy1yZWdlbnhiaW8tZm9yLWJldHRlci1vZmZlci81MDYzNTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Generon moving ahead with Phase 3 trial following SPA,2017-10-11 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2VuZXJvbi1mZGEtcGhhc2UtMy1zcGEtYmluZXV0YS81MDcwNDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Anthem leaves Express Scripts behind to roll out its own PBM,2017-10-18 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW50aGVtLXBibS1leHByZXNzLXNjcmlwdHMtY3ZzLzUwNzYwMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"What keeps pharma execs up at night? Apparently a lot, says new ...",2017-10-06 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2hhdC1rZWVwcy1waGFybWEtZXhlY3MtdXAtYXQtbmlnaHQtYXBwYXJlbnRseS1hLWxvdC1zYXlzLW5ldy1yZXBvcnQvNTA2NzI1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA hands PTC its latest rejection,2017-10-25 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWhhbmRzLXB0Yy1pdHMtbGF0ZXN0LXJlamVjdGlvbi81MDgxNzYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Biopharma, medical M&A activity slows in 2017: report",2017-10-17 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvcGhhcm1hLW1lZGljYWwtbWEtYWN0aXZpdHktc2xvd3MtaW4tMjAxNy1yZXBvcnQvNTA3NDg5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
TG stumbles on FDA feedback for cancer combo,2017-10-17 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGctc3R1bWJsZXMtb24tZmRhLWZlZWRiYWNrLWZvci1jYW5jZXItY29tYm8vNTA3NDMyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Finch, Crestovo merger pushes forward C diff therapeutic",2017-10-24 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmluY2gtY3Jlc3Rvdm8tbWVyZ2VyLXB1c2hlcy1mb3J3YXJkLWMtZGlmZi10aGVyYXBldXRpYy81MDc5OTgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Prescribed Reading: A week of game-changers in pharma,2017-10-13 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHJlc2NyaWJlZC1yZWFkaW5nLVBmaXplci1leHByZXNzLXNjcmlwdHMtbWVyY2stc3BhcmsvNTA3MjQxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie taps Alector for deeper dive into Alzheimer's,2017-10-25 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLXRhcHMtYWxlY3Rvci1mb3ItZGVlcGVyLWRpdmUtaW50by1hbHpoZWltZXJzLzUwODEyOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Lonza snatches Shire facility as biologics manufacturing rakes in ...,2017-10-05 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2hpcmUtbG9uemEtbWFudWZhY3R1cmluZy1mYWNpbGl0eS1kZWFsLW1hbW1hbGlhbi81MDY2MTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Merck slashes sales staff in cost-cutting exercise,2017-10-23 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stc2xhc2hlcy1zYWxlcy1zdGFmZi1pbi1jb3N0LWN1dHRpbmctZXhlcmNpc2UvNTA3ODY5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Teva hit with surprise Copaxone generic, Mylan celebrates",2017-10-04 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS1teWxhbi1jb3BheG9uZS1nZW5lcmljLWFwcHJvdmFsLzUwNjQ2My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J says Puerto Rico plants returning to full operations,2017-10-19 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam9obnNvbi1hbmQtam9obnNvbi1wdWVydG8tcmljby1wbGFudHMtZnVsbC1vcGVyYXRpb25zLWh1cnJpY2FuZS1tYXJpYS81MDc3MDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Trevena cuts workforce 30% to free up cash,2017-10-13 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdHJldmVuYS1jdXRzLXdvcmtmb3JjZS0zMC10by1mcmVlLXVwLWNhc2gvNTA3MjYxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Merck drops hep C programs in 'strategic decision',2017-10-02 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stZHJvcHMtaGVwLWMtcHJvZ3JhbXMtaW4tc3RyYXRlZ2ljLWRlY2lzaW9uLzUwNjI2Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Bayer, J&J pull the plug on large Xarelto study",2017-10-09 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmF5ZXItamotcHVsbC10aGUtcGx1Zy1vbi1sYXJnZS14YXJlbHRvLXN0dWR5LzUwNjgzMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"RedHill reports positive Bekinda data, but investors wary",2017-10-03 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVkaGlsbC1iZWtpbmRhLWRhdGEtc3RvY2stZmFsbC81MDYzNzgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Slow Otezla growth dampens Celgene's long-term prospects,2017-10-26 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2xvdy1vdGV6bGEtZ3Jvd3RoLWRhbXBlbnMtY2VsZ2VuZXMtbG9uZy10ZXJtLXByb3NwZWN0cy81MDgyNDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Prescribed Reading: Disappointing quarters all around,2017-10-27 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHJlc2NyaWJlZC1yZWFkaW5nLWRpc2FwcG9pbnRpbmctcXVhcnRlcnMtYWxsLWFyb3VuZC81MDgzNDcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Mixed results in NASH for Gilead,2017-10-25 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWl4ZWQtcmVzdWx0cy1pbi1uYXNoLWZvci1naWxlYWQvNTA4MTAyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Motif delivers more strong data on its antibiotic,2017-10-05 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbW90aWYtZGVsaXZlcnMtbW9yZS1zdHJvbmctZGF0YS1vbi1pdHMtYW50aWJpb3RpYy81MDY1OTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Biosimilars could save US $150B over next decade,2017-10-24 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvc2ltaWxhcnMtY291bGQtc2F2ZS11cy0xNTBiLW92ZXItbmV4dC1kZWNhZGUvNTA3OTgyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Eisai shows confidence in Biogen's Alzheimer's drug,2017-10-23 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWlzYWktc2hvd3MtY29uZmlkZW5jZS1pbi1iaW9nZW5zLWFsemhlaW1lcnMtZHJ1Zy81MDc4OTkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Express Scripts drops $3.6B for healthcare management company,2017-10-10 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXhwcmVzcy1zY3JpcHRzLWV2aWNvcmUtZGVhbC1hY3F1aXNpdGlvbi81MDY5NTUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"J&J ditches sirukumab, raising questions about immunology",2017-10-17 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam9obnNvbi1zaXJ1a3VtYWItaW1tdW5vbG9neS1lYXJuaW5ncy10YXgtcmVmb3JtLzUwNzQ2MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
UniQure shares jump on trial plans for revamped hemophilia gene ...,2017-10-20 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdW5pcXVyZS1oZW1vcGhpbGlhLWdlbmUtdGhlcmFweS1waXZvdGFsLXN0dWR5LTIwMTgtc2hhcmVzLXN1cmdlLzUwNzc4NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
CETP class shelved as Merck pulls out,2017-10-12 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2V0cC1jbGFzcy1zaGVsdmVkLWFzLW1lcmNrLXB1bGxzLW91dC81MDcxNTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amgen faces conundrum as biosimilars both help and hurt,2017-10-26 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tZmFjZXMtY29udW5kcnVtLWFzLWJpb3NpbWlsYXJzLWJvdGgtaGVscC1hbmQtaHVydC81MDgyMjgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Lilly turns away from animal health, toward diabetes",2017-10-24 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpLWxpbGx5LWRpYWJldGVzLWh1bWFsb2ctZWxhbmNvLWFuaW1hbC1oZWFsdGgvNTA3OTkzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Six factors shaping healthcare in emerging markets | pharmaphorum,2017-10-10 00:00:00,https://news.google.com/./articles/CBMiR2h0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS92aWV3cy1hbmQtYW5hbHlzaXMvaGVhbHRoY2FyZS1lbWVyZ2luZy1tYXJrZXRz0gEA?hl=en-US&gl=US&ceid=US%3Aen
Ardelyx IBS drug edges closer to the market,2017-10-12 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJkZWx5eC1pYnMtZHJ1Zy1lZGdlcy1jbG9zZXItdG8tdGhlLW1hcmtldC81MDcxMDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"For Endo's new campaign partner, golf pro Herron, Dupuytren's is all ...",2017-10-04 00:00:00,https://news.google.com/./articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2VuZG8taGlyZXMtZm9ybWVyLXByby1nb2xmZXItdG8tdGVsbC1mYW1pbHktc3RvcnktbmV3LWF3YXJlbmVzcy1lZmZvcnQtZm9yLWR1cHV5dHJlbi1z0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try ...",2017-10-05 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3Nhbm9maS1hbmQtcmVnZW5lcm9uLXNlZWtpbmctdG8tc2hpZWxkLWR1cGl4ZW50LWxvc2UtZmlyc3QtaXByLXRyeS1hZ2FpbnN0LWFtZ2Vu0gEA?hl=en-US&gl=US&ceid=US%3Aen
Allergan settles Restasis litigation with Pfizer's InnoPharma as ...,2017-10-13 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbGVnYWwvYWxsZXJnYW4tcGZpemVyLXMtaW5ub3BoYXJtYS1hZ3JlZS10by10ZXJtcy1yZXN0YXNpcy1nZW5lcmljLWxhdW5jaNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Come-back kid Dendreon makes key appointments,2017-10-27 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9jb21lLWJhY2stZGVuZHJlb24tbWFrZXMta2V5LWFwcG9pbnRtZW50c9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"With an FDA decision looming, Dynavax is shopping a deal on ...",2017-10-02 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vZW5kcHRzLmNvbS93aXRoLWFuLWZkYS1kZWNpc2lvbi1sb29taW5nLWR5bmF2YXgtaXMtc2hvcHBpbmctYS1kZWFsLW9uLWhlcGxpc2F2LXJlcG9ydC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Apellis Pharmaceuticals prices initial public offering at $14 per share ...,2017-11-09 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9sb3Vpc3ZpbGxlL25ld3MvMjAxNy8xMS8wOS9hcGVsbGlzLXBoYXJtYWNldXRpY2Fscy1wcmljZXMtMTUwLW1pbGxpb24taXBvLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Complement Inhibitor Fails in Trials for Geographic Atrophy,2017-11-13 00:00:00,https://news.google.com/./articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS84ODg1MDjSAQA?hl=en-US&gl=US&ceid=US%3Aen
Mylan exec added to sweeping price fixing lawsuit,2017-11-01 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXlsYW4tcmFqaXYtbWFsaWstZ2VuZXJpYy1kcnVnLWxhd3N1aXQtcHJpY2UtZml4aW5nLzUwOTc1MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Dynacure secures rights to Ionis rare disease drug,2017-11-10 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHluYWN1cmUtc2VjdXJlcy1yaWdodHMtdG8taW9uaXMtcmFyZS1kaXNlYXNlLWRydWcvNTEwNjAwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Teva restructures to stabilize struggling business,2017-11-27 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS1yZXN0cnVjdHVyZXMtdG8tc3RhYmlsaXplLXN0cnVnZ2xpbmctYnVzaW5lc3MvNTExNjE3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Anthem reverses course, agrees to cover Sarepta's Duchenne drug",2017-11-13 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW50aGVtLXJldmVyc2VzLWNvdXJzZS1hZ3JlZXMtdG8tY292ZXItc2FyZXB0YXMtZHVjaGVubmUtZHJ1Zy81MTA3NDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
AvidBiotics split creates two biotechs in hot areas,2017-11-02 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXZpZGJpb3RpY3Mtc3BsaXQtY3JlYXRlcy10d28tYmlvdGVjaHMtaW4taG90LWFyZWFzLzUwOTg2OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Juno analysis of shuttered study offers clues for CAR-T,2017-11-10 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvanVuby1hbmFseXNpcy1vZi1zaHV0dGVyZWQtc3R1ZHktb2ZmZXJzLWNsdWVzLWZvci1jYXItdC81MTA2MzQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Concordia faces fine for bad pricing behavior,2017-11-22 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY29uY29yZGlhLXVrLWNtYS1wcmljZS1nb3VnaW5nLXRoeXJvaWQtZHJ1Zy81MTE1NjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Ultragenyx wins first drug approval, valuable PRV",2017-11-16 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdWx0cmFnZW55eC13aW5zLWZpcnN0LWRydWctYXBwcm92YWwtdmFsdWFibGUtcHJ2LzUxMTEwMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis turns to startup to boost gene editing efforts,2017-11-13 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaG9tb2xvZ3ktbWVkaWNpbmUtbm92YXJ0aXMtZ2VuZS1lZGl0aW5nLWNvbGxhYm9yYXRpb24vNTEwODIyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novartis sets Cosentyx hopes higher,2017-11-15 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY29zZW50eXgtZ3Jvd3RoLWltbXVub2xvZ3ktdG5mLzUxMTAxMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J drops suit against Remicade biosimilar maker,2017-11-14 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotZHJvcHMtc3VpdC1hZ2FpbnN0LXJlbWljYWRlLWJpb3NpbWlsYXItc2Ftc3VuZy1iaW9lcGlzLzUxMDkyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer, Merck KGaA's Bavencio falls short in gastric cancer study",2017-11-28 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLW1lcmNrLWtnYWFzLWJhdmVuY2lvLWZhbGxzLXNob3J0LWluLWdhc3RyaWMtY2FuY2VyLXN0dWR5LzUxMTc2OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Dermira drops UCB drug to fund other launches,2017-11-07 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGVybWlyYS1kcm9wcy11Y2ItZHJ1Zy10by1mdW5kLW90aGVyLWxhdW5jaGVzLzUxMDIyOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
The globalization of the pharma industry,2017-11-01 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGhlLWdsb2JhbGl6YXRpb24tb2YtdGhlLXBoYXJtYS1pbmR1c3RyeS81MDk3OTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
How much is your vision worth? Spark CEO Jeff Marrazzo has a ...,2017-11-08 00:00:00,https://news.google.com/./articles/CBMiiQFodHRwczovL2VuZHB0cy5jb20vc3BhcmstY2VvLWplZmYtbWFycmF6em8taGFzLWRvbmUtdGhlLW1hdGgtb24tYmxpbmRuZXNzLWFuZC1oZXMtY29tZS11cC13aXRoLWEtYmxvY2tidXN0ZXItcHJpY2UtZm9yLWxlYWQtZ2VuZS10aGVyYXB5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Bluebird Bio doubles down on viral manufacturing,2017-11-29 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmx1ZWJpcmQtYmlvLWRvdWJsZXMtZG93bi1vbi12aXJhbC1tYW51ZmFjdHVyaW5nLzUxMTg3NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca wins US approval for asthma biologic,2017-11-15 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2Etd2lucy1mZGEtYXBwcm92YWwtZmFzZW5yYS1iZW5yYWxpenVtYWItYXN0aG1hLzUxMDk5MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis pushing Kisqali into younger patients to gain edge,2017-11-08 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtcHVzaGluZy1raXNxYWxpLWludG8teW91bmdlci1wYXRpZW50cy10by1nYWluLWVkZ2UvNTEwMzkxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Auris dumps Phase 3 trial after failure,2017-11-28 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXVyaXMtZHVtcHMtcGhhc2UtMy10cmlhbC1hZnRlci1mYWlsdXJlLzUxMTc3My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Navigating through Fair Market Value ambiguity,2017-11-15 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL25hdmlnYXRpbmctdGhyb3VnaC1mYWlyLW1hcmtldC12YWx1ZS1hbWJpZ3VpdHkvNTEwNjQwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Novo leaning heavily on Tresiba, semaglutide for growth",2017-11-01 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by1sZWFuaW5nLWhlYXZpbHktb24tdHJlc2liYS1zZW1hZ2x1dGlkZS1mb3ItZ3Jvd3RoLzUwOTc5MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Dynavax finally pushes hep B vaccine over the finish line,2017-11-09 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHluYXZheC1maW5hbGx5LXB1c2hlcy1oZXAtYi12YWNjaW5lLW92ZXItdGhlLWZpbmlzaC1saW5lLzUxMDU1Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Valeant sells female libido drug back to former owners ...,2017-11-07 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL3ZhbGVhbnQtc2VsbHMtZmVtYWxlLWxpYmlkby1kcnVnLWJhY2stZm9ybWVyLW93bmVyc9IBAA?hl=en-US&gl=US&ceid=US%3Aen
United Therapeutics inks $210M deal to wrap charity kickbacks probe,2017-12-21 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbGVnYWwvdW5pdGVkLXRoZXJhcGV1dGljcy1pbmtzLTIxMG0tc2V0dGxlbWVudC1vdmVyLWNoYXJpdHktZG9uYXRpb25z0gEA?hl=en-US&gl=US&ceid=US%3Aen
Top 25 Biopharma IPOs of 2017,2017-12-18 00:00:00,https://news.google.com/./articles/CBMiQWh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2EtbGlzdHMvdG9wLTI1LWJpb3BoYXJtYS1pcG9zLW9mLTIwMTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Mallinckrodt builds pipeline through $1.2B Sucampo deal,2017-12-26 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFsbGluY2tyb2R0LWJ1eS1zdWNhbXBvLWRlYWwtbmV3LWRydWdzLXBpcGVsaW5lLzUxMzc1OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Allergan picks up Repros to boost women's health offerings,2017-12-12 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tcGlja3MtdXAtcmVwcm9zLXRvLWJvb3N0LXdvbWVucy1oZWFsdGgtb2ZmZXJpbmdzLzUxMjg1Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Stock Picks & Analyst Ratings from Robert W. Baird,2019-11-10 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL3JhdGluZ3MvYnktaXNzdWVyL3JvYmVydC13LWJhaXJkLXN0b2NrLXJlY29tbWVuZGF0aW9ucy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Ra shares tank on Soliris comparison,2017-12-05 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmEtc2hhcmVzLXRhbmstb24tc29saXJpcy1jb21wYXJpc29uLzUxMjI2My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Shire CEO: Hemophilia will remain a core business,2017-12-10 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2hpcmUtb3Juc2tvdi1oZW1vcGhpbGlhLXJvY2hlLWdlbmUtdGhlcmFweS1jb21wZXRpdGlvbi81MTI2ODMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Prescribed Reading: FDA approval spree, tax reform, deals pick up",2017-12-22 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHJlc2NyaWJlZC1yZWFkaW5nLWZkYS1hcHByb3ZhbC1zcHJlZS10YXgtcmVmb3JtLWRlYWxzLXBpY2stdXAvNTEzNzIwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Biogen inks outcomes-based contract for MS meds,2017-12-06 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2VuLW91dGNvbWVzLWJhc2VkLWNvbnRyYWN0LXByaW1lLW11bHRpcGxlLXNjbGVyb3Npcy81MTI0MjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA approves Spark blindness drug in gene therapy first,2017-12-19 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXNwYXJrLWJsaW5kbmVzcy10cmVhdG1lbnQtZ2VuZS10aGVyYXB5LWx1eHR1cm5hLzUxMzQzMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Arena strikes a partnership in Asia,2017-12-05 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJlbmEtc3RyaWtlcy1hLXBhcnRuZXJzaGlwLWluLWFzaWEvNTEyMzE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pharma of the Year: AbbVie,2017-12-04 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhcm1hLW9mLXRoZS15ZWFyLWFiYnZpZS1odW1pcmEtMjAxNy81MDk5MTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Denali IPO hits a 2017 record $1.7B market valuation, raising $250 ...",2017-12-08 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vZW5kcHRzLmNvbS9kZW5hbGktaGl0cy1hLTIwMTctcmVjb3JkLTEtN2ItbWFya2V0LXZhbHVhdGlvbi1yYWlzaW5nLTI1MG0tZm9yLW5ldXJvZGVnZW5hdGlvbi1yZC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Wuxi preps for biologics manufacturing surge in China,2017-12-07 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd3V4aS1wcmVwcy1mb3ItYmlvbG9naWNzLW1hbnVmYWN0dXJpbmctc3VyZ2UtaW4tY2hpbmEvNTEyNTI2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Biogen's Alzheimer's drug fails, putting focus all on aducanumab",2017-12-21 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2Vucy1hbHpoZWltZXJzLWRydWctZmFpbHMtcHV0dGluZy1mb2N1cy1hbGwtb24tYWR1Y2FudW1hYi81MTM2MjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Most Impressive Drug Launch: Roche's Ocrevus,2017-12-04 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbW9zdC1pbXByZXNzaXZlLWRydWctbGF1bmNoLXJvY2hlLW9jcmV2dXMtMjAxNy81MTA4MTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Gilead deepens CAR-T push with deal for Cell Design,2017-12-07 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2lsZWFkLWJ1eXMtY2VsbC1kZXNpZ24tY2FyLXQtNTY3LW1pbGxpb24vNTEyNTgwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
ASH17: Seattle Genetics sees market opportunity in cancer combo ...,2017-12-10 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXNoMTctc2VhdHRsZS1nZW5ldGljcy1zZWVzLW1hcmtldC1vcHBvcnR1bml0eS1pbi1jYW5jZXItY29tYm8tc3VjY2Vzcy81MTI2Njcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
New report proposes 8 fixes for high drug costs,2017-12-04 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmV3LXJlcG9ydC1wcm9wb3Nlcy04LWZpeGVzLWZvci1oaWdoLWRydWctY29zdHMvNTEyMTc0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
OS miss prompts Lilly to drop Cyramza expansion,2017-12-11 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb3MtbWlzcy1wcm9tcHRzLWxpbGx5LXRvLWRyb3AtY3lyYW16YS1leHBhbnNpb24vNTEyNzMzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Kymriah, Yescarta could be cost-effective, ICER finds",2017-12-21 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWNlci1kcmFmdC1jYXItdC1jb3N0LWVmZmVjdGl2ZS1reW1yaWFoLXllc2NhcnRhLXByaWNlLzUxMzYyNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novasep moves eravacycline API to commercial-scale production,2017-12-14 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9ub3Zhc2VwLW1vdmVzLWVyYXZhY3ljbGluZS1hcGktdG8tY29tbWVyY2lhbC1zY2FsZS1wcm9kdWN0aW9u0gEA?hl=en-US&gl=US&ceid=US%3Aen
With 3K-plus Teva layoffs slated in Israel and labor protests brewing ...,2017-12-12 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RldmEtdHVybm92ZXItY29udGludWVzLXJlc2lnbmF0aW9uLWZvcm1lci1jaGFpcm1hbi1pbnRlcmltLWNoaWVmLXJlcG9ydNIBAA?hl=en-US&gl=US&ceid=US%3Aen
"To succeed in digital health, life sciences companies should sweat ...",2017-12-21 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTcvMTIvc3VjY2VlZC1kaWdpdGFsLWhlYWx0aC1saWZlLXNjaWVuY2VzLWNvbXBhbmllcy1zd2VhdC1zbWFsbC1zdHVmZi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Apellis Pharmaceuticals: This Horse Is Lame (NASDAQ:APLS),2018-01-09 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQxMzYxODYtYXBlbGxpcy1waGFybWFjZXV0aWNhbHMtdGhpcy1ob3JzZS1pcy1sYW1l0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Celgene buys Juno for $9B, deepening bet on CAR-T",2018-01-22 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1idXlzLWp1bm8tOS1iaWxsaW9uLWRlZXBlbmluZy1iZXQtY2FyLXQvNTE1MjI2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AndexXa's route to the market clots again,2018-01-03 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW5kZXh4YXMtcm91dGUtdG8tdGhlLW1hcmtldC1jbG90cy1hZ2Fpbi81MTM5Mzcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
JPM18: Incyte and Syros to collaborate in cancer R&D,2018-01-10 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvanBtMTgtaW5jeXRlLWFuZC1zeXJvcy10by1jb2xsYWJvcmF0ZS1pbi1jYW5jZXItcmQvNTE0NDY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Braeburn hits setback with CRL for opioid disorder,2018-01-22 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJhZWJ1cm4taGl0cy1zZXRiYWNrLXdpdGgtY3JsLWZvci1vcGlvaWQtZGlzb3JkZXIvNTE1MjE1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA issues PRV guidance for medical countermeasures,2018-01-19 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWlzc3Vlcy1wcnYtZ3VpZGFuY2UtZm9yLW1lZGljYWwtY291bnRlcm1lYXN1cmVzLzUxNTEyNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer pulls back from neuroscience, ending research",2018-01-07 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLWVuZHMtbmV1cm9zY2llbmNlLWFsemhlaW1lcnMtcmVzZWFyY2gtY3V0cy0zMDAtam9icy81MTQyMTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
5 Drivers spurring use of real-world evidence,2018-01-29 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3BvdGxpZ2h0LXJlYWwtd29ybGQtZGF0YS1kcnVnLWV2aWRlbmNlLWRyaXZlcnMtdmFsdWUvNTE1NjkyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Biotech CEOs: Working with CROs is challenging,2018-01-23 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvdGVjaC1jZW9zLXdvcmtpbmctd2l0aC1jcm9zLWlzLWNoYWxsZW5naW5nLzUxNTI4My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Price for Spark gene therapy too high, ICER says",2018-01-16 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWNlci1maW5kcy1zcGFyay1sdXh0dXJuYS1nZW5lLXRoZXJhcHktdG9vLWV4cGVuc2l2ZS1wcmljZS81MTQ4MjEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA approves Novartis-acquired Lutathera for certain gut cancers,2018-01-29 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWFwcHJvdmVzLW5vdmFydGlzLWFjcXVpcmVkLWx1dGF0aGVyYS1mb3ItY2VydGFpbi1ndXQtY2FuY2Vycy81MTU3NDUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"In surprise move, Pfizer hands back IDO1 inhibitor",2018-01-05 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW4tc3VycHJpc2UtbW92ZS1wZml6ZXItaGFuZHMtYmFjay1pZG8xLWluaGliaXRvci81MTQxNDUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Novartis predicts growth pick-up on back of Cosentyx, Entresto",2018-01-24 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtcHJlZGljdHMtZ3Jvd3RoLXBpY2stdXAtb24tYmFjay1vZi1jb3NlbnR5eC1lbnRyZXN0by81MTU0NDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Astellas, Vical's CMV vaccine comes up short in Phase 3",2018-01-23 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0ZWxsYXMtdmljYWxzLWNtdi12YWNjaW5lLXBoYXNlLTMtZmFpbHVyZS1taXNzLzUxNTM0Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Celgene aims to quell growth worries with $7B Impact deal,2018-01-07 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1idXktaW1wYWN0LWJpb21lZGljaW5lcy03LWJpbGxpb24tZmVkcmF0aW5pYi1qcC1tb3JnYW4vNTE0MjQzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Allergan to cut 1000 jobs as generic competition threatens,2018-01-03 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tdG8tY3V0LTEwMDAtam9icy1hcy1nZW5lcmljLWNvbXBldGl0aW9uLXRocmVhdGVucy81MTM5OTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Pharmaceutical M&A deals in 2017,2018-01-03 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9waGFybWFjZXV0aWNhbC1tLWEtZGVhbHMtaW4tMjAxN9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Teva's Cinqair fails to deliver in Phase 3 asthma studies,2018-01-23 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YXMtY2lucWFpci1mYWlscy10by1kZWxpdmVyLWluLXBoYXNlLTMtYXN0aG1hLXN0dWRpZXMvNTE1MzExL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Aradigm stung by FDA rejection of inhaled antibiotic,2018-01-29 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJhZGlnbS1zdHVuZy1mZGEtcmVqZWN0aW9uLWNybC1pbmhhbGVkLWFudGliaW90aWMtbGluaGFsaXEvNTE1Nzc0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA changes biologics inspections from biennial to risk-based,2018-01-26 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWNoYW5nZXMtYmlvbG9naWNzLWluc3BlY3Rpb25zLWZyb20tYmllbm5pYWwtdG8tcmlzay1iYXNlZC81MTU2ODIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Evolus says its Botox biosimilar could be delayed by FDA issues ...,2018-01-25 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9mZGEtZmluZHMtaXNzdWVzLWRhZXdvb25nLXBsYW50LXdpbGwtbWFrZS1ldm9sdXMtYm90b3gtYmlvc2ltaWxhctIBAA?hl=en-US&gl=US&ceid=US%3Aen
"Avid sells off cancer assets, transitioning to CDMO",2018-02-13 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb25jb2xvZ2llLXNuYXBzLXVwLWF2aWRzLWNhbmNlci1hc3NldHMvNTE2OTQ3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Roche buys cancer data company Flatiron Health for $1.9B,2018-02-16 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtYnV5cy1jYW5jZXItZGF0YS1jb21wYW55LWZsYXRpcm9uLWhlYWx0aC1mb3ItMTliLzUxNzI4NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
EyeGate eye treatment stumbles in mid-stage study,2018-02-06 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXllZ2F0ZS1leWUtdHJlYXRtZW50LXN0dW1ibGVzLWluLW1pZC1zdGFnZS1zdHVkeS81MTY0MDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Madrigal shares slide despite Phase 2 success,2018-02-09 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFkcmlnYWwtc2hhcmVzLXNsaWRlLWRlc3BpdGUtcGhhc2UtMi1zdWNjZXNzLzUxNjczOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA adds black box warning to Intercept's Ocaliva,2018-02-01 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWFkZHMtYmxhY2stYm94LXdhcm5pbmctdG8taW50ZXJjZXB0cy1vY2FsaXZhLzUxNjExNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Express Scripts joins Walgreens Boots to cut biosimilar costs,2018-02-21 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXhwcmVzcy1zY3JpcHRzLWpvaW5zLXdhbGdyZWVucy1ib290cy10by1jdXQtYmlvc2ltaWxhci1jb3N0cy81MTc1MzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Aveo, Eusa tout promise of tivozanib combo in kidney cancer",2018-02-12 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXZlby1ldXNhLXRvdXQtcHJvbWlzZS1vZi10aXZvemFuaWItY29tYm8taW4ta2lkbmV5LWNhbmNlci81MTY4NDQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Biogen shares fall after unexpected 'variability' in Alzheimer's studies,2018-02-15 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2VuLXNoYXJlcy1mYWxsLWFmdGVyLXVuZXhwZWN0ZWQtdmFyaWFiaWxpdHktaW4tYWx6aGVpbWVycy1zdHVkaWVzLzUxNzE5My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
TG Therapeutics posts positive MS update,2018-02-05 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGctdGhlcmFwZXV0aWNzLXBvc3RzLXBvc2l0aXZlLW1zLXVwZGF0ZS81MTYyODkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Gilead taps Sangamo to expand cell therapy after Kite buy,2018-02-22 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2lsZWFkLXNhbmdhbW8tY2VsbC10aGVyYXB5LWtpdGUtY2FyLXQvNTE3NjM0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
BIO: Pain pipeline lacking as opioid crisis continues,2018-02-14 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvLXBhaW4tcGlwZWxpbmUtbGFja2luZy1hcy1vcGlvaWQtY3Jpc2lzLWNvbnRpbnVlcy81MTcwNjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Strong data lift profile of J&J's cancer drug apalutamide,2018-02-05 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3Ryb25nLWRhdGEtbGlmdC1wcm9maWxlLW9mLWpqcy1jYW5jZXItZHJ1Zy1hcGFsdXRhbWlkZS81MTYzNDAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Ferring Pharmaceuticals building $32M biologics center in Switzerland,2018-02-20 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9mZXJyaW5nLXBoYXJtYWNldXRpY2Fscy1idWlsZGluZy0zMm0tYmlvbG9naWNzLWNlbnRlci1zd2l0emVybGFuZNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Aimmune knocks down DBV with positive peanut results,2018-02-20 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWltbXVuZS1kYnYtcGVhbnV0LWFsbGVyZ3ktcmVzdWx0cy1kYXRhLzUxNzM5Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Gilead forecasts steep slide in 2018 hepatitis C revenues,2018-02-06 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2lsZWFkLWhlcGF0aXRpcy1jLXJldmVudWVzLXNsaWRlLWZvdXJ0aC1xdWFydGVyLWVhcm5pbmdzLzUxNjQ5NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Charles River boosts CRO chops with $800M deal for MPI,2018-02-15 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2hhcmxlcy1yaXZlci1tcGktY3JvLWNtby1kZWFsLWNvbnNvbGlkYXRpb24vNTE3MjA0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Rubraca struggling from behind in PARP market,2018-02-27 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcnVicmFjYS1zdHJ1Z2dsaW5nLWZyb20tYmVoaW5kLWluLXBhcnAtbWFya2V0LzUxNzk5NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Spark lays groundwork for US Luxturna launch,2018-02-21 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3BhcmstbGF5cy1ncm91bmR3b3JrLWZvci11cy1sdXh0dXJuYS1sYXVuY2gvNTE3NTUwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Allergan picks up pneumonia indication for Avycaz,2018-02-02 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tcGlja3MtdXAtcG5ldW1vbmlhLWluZGljYXRpb24tZm9yLWF2eWNhei81MTYxODkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Ramaswamy has no regrets about Axovant,2018-02-13 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmFtYXN3YW15LWhhcy1uby1yZWdyZXRzLWFib3V0LWF4b3ZhbnQvNTE3MDIwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
J&J strikes potential $1B JAK inhibitor deal with Theravance,2018-02-07 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvamotc3RyaWtlcy1wb3RlbnRpYWwtMWItamFrLWluaGliaXRvci1kZWFsLXdpdGgtdGhlcmF2YW5jZS81MTY0NzUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Oral form of Novo's Ozempic hits primary endpoint in first Phase 3,2018-02-23 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb3JhbC1mb3JtLW9mLW5vdm9zLW96ZW1waWMtaGl0cy1wcmltYXJ5LWVuZHBvaW50LWluLWZpcnN0LXBoYXNlLTMvNTE3NzEwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Pharma sits out Super Bowl ads again, but Mr. Mucus sneaks into ...",2018-02-05 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL3BoYXJtYS1zaXRzLW91dC1zdXBlci1ib3dsLWFkLWdhbWUtYWdhaW4tbXItbXVjdXMtc25lYWtzLWludG8tYWZ0ZXItcGFydHnSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Settling a post-buyout hangover, Allergan gives Teva a $700M remedy",2018-02-01 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RldmEtdG8tcmVhcC03MDBtLWRlYnQtZWFzaW5nLWNhc2gtZnJvbS1hbGxlcmdhbi1wb3N0LWRlYWwtc2V0dGxlbWVudNIBAA?hl=en-US&gl=US&ceid=US%3Aen
DBV reveals cloudy results for milk allergy patch,2018-02-27 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGJ2LXJldmVhbHMtY2xvdWR5LXJlc3VsdHMtZm9yLW1pbGstYWxsZXJneS1wYXRjaC81MTc5Njcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Moderna's vaccines head steps down as multiple programs undergo ...,2018-03-07 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vdmFjY2luZXMvbW9kZXJuYS1zLXZhY2NpbmVzLWhlYWQtc3RlcHMtZG93bi1hcy1tdWx0aXBsZS1wcm9ncmFtcy11bmRlcmdvLXBoYXNlLTHSAQA?hl=en-US&gl=US&ceid=US%3Aen
Koligo Therapeutics Inc. raises $2 million - Louisville Business First,2018-03-21 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9sb3Vpc3ZpbGxlL25ld3MvMjAxOC8wMy8yMS9sb3Vpc3ZpbGxlcy1rb2xpZ28tdGhlcmFwZXV0aWNzLWFpbXMtdG8tc2NhbGUtdXAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Anthera shares plunge as company drops failed CF drug,2018-03-13 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW50aGVyYS1zaGFyZXMtcGx1bmdlLWFzLWNvbXBhbnktZHJvcHMtZmFpbGVkLWNmLWRydWcvNTE4OTk5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Biogen snaps up Pfizer's schizophrenia candidate,2018-03-12 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2VuLXNuYXBzLXVwLXBmaXplcnMtc2NoaXpvcGhyZW5pYS1jYW5kaWRhdGUvNTE4OTE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Watch out Endo: Sorrento is after your $1B+ drug with FDA OK of ...,2018-03-01 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vZW5kcHRzLmNvbS93YXRjaC1vdXQtZW5kby1zb3JyZW50by1pcy1hZnRlci15b3VyLTFiLWRydWctd2l0aC1mZGEtb2stb2YtenRsaWRvL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Celgene shells out $101M upfront in latest deal,2018-03-05 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS12aXZpZGlvbi1kZWFsLXByb3RlaW4vNTE4Mzk5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Roche's Hemlibra to be biggest blockbuster of next 5 years, report ...",2018-03-22 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtaGVtbGlicmEtYmxvY2tidXN0ZXItcmVwb3J0LUJpa3RhcnZ5LWRpYWJldGVzLWdpbGVhZC1ub3ZvLzUxOTc0Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Mundipharma inks third biosimilar deal with Celltrion,2018-03-20 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXVuZGlwaGFybWEtaW5rcy10aGlyZC1iaW9zaW1pbGFyLWRlYWwtd2l0aC1jZWxsdHJpb24vNTE5NTgwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Eylea positive in diabetic retinopathy, but analysts skeptical",2018-03-20 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVnZW5lcm9uLWV5bGVhLWRpYWJldGljLXJldGlub3BhdGh5LWRhdGEtbWFya2V0LzUxOTUzNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Celgene picks up early neuro drugs in Prothena deal,2018-03-21 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1wcm90aGVuYS1uZXVyb3NjaWVuY2UtZGVhbC1hbHpoZWltZXJzLXBpcGVsaW5lLzUxOTY0Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Celgene, bluebird revise deal to co-develop CAR-T therapy",2018-03-29 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1ibHVlYmlyZC1yZXZpc2UtZGVhbC10by1jby1kZXZlbG9wLWNhci10LXRoZXJhcHkvNTIwMjU1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"J&J to sell Lifescan, dropping out of diabetes diagnostics",2018-03-19 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotdG8tc2VsbC1saWZlc2Nhbi1kcm9wcGluZy1vdXQtb2YtZGlhYmV0ZXMtZGlhZ25vc3RpY3MvNTE5NDAxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Protagonist halts colitis study after missed endpoint,2018-03-27 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHJvdGFnb25pc3QtaGFsdHMtY29saXRpcy1zdHVkeS1hZnRlci1taXNzZWQtZW5kcG9pbnQvNTIwMDMwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Heritage Pharmaceuticals opens new production facility in New Jersey,2018-03-26 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9oZXJpdGFnZS1waGFybWFjZXV0aWNhbHMtb3BlbnMtbmV3LXByb2R1Y3Rpb24tZmFjaWxpdHktbmV3LWplcnNledIBAA?hl=en-US&gl=US&ceid=US%3Aen
"Biogen, AbbVie withdraw MS drug after safety signals",2018-03-02 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2VuLWFiYnZpZS13aXRoZHJhdy1tcy1kcnVnLWFmdGVyLXNhZmV0eS1zaWduYWxzLzUxODI4OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"EMA clears biosimilars for Herceptin, Remicade",2018-03-26 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW1hLWNsZWFycy1iaW9zaW1pbGFycy1mb3ItaGVyY2VwdGluLXJlbWljYWRlLzUxOTkzMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Fujifilm lays down $800M for Irvine Scientific,2018-03-29 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZnVqaWZpbG0tbGF5cy1kb3duLTgwMG0tZm9yLWlydmluZS1zY2llbnRpZmljLzUyMDI5MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Aetna to offer point of sale pharmacy rebates to 3M customers,2018-03-27 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWV0bmEtdG8tb2ZmZXItcG9pbnQtb2Ytc2FsZS1waGFybWFjeS1yZWJhdGVzLXRvLTNtLWN1c3RvbWVycy81MjAwNjcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Solid Biosciences reveals upgraded clinical hold for gene therapy,2018-03-15 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc29saWQtYmlvc2NpZW5jZXMtcmV2ZWFscy11cGdyYWRlZC1jbGluaWNhbC1ob2xkLWZvci1nZW5lLXRoZXJhcHkvNTE5MjYyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Personalized medicine requires personalized measurement,2018-03-26 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3BlcnNvbmFsaXplZC1tZWRpY2luZS1yZXF1aXJlcy1wZXJzb25hbGl6ZWQtbWVhc3VyZW1lbnQvNTE5NjY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"J&J's CANVAS study positive, pitting Invokana against Jardiance",2018-03-12 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvampzLWNhbnZhcy1zdHVkeS1wb3NpdGl2ZS1waXR0aW5nLWludm9rYW5hLWFnYWluc3QtamFyZGlhbmNlLzUxODg5Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Opioid antagonists vs. agonists: A battle to fight addiction,2018-03-26 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3BvdGxpZ2h0LXBhaW4tb3Bpb2lkLWFkZGljdGlvbi10cmVhdG1lbnRzLXZpdml0cm9sLW5hbG94b25lLzUxOTU1MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Amgen taps Omnicom's Hearts & Science for media job,2018-03-23 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tdGFwcy1vbW5pY29tcy1oZWFydHMtc2NpZW5jZS1mb3ItbWVkaWEtam9iLzUxOTg0Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie oncology push in question after Rova-T disappoints,2018-03-22 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLW9uY29sb2d5LXB1c2gtaW4tcXVlc3Rpb24tYWZ0ZXItcm92YS10LWRpc2FwcG9pbnRzLzUxOTc2Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Biohaven falls on weak migraine data,2018-03-26 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvaGF2ZW4tZmFsbHMtb24td2Vhay1taWdyYWluZS1kYXRhLzUxOTk2Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Helsinn to acquire worldwide rights to Valchlor/Ledaga,2018-03-21 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9oZWxzaW5uLXRvLWFjcXVpcmUtd29ybGR3aWRlLXJpZ2h0cy10by12YWxjaGxvci1sZWRhZ2HSAQA?hl=en-US&gl=US&ceid=US%3Aen
Indivior loses patent battle for Suboxone Film,2018-03-23 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5kaXZpb3ItbG9zZXMtcGF0ZW50LWJhdHRsZS1mb3Itc3Vib3hvbmUtZmlsbS81MTk4Njgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"In push to use pot for pain, synthetics hold upper hand",2018-03-26 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGFpbi1tYXJpanVhbmEtcG90LXBsYW50LW5vbi1vcGlvaWQtZHJ1Zy1kZXZlbG9wbWVudC81MTk2ODAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
VBL brain cancer drug flunks Phase 3,2018-03-08 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmJsLWJyYWluLWNhbmNlci1kcnVnLWZsdW5rcy1waGFzZS0zLzUxODcxOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Merck KGaA injects $47M into Asian manufacturing efforts,2018-03-01 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2sta2dhYS1pbmplY3RzLTQ3bS1pbnRvLWFzaWFuLW1hbnVmYWN0dXJpbmctZWZmb3J0cy81MTgxOTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Verona touts potential of mid-stage COPD drug,2018-03-27 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVyb25hLWNvcGQtZHJ1Zy1waGFzZS0yLWRhdGEvNTIwMDY0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Advaxis drops after clinical hold due to patient death,2018-03-13 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWR2YXhpcy1jbGluaWNhbC1ob2xkLXBhdGllbnQtZGVhdGgtYXhhbC81MTkwMDcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
PTx will hire 40 for U.S. Leukine plant it acquired from Sanofi,2018-03-22 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9wdHgtd2lsbC1oaXJlLTQwLWZvci11LXMtbGV1a2luZS1wbGFudC1pdC1hY3F1aXJlZC1mcm9tLXNhbm9madIBAA?hl=en-US&gl=US&ceid=US%3Aen
CSL Behring's Hizentra wins FDA nod for CIDP,2018-03-19 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY3NsLWJlaHJpbmdzLWhpemVudHJhLXdpbnMtZmRhLW5vZC1mb3ItY2lkcC81MTk0NDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Defendant in Tennessee wholesaling scam convicted; two others ...,2018-03-07 00:00:00,https://news.google.com/./articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9kZWZlbmRhbnQtdGVubmVzc2Utd2hvbGVzYWxpbmctc2NhbS1jb252aWN0ZWQtdHdvLW90aGVycy1wcmV2aW91c3ktcGxlYWRlZC1ndWlsdHnSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Alnylam, Dicerna settle RNAi trade secrets lawsuit",2018-04-21 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxueWxhbS1kaWNlcm5hLXNldHRsZS1ybmFpLXRyYWRlLXNlY3JldHMtbGF3c3VpdC81MjE4ODgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Lilly's next diabetes play would have patients implanted with ...,2018-04-04 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktc2lnaWxvbi1kaWFiZXRlcy1jZWxsLXRoZXJhcHktZGVhbC81MjA2MDQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA removes clinical hold on Bellicum's cell therapy,2018-04-13 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXJlbW92ZXMtY2xpbmljYWwtaG9sZC1vbi1iZWxsaWN1bXMtY2VsbC10aGVyYXB5LzUyMTMxOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
NGM Bio hits endpoint in Phase 2 NASH study,2018-04-16 00:00:00,https://news.google.com/./articles/CBMiP2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmdtLWJpby1waGFzZS0yLW5hc2gvNTIxMzgyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Epizyme nosedives following clinical hold,2018-04-25 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXBpenltZS1ub3NlZGl2ZXMtZm9sbG93aW5nLWNsaW5pY2FsLWhvbGQvNTIyMTE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
ADC Therapeutics axes HER2 program,2018-04-26 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWRjLXRoZXJhcGV1dGljcy1heGVzLWhlcjItcHJvZ3JhbS81MjIyMjEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Ferring buys up PhIII microbiome drug with acquisition of Rebiotix,2018-04-05 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vZW5kcHRzLmNvbS9mZXJyaW5nLWJ1eXMtdXAtcGhpaWktbWljcm9iaW9tZS1kcnVnLXdpdGgtYWNxdWlzaXRpb24tb2YtcmViaW90aXgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
J&J unfazed by falling Remicade sales,2018-04-17 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotdW5mYXplZC1ieS1mYWxsaW5nLXJlbWljYWRlLXNhbGVzLzUyMTUxNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Redx study on hold before getting off the ground,2018-04-02 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVkeC1zdHVkeS1vbi1ob2xkLWJlZm9yZS1nZXR0aW5nLW9mZi10aGUtZ3JvdW5kLzUyMDM2NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Tris Pharma, a CMO for Pfizer, hit with FDA warning letter for ADHD ...",2018-04-12 00:00:00,https://news.google.com/./articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy90cmlzLXBoYXJtYS1hLWNtby1mb3ItcGZpemVyLWhpdC1mZGEtd2FybmluZy1sZXR0ZXItZm9yLWFkaGQtZHJ1Zy1tb3JwaGluZS1zb2x1dGlvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen
Amgen focuses on migraine launch as growth remains slow,2018-04-25 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tZm9jdXNlcy1vbi1taWdyYWluZS1sYXVuY2gtYXMtZ3Jvd3RoLXJlbWFpbnMtc2xvdy81MjIxNDAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
MedImmune inks deal for rights to early I/O candidates,2018-04-03 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVkaW1tdW5lLWlua3MtZGVhbC1mb3ItcmlnaHRzLXRvLWVhcmx5LWlvLWNhbmRpZGF0ZXMvNTIwNDY3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Kadmon gets FDA go-ahead for ROCK2 inhibitor study,2018-04-11 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2FkbW9uLWdldHMtZmRhLWdvLWFoZWFkLWZvci1yb2NrMi1pbmhpYml0b3Itc3R1ZHkvNTIxMDg2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"After some Thursday drama, Shire weighs Takeda's cash ...",2018-04-21 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3NoaXJlLXdlaWdocy10YWtlZGEtcy1mb3VydGgtYnV5b3V0LW9mZmVyLTYxYi1wbHVz0gEA?hl=en-US&gl=US&ceid=US%3Aen
"The lines that define healthcare industry segments are blurring, but ...",2018-04-17 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMDQvaGVhbHRoY2FyZS1pbmR1c3RyeS1zZWdtZW50cy1hcmUtYmx1cnJpbmcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
US WorldMeds LLC to raise $30 million in debt and equity securities ...,2018-04-13 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9sb3Vpc3ZpbGxlL25ld3MvMjAxOC8wNC8xMy91cy13b3JsZG1lZHMtdG8tcmFpc2UtMzAtbWlsbGlvbi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
Institutional Top Ideas Series: Ra Capital Management,2018-05-10 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQxNzIwNTQtaW5zdGl0dXRpb25hbC10b3AtaWRlYXMtc2VyaWVzLXJhLWNhcGl0YWwtbWFuYWdlbWVudNIBAA?hl=en-US&gl=US&ceid=US%3Aen
La Jolla inks royalty deal to support Giapreza launch,2018-05-14 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGEtam9sbGEtaW5rcy1yb3lhbHR5LWRlYWwtdG8tc3VwcG9ydC1naWFwcmV6YS1sYXVuY2gvNTIzNDMxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca finally gets US Lokelma approval,2018-05-21 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtZmluYWxseS1nZXRzLXVzLWxva2VsbWEtYXBwcm92YWwvNTIzOTM1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer's Epogen biosimilar finally gets FDA go-ahead,2018-05-16 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVycy1lcG9nZW4tYmlvc2ltaWxhci1maW5hbGx5LWdldHMtZmRhLWdvLWFoZWFkLzUyMzYzNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA approves first TPO agonist for chronic liver disease,2018-05-22 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWFwcHJvdmVzLWZpcnN0LXRwby1hZ29uaXN0LWZvci1jaHJvbmljLWxpdmVyLWRpc2Vhc2UvNTI0MDUzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Achieve KAM success by overcoming the 'challenge from within',2018-05-29 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL2FjaGlldmUta2FtLXN1Y2Nlc3MtYnktb3ZlcmNvbWluZy10aGUtY2hhbGxlbmdlLWZyb20td2l0aGluLzUyNDEwMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Liver safety the death knell for J&J Alzheimer's drug,2018-05-21 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGl2ZXItc2FmZXR5LXRoZS1kZWF0aC1rbmVsbC1mb3ItamotYWx6aGVpbWVycy1kcnVnLzUyMzkzNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
TapImmune and Marker Therapeutics merge to create new I/O ...,2018-05-15 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGFwaW1tdW5lLWFuZC1tYXJrZXItdGhlcmFwZXV0aWNzLW1lcmdlLXRvLWNyZWF0ZS1uZXctaW8tY29tcGFueS81MjM1Mjkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Priority review voucher prices fall again after Spark's $110m sale ...,2018-05-01 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL3NwYXJrLXNlbGxzLXByaW9yaXR5LXJldmlldy12b3VjaGVyLXRvLWphenrSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Avid CEO talks expansion, capacity and Asia",2018-05-10 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXZpZC1jZW8tdGFsa3MtZXhwYW5zaW9uLWNhcGFjaXR5LWFuZC1hc2lhLzUyMzI4Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
UAE's Neopharma and ASKA of Japan to build drug plant in India in ...,2018-05-03 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy91YWUtcy1uZW9waGFybWEtYW5kLWFza2EtamFwYW4tNTNtLWp2LXRvLWJ1aWxkLWRydWctcGxhbnQtaW5kaWHSAQA?hl=en-US&gl=US&ceid=US%3Aen
Bring your pharma brand to life with Facebook Live,2018-05-09 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMDUvYnJpbmcteW91ci1waGFybWEtYnJhbmQtdG8tbGlmZS13aXRoLWZhY2Vib29rLWxpdmUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Lights, camera, action – DMD and chasing your dreams ...",2018-05-17 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS92aWV3cy1hbmQtYW5hbHlzaXMvbGlnaHRzLWNhbWVyYS1hY3Rpb24tZG1kLWFuZC1jaGFzaW5nLXlvdXItZHJlYW1z0gEA?hl=en-US&gl=US&ceid=US%3Aen
Apellis Pharmaceuticals (APLS) Investor Presentation - Slideshow ...,2018-06-27 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQxODQzMjktYXBlbGxpcy1waGFybWFjZXV0aWNhbHMtYXBscy1pbnZlc3Rvci1wcmVzZW50YXRpb24tc2xpZGVzaG930gEA?hl=en-US&gl=US&ceid=US%3Aen
Q&A: Apellis Pharmaceuticals CEO Dr. Cedric Francois,2018-06-28 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vY2hpZWZleGVjdXRpdmUubmV0L3FhLWFwZWxsaXMtcGhhcm1hY2V1dGljYWxzLWNlby1kci1jZWRyaWMtZnJhbmNvaXMv0gFRaHR0cHM6Ly9jaGllZmV4ZWN1dGl2ZS5uZXQvcWEtYXBlbGxpcy1waGFybWFjZXV0aWNhbHMtY2VvLWRyLWNlZHJpYy1mcmFuY29pcy9hbXAv?hl=en-US&gl=US&ceid=US%3Aen
Vertex opens doors to new research site in San Diego,2018-06-19 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LW9wZW5zLWRvb3JzLXRvLW5ldy1yZXNlYXJjaC1zaXRlLWluLXNhbi1kaWVnby81MjYwMDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Versartis stock climbs on reverse merger with Aravive,2018-06-05 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVyc2FydGlzLXN0b2NrLWNsaW1icy1vbi1yZXZlcnNlLW1lcmdlci13aXRoLWFyYXZpdmUvNTI0OTc0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Roche buys out Foundation Med in $2.4B bet on targeted cancer ...,2018-06-19 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtYnV5cy1vdXQtZm91bmRhdGlvbi1tZWQtaW4tMjRiLWJldC1vbi10YXJnZXRlZC1jYW5jZXItdHJlYXRtZW50LzUyNjAyOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
BridgeBio launches new biotech to develop Alexion drug,2018-06-12 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpZGdlYmlvLWxhdW5jaGVzLW5ldy1iaW90ZWNoLXRvLWRldmVsb3AtYWxleGlvbi1kcnVnLzUyNTQ4OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Emulate raises $36M to develop organ-on-chip tech,2018-06-21 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW11bGF0ZS1yYWlzZXMtMzZtLXRvLWRldmVsb3Atb3JnYW4tb24tY2hpcC10ZWNoLzUyNjIxMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Garabedian has few regrets and is ready to be seen,2018-06-11 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2hyaXMtZ2FyYWJlZGlhbi14b250b2dlbnktc2FyZXB0YS81MjQ4MDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"New drug shortages on the rise in 2017, after years of steady declines",2018-06-21 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmV3LWRydWctc2hvcnRhZ2VzLW9uLXRoZS1yaXNlLWluLTIwMTctYWZ0ZXIteWVhcnMtb2Ytc3RlYWR5LWRlY2xpbmVzLzUyNjI0Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Lilly's baricitinib gets FDA OK, but faces hurdles",2018-06-01 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHlzLWJhcmljaXRpbmliLWdldHMtZmRhLW9rLWJ1dC1mYWNlcy1odXJkbGVzLzUyNDgwNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Lilly's experimental colitis drug posts positive Phase 2 data,2018-06-06 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHlzLWV4cGVyaW1lbnRhbC1jb2xpdGlzLWRydWctcG9zdHMtcG9zaXRpdmUtcGhhc2UtMi1kYXRhLzUyNTA3Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"This extravagant party during #BIO18 featured topless dancers, and ...",2018-06-13 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vZW5kcHRzLmNvbS90aGlzLWV4dHJhdmFnYW50LXBhcnR5LWR1cmluZy1iaW8xOC1mZWF0dXJlZC10b3BsZXNzLWRhbmNlcnMtYW5kLWluZHVzdHJ5LWxlYWRlcnMtYXJlLW5vdC1wbGVhc2VkL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Instead of 'curling up in a corner,' Mylan CEO says, she used EpiPen ...",2018-06-04 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL215bGFuLWNlby1icmVzY2gtZXBpcGVuLXNjYW5kYWwtd2FzLW9wcG9ydHVuaXR5LXRvLWRpc2N1c3MtZmxhd2VkLXByaWNpbmctc3lzdGVt0gEA?hl=en-US&gl=US&ceid=US%3Aen
GSK collaborates on AI-driven drug design with Cloud ...,2018-06-01 00:00:00,https://news.google.com/./articles/CBMiR2h0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL2dzay1haS1kcnVnLWRlc2lnbi1jbG91ZC1waGFybWFjZXV0aWNhbHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Noven recalls thousands of hormone patches that failed to meet ...,2018-06-28 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9ub3Zlbi1yZWNhbGxzLXRob3VzYW5kcy1ob3Jtb25lLXBhdGNoZXMtZmFpbGVkLXNwZWNz0gEA?hl=en-US&gl=US&ceid=US%3Aen
The potential for conflict of interest when health policy experts also ...,2018-06-29 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMDYvcGhhcm1hLWNvbXBhbmllcy1hbmQtY29uZmxpY3Qtb2YtaW50ZXJlc3Qv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Meet the 'preeminent AI company on earth,' but can it succeed in ...",2018-06-25 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMDYvbWVldC10aGUtcHJlZW1pbmVudC1haS1jb21wYW55LW9uLWVhcnRoLWJ1dC1jYW4taXQtc3VjY2VlZC1pbi1oZWFsdGhjYXJlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Regulators recall valsartan after finding impurity tied to cancer risk,2018-07-19 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVndWxhdG9ycy1yZWNhbGwtdmFsc2FydGFuLWFmdGVyLWZpbmRpbmctaW1wdXJpdHktdGllZC10by1jYW5jZXItcmlzay81MjgxNDAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"CDMO Cambrex snatches Halo Pharma, getting 2 plants and 425 ...",2018-07-23 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9jZG1vLWNhbWJyZXgtYnV5cy1oYWxvLXBoYXJtYS1nZXR0aW5nLXR3by1wbGFudHMtNDI1LWVtcGxveWVlc9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Rice-sized form of Roche's Lucentis heads for advanced testing,2018-07-25 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmljZS1zaXplZC1mb3JtLW9mLXJvY2hlcy1sdWNlbnRpcy1oZWFkcy1mb3ItYWR2YW5jZWQtdGVzdGluZy81Mjg2NDYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Ironwood cuts 40 jobs ahead of company split,2018-07-06 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaXJvbndvb2QtY3V0cy00MC1qb2JzLWFoZWFkLW9mLWNvbXBhbnktc3BsaXQvNTI3MjA3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Sobi picks up Novimmune drug, strengthening pipeline",2018-07-23 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc29iaS1waWNrcy11cC1ub3ZpbW11bmUtZHJ1Zy1lbWFwYWx1bWFiLXBpcGVsaW5lLzUyODM2OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Gottlieb teases guidance on continuous trials, touts surrogate ...",2018-07-30 00:00:00,https://news.google.com/./articles/CBMic2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWdvdHRsaWViLXRlYXNlcy1ndWlkYW5jZS1jb250aW51b3VzLXRyaWFscy10b3V0cy1zdXJyb2dhdGUtZW5kcG9pbnRzLzUyODkxMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Regulus lays off 60% of staff, halts development",2018-07-06 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVndWx1cy1sYXlzLW9mZi02MC1vZi1zdGFmZi1oYWx0cy1kZXZlbG9wbWVudC81MjcyMzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie's new endometriosis drug to cost $10K per year,2018-07-24 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLWVsYWdvbGl4LWFwcHJvdmFsLW9ybGlzc2EtZW5kb21ldHJpb3Npcy1jb3N0LzUyODUxNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA rejects Insys opioid pain spray,2018-07-30 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXJlamVjdHMtaW5zeXMtb3Bpb2lkLXBhaW4tc3ByYXkvNTI4ODg0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Genevant inks development deal with BioNTech,2018-07-10 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2VuZXZhbnQtZGV2ZWxvcG1lbnQtZGVhbC1iaW9udGVjaC1yb2l2YW50LXJuYS1yYXJlLWRpc2Vhc2UvNTI3NDQ0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Diabetic Retinopathy: Reality and Risk of Loss to Follow-up,2018-07-27 00:00:00,https://news.google.com/./articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS84OTk2NDnSAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA calls Pfizer Estring marketing misleading,2018-07-03 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWNhbGxzLXBmaXplci1lc3RyaW5nLW1hcmtldGluZy1taXNsZWFkaW5nLzUyNzAyNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pharma is making inroads into digital health, albeit slowly",2018-07-13 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMDcvcGhhcm1hLWlzLW1ha2luZy1pbnJvYWRzLWludG8tZGlnaXRhbC1oZWFsdGgtYWxiZWl0LXNsb3dseS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Fotivda approved in Scotland for kidney cancer | pharmaphorum,2018-07-10 00:00:00,https://news.google.com/./articles/CBMiPGh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL2ZvdGl2ZGEtc2NvdGxhbmQta2lkbmV5LWNhbmNlctIBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA approves Agios Pharmaceuticals' Tibsovo for acute myeloid ...,2018-07-20 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMDcvZmRhLWFwcHJvdmVzLWFnaW9zLXBoYXJtYWNldXRpY2Fscy10aWJzb3ZvLWZvci1hY3V0ZS1teWVsb2lkLWxldWtlbWlhL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
When healthcare devices go over the counter,2018-07-25 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMDcvd2hlbi1oZWFsdGhjYXJlLWRldmljZXMtZ28tb3Zlci10aGUtY291bnRlci_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Kentucky biotech Apellis Pharmaceuticals plans major expansion in ...,2018-08-23 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDE4LzA4LzIzL2tlbnR1Y2t5LWJpb3RlY2gtYXBlbGxpcy1wbGFucy1tYWpvci1leHBhbnNpb24taW4uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay,2018-08-16 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RldmEtcy1jb3B5Y2F0LW15bGFuLXMtZXBpcGVuLXdpbnMtZmRhLWFmdGVyLXR3by15ZWFyLWRlbGF50gEA?hl=en-US&gl=US&ceid=US%3Aen
'Facts of Life' co-stars Kim Fields and Mindy Cohn reunite for Charlotte Rae's memorial service,2018-08-13 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9mYWN0cy1saWZlLWNvLXN0YXJzLWtpbS1maWVsZHMtbWluZHktY29obi1yZXVuaXRlLWNoYXJsb3R0ZS1yYWVzLWZ1bmVyYWwtMTc1NDUyMDM5Lmh0bWzSAX5odHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9mYWN0cy1saWZlLWNvLXN0YXJzLWtpbS1maWVsZHMtbWluZHktY29obi1yZXVuaXRlLWNoYXJsb3R0ZS1yYWVzLWZ1bmVyYWwtMTc1NDUyMDM5Lmh0bWw?hl=en-US&gl=US&ceid=US%3Aen
CVS adopts ICER metrics in shift to value-based drug pricing,2018-08-15 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY3ZzLWFkb3B0cy1pY2VyLW1ldHJpY3MtaW4tc2hpZnQtdG8tdmFsdWUtYmFzZWQtZHJ1Zy1wcmljaW5nLzUzMDE4MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Perrigo to split off generic drugs unit,2018-08-10 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGVycmlnby10by1zcGxpdC1vZmYtZ2VuZXJpYy1kcnVncy11bml0LzUyOTgxNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"GSK will close manufacturing plant in Ireland, cutting 165 jobs",2018-08-21 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ3NrLXdpbGwtY2xvc2UtbWFudWZhY3R1cmluZy1wbGFudC1pbi1pcmVsYW5kLWN1dHRpbmctMTY1LWpvYnMvNTMwNTY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Mallinckrodt gets CRL for newborn jaundice drug,2018-08-23 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFsbGluY2tyb2R0LWZkYS1jcmwtZm9yLW5ld2Jvcm4tamF1bmRpY2Utc3Rhbm5zb3BvcmZpbi81MzA3NzIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Emergent BioSolutions to acquire PaxVax and two travel vaccines in ...,2018-08-13 00:00:00,https://news.google.com/./articles/CBMicmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vdmFjY2luZXMvZW1lcmdlbnQtYmlvc29sdXRpb25zLXRvLWFjcXVpcmUtcGF4dmF4LWFuZC10d28tdHJhdmVsZXJzLXZhY2NpbmVzLTI3MG0tZGVhbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA bans products from another Chinese API maker,2018-08-21 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9mZGEtYmFucy1wcm9kdWN0cy1mcm9tLWFub3RoZXItY2hpbmVzZS1hcGktbWFrZXLSAQA?hl=en-US&gl=US&ceid=US%3Aen
Bellerophon halts Phase 3 trial for futility after interim data check,2018-08-08 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmVsbGVyb3Bob24taGFsdHMtcGhhc2UtMy10cmlhbC1mb3ItZnV0aWxpdHktYWZ0ZXItaW50ZXJpbS1kYXRhLWNoZWNrLzUyOTY1Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Cha-ching: Small biotechs write some of America's biggest paychecks,2018-08-07 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL21vcmUtdGhhbi1oYWxmLWFtZXJpY2Etcy1oaWdoZXN0LXNhbGFyaWVzLWFyZS1wYWlkLWJ5LXBoYXJtYS1jb21wYW5pZXMtcmVwb3J00gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA OKs first generic under new approval pathway,2018-08-08 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLW9rcy1maXJzdC1nZW5lcmljLXVuZGVyLW5ldy1hcHByb3ZhbC1wYXRod2F5LzUyOTY5My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"J&J, Bayer to shutter production plants in South Korea: report",2018-08-09 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotYmF5ZXItdG8tc2h1dHRlci1wcm9kdWN0aW9uLXBsYW50cy1pbi1zb3V0aC1rb3JlYS1yZXBvcnQvNTI5NDQ2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Harvard Pilgrim offers rare peek at 6 years of drug costs,2018-08-28 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaGFydmFyZC1waWxncmltLW9mZmVycy1yYXJlLXBlZWstYXQtNi15ZWFycy1vZi1kcnVnLWNvc3RzLzUzMTEwNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"SEC charges former Sangamo exec, others with insider trading",2018-08-24 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2VjLWNoYXJnZXMtZm9ybWVyLXNhbmdhbW8tZXhlYy1vdGhlcnMtd2l0aC1pbnNpZGVyLXRyYWRpbmcvNTMwODY5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
No more hands-off Roche supervision? Genentech brings out the ...,2018-08-16 00:00:00,https://news.google.com/./articles/CBMic2h0dHBzOi8vZW5kcHRzLmNvbS9uby1tb3JlLWhhbmRzLW9mZi1yb2NoZS1zdXBlcnZpc2lvbi1nZW5lbnRlY2gtYnJpbmdzLW91dC10aGUtYXhlLXByZXBzLWxheW9mZnMtZm9yLTIyMy1zdGFmZmVycy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Emergent gets shot in the arm with $270M deal for PaxVax,2018-08-10 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW1lcmdlbnQtZ2V0cy1zaG90LWluLXRoZS1hcm0td2l0aC0yNzBtLWRlYWwtZm9yLXBheHZheC81Mjk4MjQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Regeneron plots DTC advertising and discount push to put Eylea ...,2018-08-02 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JlZ2VuZXJvbi1zLW5ldy1sYXVuY2hlcy1zdGVwLXRvLXBpY2stdXAtZXlsZWEtcy1zbGFja9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA warns of link between some diabetes drugs and serious infection,2018-08-30 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXdhcm5zLW9mLWxpbmstYmV0d2Vlbi1zb21lLWRpYWJldGVzLWRydWdzLWFuZC1zZXJpb3VzLWluZmVjdGlvbi81MzEyOTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
TraceLink raises $93 million in Series D financing round,2018-08-24 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMDgvdHJhY2VsaW5rLXJhaXNlcy05My1taWxsaW9uLWluLXNlcmllcy1kLWZpbmFuY2luZy1yb3VuZC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Alexion to buy Syntimmune in potential $1.2B deal,2018-09-26 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi10by1idXktc3ludGltbXVuZS1pbi1wb3RlbnRpYWwtMTJiLWRlYWwvNTMzMjgwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Romania's Polisano Pharma now under control of local rail freight ...,2018-09-19 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9yb21hbmlhLXMtcG9saXNhbm8tcGhhcm1hLW5vdy11bmRlci1jb250cm9sLWxvY2FsLXJhaWwtZnJlaWdodC1ncm91cNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Roche jumps on Tregs trend with a potential $750M deal,2018-09-28 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtanVtcHMtb24tdHJlZ3MtdHJlbmQtd2l0aC1hLXBvdGVudGlhbC03NTBtLWRlYWwvNTMzNDk4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"PhRMA, hospital war over drug prices heats up",2018-09-06 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhybWEtaG9zcGl0YWwtd2FyLW92ZXItZHJ1Zy1wcmljZXMtaGVhdHMtdXAvNTMxNzU2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Narcan developer secures grant for counter to opioid weaponization,2018-09-21 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmFyY2FuLWRldmVsb3Blci1zZWN1cmVzLWdyYW50LWZvci1jb3VudGVyLXRvLW9waW9pZC13ZWFwb25pemF0aW9uLzUzMjk0NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi reaches $25M settlement with SEC on bribery charges,2018-09-05 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLXNldHRsZW1lbnQtc2VjLWJyaWJlcnktY2hhcmdlcy81MzE2MDAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
NICE says no to Kymriah for adult lymphoma despite offer on price,2018-09-19 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmljZS1zYXlzLW5vLXRvLWt5bXJpYWgtZm9yLWFkdWx0LWx5bXBob21hLWRlc3BpdGUtb2ZmZXItb24tcHJpY2UvNTMyNzM4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma,2018-09-20 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9jYW1icmV4LWNsb3Nlcy00MjVtLWRlYWwtZm9yLWRvc2FnZS1mb3JtLWNkbW8taGFsby1waGFybWHSAQA?hl=en-US&gl=US&ceid=US%3Aen
UK High Court OKs Avastin off-label use in wet AMD,2018-09-24 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdWstaGlnaC1jb3VydC1va3MtYXZhc3Rpbi1vZmYtbGFiZWwtdXNlLWluLXdldC1hbWQvNTMzMDQ2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
ADMA looks for FDA approvals of genetic disorder treatments after ...,2018-09-05 00:00:00,https://news.google.com/./articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9hZG1hLWxvb2tzLWZvci1mZGEtYXBwcm92YWxzLWdlbmV0aWMtZGlzb3JkZXItdHJlYXRtZW50cy1hZnRlci1maXhpbmctcGxhbnQtaXNzdWVz0gEA?hl=en-US&gl=US&ceid=US%3Aen
Apellis Pharmaceuticals CEO Cedric Francois on the state of the ...,2018-10-01 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9sb3Vpc3ZpbGxlL25ld3MvMjAxOC8xMC8wMS9leGNsdXNpdmUtYXBlbGxpcy1jZW8tc2F5cy1jb21wYW55LWhhcy1uby1wbGFucy10by5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Nestlé, Coca-Cola and Unilever in final bidding war for GSK's ...",2018-10-02 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25lc3RsZS1jb2NhLWNvbGEtYW5kLXVuaWxldmVyLWFkdmFuY2UtYmlkZGluZy13YXItZm9yLWdzay1zLWhvcmxpY2tzLXJlcG9ydNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Doubts grow around Omeros’s kidney disease contender,2018-10-02 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvZG91YnRzLWdyb3ctYXJvdW5kLW9tZXJvc3Mta2lkbmV5LWRpc2Vhc2UtY29udGVuZGVy0gEmaHR0cDovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xMzg3Ni9hbXA?hl=en-US&gl=US&ceid=US%3Aen
Hope on the horizon for rare kidney disease,2018-10-11 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3Nwb3RsaWdodC9ob3BlLWhvcml6b24tcmFyZS1raWRuZXktZGlzZWFzZdIBJmh0dHA6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTM4OTkvYW1w?hl=en-US&gl=US&ceid=US%3Aen
"Momenta to halve workforce with 110 job cuts, including co-founder ...",2018-10-02 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbW9tZW50YS10by1oYWx2ZS13b3JrZm9yY2Utd2l0aC0xMTAtam9iLWN1dHMtaW5jbHVkaW5nLWNvLWZvdW5kZXItYW5kLWNmby81Mzg2NTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Eli Lilly puts up $100M in RNAi deal with Dicerna,2018-10-29 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpLWxpbGx5LXB1dHMtdXAtMTAwbS1pbi1ybmFpLWRlYWwtd2l0aC1kaWNlcm5hLzU0MDgyNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
GSK opens new Ellipta plant in Scotland,2018-10-25 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ3NrLW9wZW5zLW5ldy1lbGxpcHRhLXBsYW50LWluLXNjb3RsYW5kLzU0MDYwNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Shire debuts plasma facility in boost to manufacturing,2018-10-18 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2hpcmUtZGVidXRzLXBsYXNtYS1mYWNpbGl0eS1pbi1ib29zdC10by1tYW51ZmFjdHVyaW5nLzUzOTk5OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie reaches 5th deal to secure Humira through 2023,2018-10-19 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLXJlYWNoZXMtNXRoLWRlYWwtdG8tc2VjdXJlLWh1bWlyYS10aHJvdWdoLTIwMjMvNTQwMDk1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
J&J's top-seller Stelara looks set to expand into ulcerative colitis,2018-10-09 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvampzLXRvcC1zZWxsZXItc3RlbGFyYS1sb29rcy1zZXQtdG8tZXhwYW5kLWludG8tdWxjZXJhdGl2ZS1jb2xpdGlzLzUzOTIyOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Amgen launches TV spot for Aimovig in tight CGRP market,2018-10-17 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tbGF1bmNoZXMtdHYtc3BvdC1mb3ItYWltb3ZpZy1pbi10aWdodC1jZ3JwLW1hcmtldC81Mzk5NDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
How to Invest $10K Right Now • Benzinga,2020-10-13 00:00:00,https://news.google.com/./articles/CBMiMGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9tb25leS9ob3ctdG8taW52ZXN0LTEwa9IBAA?hl=en-US&gl=US&ceid=US%3Aen
From graduate to chairman: My 30 years in pharma | pharmaphorum,2018-10-02 00:00:00,https://news.google.com/./articles/CBMiRmh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9zYWxlcy1tYXJrZXRpbmcvMzBfeWVhcnNfcGhhcm1hX2tyaXNfc3RlcmtlbnPSAQA?hl=en-US&gl=US&ceid=US%3Aen
How Besse Medical is innovating in inventory management,2018-10-23 00:00:00,https://news.google.com/./articles/CBMiQ2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMTAvYmVzc2UtbWVkaWNhbC1pbnZlbnRvcnktbWFuYWdlbWVudC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Enable Injections Enters into Strategic Partnerships with UCB and ...,2018-11-13 00:00:00,https://news.google.com/./articles/CBMikQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2VuYWJsZS1pbmplY3Rpb25zLWVudGVycy1pbnRvLXN0cmF0ZWdpYy1wYXJ0bmVyc2hpcHMtd2l0aC11Y2ItYW5kLWFwZWxsaXMtcGhhcm1hY2V1dGljYWxzLTMwMDc0ODcwMC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
Treatments for Tomorrow and a Vision for the Future: A Look at ...,2018-11-26 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BvbnNvcmVkL3RyZWF0bWVudHMtZm9yLXRvbW9ycm93LWFuZC1hLXZpc2lvbi1mb3ItZnV0dXJlLWEtbG9vay1hdC1pbm5vdmF0aW9u0gEA?hl=en-US&gl=US&ceid=US%3Aen
UK calls Vertex on contentious Orkambi negotiations,2018-11-12 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LW9ya2FtYmktdWstcHJpY2UtY2YtcmVpbWJ1cnNlbWVudC1sZXR0ZXIvNTQxOTk5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
The top 10 cancer drug makers of 2024,2018-11-12 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTEwLWNhbmNlci1kcnVnbWFrZXJzLTIwMjTSAQA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie staves off 6th Humira biosimilar in US,2018-11-07 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLXN0YXZlcy1vZmYtNnRoLWh1bWlyYS1iaW9zaW1pbGFyLWluLXVzLzU0MTY2NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Sandoz recalls losartan products that contain impurity,2018-11-12 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9zYW5kb3otcmVjYWxscy1sb3NhcnRhbi1wcm9kdWN0cy1jb250YWluLWltcHVyaXR50gEA?hl=en-US&gl=US&ceid=US%3Aen
Tapping into collective intelligence: Why collaboration is critical for ...,2018-11-09 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3RhcHBpbmctaW50by1jb2xsZWN0aXZlLWludGVsbGlnZW5jZS13aHktY29sbGFib3JhdGlvbi1pcy1jcml0aWNhbC1mb3ItdGhlLzU0MDE2Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Mallinckrodt's rare disease drug set back by confusing trial result,2018-11-08 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFsbGluY2tyb2R0cy1yYXJlLWRpc2Vhc2UtZHJ1Zy1zZXQtYmFjay1ieS1jb25mdXNpbmctdHJpYWwtcmVzdWx0LzU0MTczMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Court opens path for Dr. Reddy's to launch generic Suboxone,2018-11-21 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY291cnQtb3BlbnMtcGF0aC1mb3ItZHItcmVkZHlzLXRvLWxhdW5jaC1nZW5lcmljLXN1Ym94b25lLzU0Mjc3NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
England's NHS says Humira biosimilar pacts to save more than $300M,2018-11-27 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW5nbGFuZHMtbmhzLXNheXMtaHVtaXJhLWJpb3NpbWlsYXItcGFjdHMtdG8tc2F2ZS1tb3JlLXRoYW4tMzAwbS81NDMwMjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Roche pulls EU application for Tecentriq in kidney cancer,2018-11-19 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtcHVsbHMtZXUtYXBwbGljYXRpb24tZm9yLXRlY2VudHJpcS1pbi1raWRuZXktY2FuY2VyLzU0MjU4NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Allergan axes expansion plan, but reiterates commitment to Waco ...",2018-11-01 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tYXhlcy1leHBhbnNpb24tcGxhbi1idXQtcmVpdGVyYXRlcy1jb21taXRtZW50LXRvLXdhY28tcGxhbnQvNTQxMDMxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Luxturna cleared for sale in Europe, but payer support uncertain",2018-11-26 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbHV4dHVybmEtY2xlYXJlZC1mb3Itc2FsZS1pbi1ldXJvcGUtYnV0LXBheWVyLXN1cHBvcnQtdW5jZXJ0YWluLzU0MjkwMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Mylan, Theravance win FDA approval for COPD drug",2018-11-12 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXlsYW4tdGhlcmF2YW5jZS15dWxwZXJpLWNvcGQtYXBwcm92YWwvNTQxOTk0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
GE Healthcare opens new manufacturing center in England,2018-11-29 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2UtaGVhbHRoY2FyZS1vcGVucy1uZXctbWFudWZhY3R1cmluZy1jZW50ZXItaW4tZW5nbGFuZC81NDMxNDUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Coherus biosimilar to launch in US at 33% discount to Neulasta,2018-11-09 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY29oZXJ1cy1iaW9zaW1pbGFyLXRvLWxhdW5jaC1pbi11cy1hdC0zMy1kaXNjb3VudC10by1uZXVsYXN0YS81NDE4NTkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Lilly snaps up regulatory 'fast pass' for bargain price,2018-11-02 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktc25hcHMtdXAtcmVndWxhdG9yeS1mYXN0LXBhc3MtZm9yLWJhcmdhaW4tcHJpY2UvNTQxMjYwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
An interview with Nobel Prize-winning cancer immunologist Jim ...,2018-11-29 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW4taW50ZXJ2aWV3LXdpdGgtbm9iZWwtcHJpemUtd2lubmluZy1jYW5jZXItaW1tdW5vbG9naXN0LWppbS1hbGxpc29uLzU0MzIwOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
The global paroxysmal nocturnal hemoglobinuria (PNH) treatment ...,2018-11-14 00:00:00,https://news.google.com/./articles/CBMi1wFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3RoZS1nbG9iYWwtcGFyb3h5c21hbC1ub2N0dXJuYWwtaGVtb2dsb2JpbnVyaWEtcG5oLXRyZWF0bWVudC1tYXJrZXQtc2l6ZS1pcy1leHBlY3RlZC10by1yZWFjaC11c2QtNS04LWJpbGxpb24tYnktMjAyNS1hdC1hLTExLTItY2Fnci1kdXJpbmctdGhlLWZvcmVjYXN0LXBlcmlvZC0zMDA3NTA1MzEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Alexion sets up Soliris successor for switching,2018-12-24 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvYWxleGlvbi1zZXRzLXNvbGlyaXMtc3VjY2Vzc29yLXN3aXRjaGluZ9IBJmh0dHA6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTQxNzYvYW1w?hl=en-US&gl=US&ceid=US%3Aen
Jeans and other drugs: Novartis CEO Narasimhan's prescription for ...,2018-12-07 00:00:00,https://news.google.com/./articles/CBMicmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2plYW5zLWFuZC1jdWx0dXJlLWNoYW5nZS1ub3ZhcnRpcy1jZW8tbmFyYXNpbWhhbi1zLWRvc2UtdG8tYXR0cmFjdC1taWxsZW5uaWFsc9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Ra joins the challenge to Alexion’s Soliris stranglehold,2018-12-12 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3Nwb3RsaWdodC9yYS1qb2lucy1jaGFsbGVuZ2UtYWxleGlvbnMtc29saXJpcy1zdHJhbmdsZWhvbGTSASZodHRwOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE0MTQxL2FtcA?hl=en-US&gl=US&ceid=US%3Aen
Guggenheim: Dominion's Scana Acquisition A 'Big Win',2018-12-17 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9ndWdnZW5oZWltLWRvbWluaW9ucy1zY2FuYS1hY3F1aXNpdGlvbi1iaWctMTcwNDIzMjkzLmh0bWzSAWBodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9ndWdnZW5oZWltLWRvbWluaW9ucy1zY2FuYS1hY3F1aXNpdGlvbi1iaWctMTcwNDIzMjkzLmh0bWw?hl=en-US&gl=US&ceid=US%3Aen
Sanofi inks Boston area office deal for 2700 workers,2018-12-18 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLWNhbWJyaWRnZS1sZWFzZXMtbmV3LW9mZmljZXMtd29ya2Vycy81NDQ2MzIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Chinese company at heart of valsartan investigation hit with warning ...,2018-12-12 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2hpbmVzZS1jb21wYW55LWF0LWhlYXJ0LW9mLXZhbHNhcnRhbi1pbnZlc3RpZ2F0aW9uLWhpdC13aXRoLXdhcm5pbmctbGV0dGVyLzU0NDIzNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Eli Lilly's former drug yields Phase 2 win for Vanda Pharma,2018-12-04 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpLWxpbGx5cy1mb3JtZXItZHJ1Zy15aWVsZHMtcGhhc2UtMi13aW4tZm9yLXZhbmRhLXBoYXJtYS81NDM1MzQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer taps Seattle-based Kineta in immunotherapy deal,2018-12-18 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLWtpbmV0YS1pbW11bm90aGVyYXB5LWRlYWwvNTQ0NjIwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA turns down Mallinckrodt application for reformulated oxycodone,2018-12-13 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXR1cm5zLWRvd24tbWFsbGluY2tyb2R0LWFwcGxpY2F0aW9uLWZvci1yZWZvcm11bGF0ZWQtb3h5Y29kb25lLzU0NDI5MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novo Nordisk to invest $22M in North Carolina diabetes plant,2018-12-06 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by1ub3JkaXNrLXRvLWludmVzdC0yMm0taW4tbm9ydGgtY2Fyb2xpbmEtZGlhYmV0ZXMtcGxhbnQvNTQzNzc4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"FedEx, Walgreens partner for next-day delivery of prescription drugs",2018-12-07 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2FsZ3JlZW5zLWZlZGV4LXBhcnRuZXJzaGlwLW5leHQtZGF5LWRlbGl2ZXJ5LXByZXNjcmlwdGlvbi1zZXJ2aWNlLzU0Mzk5Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"J&J, Merck back new UK vaccine manufacturing center",2018-12-06 00:00:00,https://news.google.com/./articles/CBMiRGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamFuc3Nlbi1tZXJjay12YWNjaW5lLXVrLS81NDM1NTYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Blockchain becomes a 'source of truth' for biopharma,2018-12-13 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMTIvYmxvY2tjaGFpbi1iZWNvbWVzLWEtc291cmNlLW9mLXRydXRoLWZvci1iaW9waGFybWEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Mission Bio raises $30M in Series B round to develop genomics ...,2018-12-14 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTgvMTIvbWlzc2lvbi1iaW8tcmFpc2VzLTMwbS1pbi1zZXJpZXMtYS1yb3VuZC10by1kZXZlbG9wLWdlbm9taWNzLXBsYXRmb3JtL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Present Movement: Brookfield Property Partners L.P. (NASDAQ: BPY),2018-12-03 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vcmVhZ2VudHNnbG9iYWxtYXJrZXQuY29tLzIwMTgvMTIvMDMvcHJlc2VudC1tb3ZlbWVudC1icm9va2ZpZWxkLXByb3BlcnR5LXBhcnRuZXJzLWwtcC1uYXNkYXEtYnB5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Baird: Camping World Has Work To Do To Regain Credibility,2019-01-03 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iYWlyZC1jYW1waW5nLXdvcmxkLXJlZ2Fpbi1jcmVkaWJpbGl0eS0xNTI4MDE5NzkuaHRtbNIBXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2JhaXJkLWNhbXBpbmctd29ybGQtcmVnYWluLWNyZWRpYmlsaXR5LTE1MjgwMTk3OS5odG1s?hl=en-US&gl=US&ceid=US%3Aen
Akorn's drug pipeline 'held hostage' with FDA warning letter,2019-01-10 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWtvcm5zLWRydWctcGlwZWxpbmUtaGVsZC1ob3N0YWdlLXdpdGgtZmRhLXdhcm5pbmctbGV0dGVyLzU0NTc1OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pharma DTC spending outpaces rest of medical marketing, JAMA ...",2019-01-07 00:00:00,https://news.google.com/./articles/CBMicmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhcm1hLWR0Yy1zcGVuZGluZy1vdXRwYWNlcy1yZXN0LW9mLW1lZGljYWwtbWFya2V0aW5nLWphbWEtc3R1ZHktZmluZHMvNTQ1NDQxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Bluebird proposes installment plan for LentiGlobin gene therapy,2019-01-09 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvanBtMTktYmx1ZWJpcmQtcHJvcG9zZXMtaW5zdGFsbG1lbnQtcGxhbi1mb3ItbGVudGlnbG9iaW4tZ2VuZS10aGVyYXB5LzU0NTY0Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Vertex fires COO Ian Smith for unspecified code of conduct violation,2019-01-23 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3ZlcnRleC1maXJlcy1jb28taWFuLXNtaXRoLWZvci11bnNwZWNpZmllZC1jb2RlLWNvbmR1Y3QtdmlvbGF0aW9u0gEA?hl=en-US&gl=US&ceid=US%3Aen
Potential Restasis rival falls short in head-to-head study,2019-01-22 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcG90ZW50aWFsLXJlc3Rhc2lzLXJpdmFsLWZhbGxzLXNob3J0LWluLWhlYWQtdG8taGVhZC1zdHVkeS81NDY1NDUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Takeda takes another step into cell therapy research,2019-01-04 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGFrZWRhLXRha2VzLWFub3RoZXItc3RlcC1pbnRvLWNlbGwtdGhlcmFweS1yZXNlYXJjaC81NDUyNzkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Esperion licenses European rights on cholesterol drug for $300M,2019-01-04 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXNwZXJpb24tYmVtcGVkb2ljLWFjaWQtZGFpaWNoaS1saWNlbnNlLWNob2xlc3Rlcm9sLzU0NTIzNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Kindred CEO Ben Breier on company’s changes,2019-01-25 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vd3d3LndhdmUzLmNvbS8yMDE5LzAxLzI2L2tpbmRyZWRzLWNlby1iZW4tYnJlaWVyLWNvbXBhbnlzLWNoYW5nZXMv0gFZaHR0cHM6Ly93d3cud2F2ZTMuY29tLzIwMTkvMDEvMjYva2luZHJlZHMtY2VvLWJlbi1icmVpZXItY29tcGFueXMtY2hhbmdlcy8_b3V0cHV0VHlwZT1hbXA?hl=en-US&gl=US&ceid=US%3Aen
Spectrum Pharmaceuticals sells marketed drugs to Aurobindo ...,2019-01-17 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDEvc3BlY3RydW0tcGhhcm1hY2V1dGljYWxzLXNlbGxzLW1hcmtldGVkLWRydWdzLXRvLWF1cm9iaW5kby1zdWJzaWRpYXJ5LWZvci11cC10by0zMDBtL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Amid worldwide cutbacks, Bayer to shutter Pennsylvania site, cut ...",2019-01-16 00:00:00,https://news.google.com/./articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL3BoYXJtYS9iYXllci10by1jbG9zZS1yb2JpbnNvbi1wZW5uc3lsdmFuaWEtc2l0ZS1hZmZlY3RpbmctNjAwLWpvYnMtZmlyc3Qtc3RlcC10b3dhcmQtY29uc29saWRhdGlvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen
RNA Therapy Improves Vision in Child Blindness-More ...,2019-01-02 00:00:00,https://news.google.com/./articles/CBMigQFodHRwczovL3BoYXJtYXBob3J1bS5jb20vcGFydG5lci1jb250ZW50L3JuYS10aGVyYXB5LWltcHJvdmVzLXZpc2lvbi1pbi1jaGlsZC1ibGluZG5lc3MtbW9yZS1kZXZlbG9wbWVudHMtYXQtcm5hLXRoZXJhcGV1dGljcy0xOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Bristol-Myers' rumored activists 'haven't made a decision' on the ...,2019-02-06 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtcnVtb3JlZC1hY3RpdmlzdHMtaGF2ZW4tdC1tYWRlLWEtZGVjaXNpb24tY29tcGFueS15ZXQtc3RhcmJvYXJkLWNlb9IBAA?hl=en-US&gl=US&ceid=US%3Aen
A 'disoriented' Pain Therapeutics flips out after FDA rejects appeal ...,2019-02-05 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vZW5kcHRzLmNvbS9hLWRpc29yaWVudGVkLXBhaW4tdGhlcmFwZXV0aWNzLWZsaXBzLW91dC1hZnRlci1mZGEtcmVqZWN0cy1hcHBlYWwtb24tcmVtb3h5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Christie Brinkley, 65, looks better than ever — and these are her anti-aging secrets",2019-02-01 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jaHJpc3RpZS1icmlua2xleS02NS1sb29rcy1iZXR0ZXItZXZlci1hbnRpLWFnaW5nLXNlY3JldHMtMjAwODE2ODcwLmh0bWzSAW9odHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9jaHJpc3RpZS1icmlua2xleS02NS1sb29rcy1iZXR0ZXItZXZlci1hbnRpLWFnaW5nLXNlY3JldHMtMjAwODE2ODcwLmh0bWw?hl=en-US&gl=US&ceid=US%3Aen
Sanofi chief medical officer takes on additional digital role,2019-02-15 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9jb3Jwb3JhdGUvc2Fub2ZpLWNoaWVmLW1lZGljYWwtb2ZmaWNlci10YWtlcy1vbi1hZGRpdGlvbmFsLWRpZ2l0YWwtcm9sZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J inks deal with MeiraGTx for retinal disease gene therapies,2019-02-01 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotaW5rcy1kZWFsLXdpdGgtbWVpcmFndHgtZm9yLXJldGluYWwtZGlzZWFzZS1nZW5lLXRoZXJhcGllcy81NDc0MjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Jazz set to lose rights to Erwinaze after partner cancels deal,2019-02-13 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamF6ei1zZXQtdG8tbG9zZS1yaWdodHMtdG8tZXJ3aW5hemUtYWZ0ZXItcGFydG5lci1jYW5jZWxzLWRlYWwvNTQ4MzcwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Charles River Labs snaps up early-stage CRO for $510M,2019-02-14 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2hhcmxlcy1yaXZlci1sYWJzLXNuYXBzLXVwLWVhcmx5LXN0YWdlLWNyby1mb3ItNTEwbS81NDg0NjEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Roche gains quick review for two cancer drugs,2019-02-19 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtZ2FpbnMtcXVpY2stcmV2aWV3LWZvci10d28tY2FuY2VyLWRydWdzLzU0ODcxMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Xtandi results bolster Pfizer, Astellas in prostate cancer",2019-02-12 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MveHRhbmRpLXJlc3VsdHMtYm9sc3Rlci1wZml6ZXItYXN0ZWxsYXMtaW4tcHJvc3RhdGUtY2FuY2VyLzU0ODI0Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Vertex, CRISPR Therapeutics infuse first patient in CRISPR/Cas9 ...",2019-02-25 00:00:00,https://news.google.com/./articles/CBMieGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDIvdmVydGV4LWNyaXNwci10aGVyYXBldXRpY3MtaW5mdXNlLWZpcnN0LXBhdGllbnQtaW4tY3Jpc3ByLWNhczktYmFzZWQtZ2VuZS10aGVyYXB5LXN0dWR5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Intercept could score first NASH drug approval on positive Phase III ...,2019-02-19 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDIvaW50ZXJjZXB0LWNvdWxkLXNjb3JlLWZpcnN0LW5hc2gtZHJ1Zy1hcHByb3ZhbC1vbi1wb3NpdGl2ZS1waGFzZS1paWktZGF0YS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"FDA hits United Exchange with warning letter, citing poor quality ...",2019-03-20 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9mZGEtaGl0cy11bml0ZWQtZXhjaGFuZ2Utd2FybmluZy1sZXR0ZXItY2l0aW5nLXBvb3ItcXVhbGl0eS1jb250cm9sLWlzc3Vlc9IBAA?hl=en-US&gl=US&ceid=US%3Aen
High school students involved in nude sexting scandal: 'Most have no clue they are committing a crime',2019-03-14 00:00:00,https://news.google.com/./articles/CBMieWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oaWdoLXNjaG9vbC1zdHVkZW50cy1pbnZvbHZlZC1udWRlLXNleHRpbmctc2NhbmRhbC1uby1jbHVlLWNvbW1pdHRpbmctY3JpbWUtMTE0NzIxMDU1Lmh0bWzSAYEBaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvaGlnaC1zY2hvb2wtc3R1ZGVudHMtaW52b2x2ZWQtbnVkZS1zZXh0aW5nLXNjYW5kYWwtbm8tY2x1ZS1jb21taXR0aW5nLWNyaW1lLTExNDcyMTA1NS5odG1s?hl=en-US&gl=US&ceid=US%3Aen
"As generic entry looms for its cash cow, Jazz wins FDA nod for ...",2019-03-21 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vZW5kcHRzLmNvbS9hcy1nZW5lcmljLWVudHJ5LWxvb21zLWZvci1pdHMtY2FzaC1jb3ctamF6ei13aW5zLWZkYS1ub2QtZm9yLWZvbGxvdy11cC1zbGVlcC1kaXNvcmRlci1kcnVnL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Achillion Pharmaceuticals: The Promise Of Alternative Pathway ...,2019-03-20 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQyNDk5NjQtYWNoaWxsaW9uLXBoYXJtYWNldXRpY2Fscy1wcm9taXNlLW9mLWFsdGVybmF0aXZlLXBhdGh3YXktaW5oaWJpdGlvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen
"Less than a year after Rhopressa launch, Aerie scores new ...",2019-03-13 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vZW5kcHRzLmNvbS9sZXNzLXRoYW4tYS15ZWFyLWFmdGVyLXJob3ByZXNzYS1sYXVuY2gtYWVyaWUtc2NvcmVzLW5ldy1nbGF1Y29tYS1kcnVnLWFwcHJvdmFsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Alcon will officially leave Novartis on April 9 after an 8-year run ...,2019-03-22 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FmdGVyLTgteWVhci1ydW4tYWxjb24tdG8tb2ZmaWNpYWxseS1sZWF2ZS1ub3ZhcnRpcy1hcHJpbC050gEA?hl=en-US&gl=US&ceid=US%3Aen
Biocon biosimilar plant criticized again by the FDA,2019-03-12 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9iaW9jb24tYmlvc2ltaWxhci1wbGFudC1jcml0aWNpemVkLWFnYWluLWJ5LWZkYdIBAA?hl=en-US&gl=US&ceid=US%3Aen
How Scott Gottlieb changed the FDA,2019-03-06 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaG93LXNjb3R0LWdvdHRsaWViLWNoYW5nZWQtdGhlLWZkYS81NDk4Njgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Key drugs from Merck, Roche win wider EU approvals",2019-03-14 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2V5LWRydWdzLWZyb20tbWVyY2stcm9jaGUtd2luLXdpZGVyLWV1LWFwcHJvdmFscy81NTA1MTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Louisiana selects Gilead for subscription-based hep C program,2019-03-27 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbG91aXNpYW5hLWdpbGVhZC1zdWJzY3JpcHRpb24tbW9kZWwtaGVwYXRpdGlzLWMtZHJ1Z3MvNTUxNDI4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novo uses a PRV to submit oral semaglutide to FDA,2019-03-21 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by11c2VzLWEtcHJ2LXRvLXN1Ym1pdC1vcmFsLXNlbWFnbHV0aWRlLXRvLWZkYS81NTEwNDQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Celgene's Abraxane fails late-stage pancreatic cancer study,2019-03-13 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZXMtYWJyYXhhbmUtZmFpbHMtbGF0ZS1zdGFnZS1wYW5jcmVhdGljLWNhbmNlci1zdHVkeS81NTA0MTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
California's Women Requirement for Company Boards Could Pave ...,2019-03-21 00:00:00,https://news.google.com/./articles/CBMiOGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vZ3JhcGhpY3MvMjAxOS13b21lbi1vbi1ib2FyZHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Novo, seeking edge in diabetes, posts positive Ozempic data",2019-03-05 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by1zZWVraW5nLWVkZ2UtaW4tZGlhYmV0ZXMtcG9zdHMtcG9zaXRpdmUtb3plbXBpYy1kYXRhLzU0OTc3NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Tucker Carlson's off-the-rail insults put pharma advertisers in hot seat,2019-03-12 00:00:00,https://news.google.com/./articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL21hcmtldGluZy9waGFybWEtdHYtYWR2ZXJ0aXNlcnMtdGFrZS1oZWF0LWZvci1idXlpbmctYWRzLWZveC1zaG93LWFmdGVyLWNvbnRyb3ZlcnNpYWwtaG9zdC1jb21tZW50c9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Report: UPS to launch healthcare delivery service as competition ...,2019-03-25 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDMvcmVwb3J0LXVwcy10by1sYXVuY2gtaGVhbHRoY2FyZS1kZWxpdmVyeS1idXNpbmVzcy1hcy1jb21wZXRpdGlvbi13aXRoLWFtYXpvbi1oZWF0cy11cC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Contenders line up to steal the show at AACR 2019,2019-03-28 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9jb250ZW5kZXJzLWxpbmUtdXAtdG8tc3RlYWwtdGhlLXNob3ctYXQtYWFjci0yMDE50gEA?hl=en-US&gl=US&ceid=US%3Aen
Teen surprises his single mom with a car: ‘I am speechless’,2019-04-01 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90ZWVuLXN1cnByaXNlcy1zaW5nbGUtbW9tLWNhci1zcGVlY2hsZXNzLTE1MzUzNTg5OC5odG1s0gFeaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvdGVlbi1zdXJwcmlzZXMtc2luZ2xlLW1vbS1jYXItc3BlZWNobGVzcy0xNTM1MzU4OTguaHRtbA?hl=en-US&gl=US&ceid=US%3Aen
White supremacist executed in Texas for brutal dragging death of black man,2019-04-25 00:00:00,https://news.google.com/./articles/CBMieGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aGl0ZS1zdXByZW1hY2lzdC1leGVjdXRlZC1pbi10ZXhhcy1mb3ItYnJ1dGFsLWRyYWdnaW5nLWRlYXRoLW9mLWJsYWNrLW1hbi0wODQyMTU4OTEuaHRtbNIBgAFodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy93aGl0ZS1zdXByZW1hY2lzdC1leGVjdXRlZC1pbi10ZXhhcy1mb3ItYnJ1dGFsLWRyYWdnaW5nLWRlYXRoLW9mLWJsYWNrLW1hbi0wODQyMTU4OTEuaHRtbA?hl=en-US&gl=US&ceid=US%3Aen
Vertex brings in Ortho Clinical exec to fill CFO role,2019-04-02 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LWJyaW5ncy1pbi1vcnRoby1jbGluaWNhbC1leGVjLXRvLWZpbGwtY2ZvLXJvbGUvNTUxODU1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
The top 15 pharma companies by 2018 revenue,2019-04-08 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTE1LXBoYXJtYS1jb21wYW5pZXMtYnktMjAxOC1yZXZlbnVl0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Corning Valor® Glass, A Glass Package Designed Specifically for ...",2019-04-22 00:00:00,https://news.google.com/./articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BvbnNvcmVkL2Nvcm5pbmctdmFsb3Itci1nbGFzcy1hLWdsYXNzLXBhY2thZ2UtZGVzaWduZWQtc3BlY2lmaWNhbGx5LWZvci1waGFybWFjZXV0aWNhbC11c2XSAQA?hl=en-US&gl=US&ceid=US%3Aen
Lilly to withdraw FDA-approved cancer drug after clinical failure,2019-04-25 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktdG8td2l0aGRyYXctZmRhLWFwcHJvdmVkLWNhbmNlci1kcnVnLWFmdGVyLWNsaW5pY2FsLWZhaWx1cmUvNTUzNDQzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Three ways to get the most from your field-based roles,2019-04-25 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3RocmVlLXdheXMtdG8tZ2V0LXRoZS1tb3N0LWZyb20teW91ci1maWVsZC1iYXNlZC1yb2xlcy81NTMxNzAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novo seeks Victoza label expansion with fresh pediatric trial results,2019-04-29 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92b3MtdmljdG96YS10eXBlLTItZGlhYmV0ZXMtbGFiZWwtZXhwYW5zaW9uLXdpdGgtZWxsaXBzZS1uZWptLXN0dWR5LzU1MzY1Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Slam dunk? Arbor taps O'Neal for heart failure drug's first consumer ...,2019-04-04 00:00:00,https://news.google.com/./articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL21hcmtldGluZy9zbGFtLWR1bmstYXJib3ItdGFwcy1zaGFxdWlsbGUtby1uZWFsLWZvci1maXJzdC1jb25zdW1lci1wdXNoLWZvci1oZWFydC1mYWlsdXJlLW1lZC1iaWRpbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
United Therapeutics teamed with pumpmaker to block Remodulin ...,2019-04-18 00:00:00,https://news.google.com/./articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3VuaXRlZC10aGVyYXBldXRpY3MtYW5kLWRldmljZS1tYWtlci1wbGFjZWQtYXJ0aWZpY2lhbC1yZXN0cmljdGlvbnMtcHVtcHMtdG8tYmxvY2stZ2VuZXJpY9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Hospital-led generic drugmaker Civica Rx opens HQ in Utah,2019-04-18 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaG9zcGl0YWwtbGVkLWdlbmVyaWMtZHJ1Z21ha2VyLWNpdmljYS1yeC1vcGVucy1ocS1pbi11dGFoLzU1MzI0NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Teva gives up on cluster headache for Ajovy, ending Phase 3 study",2019-04-23 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS1ham92eS1jbHVzdGVyLWhlYWRhY2hlLXBoYXNlLTMtbGlsbHktZW1nYWxpdHkvNTUzMjUyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Japan's Ajinomoto Bio-Pharma Services takes control of GeneDesign,2019-04-15 00:00:00,https://news.google.com/./articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9qYXBhbi1zLWFqaW5vbW90by1iaW8tcGhhcm1hLXNlcnZpY2VzLWFkZHMtZ2VuZS1zZXJ2aWNlcy1nZW5lZGVzaWduLWRlYWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Teva wins generic Narcan approval as FDA mulls bolder actions,2019-04-22 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS1uYXJjYW4tZ2VuZXJpYy1mZGEtYXBwcm92YWwtY28tcHJlc2NyaXB0aW9uLzU1MzE0OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Blow for Gilead as another NASH trial fails | pharmaphorum,2019-04-26 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL2Jsb3ctZm9yLWdpbGVhZC1hcy1hbm90aGVyLW5hc2gtdHJpYWwtZmFpbHPSAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis in nearly $1.6B deal to buy NASH-focused subsidiary of ...,2019-04-01 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDQvbm92YXJ0aXMtaW4tbmVhcmx5LTEtNmItZGVhbC10by1idXktbmFzaC1mb2N1c2VkLXN1YnNpZGlhcnktb2YtaWZtLXRoZXJhcGV1dGljcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Cold agglutinin disease: current challenges and future prospects | JBM,2019-04-09 00:00:00,https://news.google.com/./articles/CBMifGh0dHBzOi8vd3d3LmRvdmVwcmVzcy5jb20vY29sZC1hZ2dsdXRpbmluLWRpc2Vhc2UtY3VycmVudC1jaGFsbGVuZ2VzLWFuZC1mdXR1cmUtcHJvc3BlY3RzLXBlZXItcmV2aWV3ZWQtZnVsbHRleHQtYXJ0aWNsZS1KQk3SAQA?hl=en-US&gl=US&ceid=US%3Aen
Intercept's Ocaliva shows continued improvement in NASH fibrosis ...,2019-04-11 00:00:00,https://news.google.com/./articles/CBMifWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDQvaW50ZXJjZXB0cy1vY2FsaXZhLXNob3dzLWNvbnRpbnVlZC1pbXByb3ZlbWVudC1pbi1uYXNoLWZpYnJvc2lzLWF0LWV1cm9wZWFuLWxpdmVyLWNvbmZlcmVuY2Uv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Living with LHON: Support and friendship fights fear and isolation ...,2019-04-04 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9kaXNlYXNlLXNwb3RsaWdodC9saXZpbmctd2l0aC1saG9uLXN1cHBvcnQtYW5kLWZyaWVuZHNoaXAtZmlnaHRzLWZlYXItYW5kLWlzb2xhdGlvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen
AI drug development partnership between GlaxoSmithKline ...,2019-04-05 00:00:00,https://news.google.com/./articles/CBMif2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDQvYWktZHJ1Zy1kZXZlbG9wbWVudC1wYXJ0bmVyc2hpcC1iZXR3ZWVuLWdsYXhvc21pdGhrbGluZS1leHNjaWVudGlhLXlpZWxkcy1maXJzdC1kcnVnLWNhbmRpZGF0ZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Sofinnova Investments Announces the Addition of Industry Veteran ...,2019-04-22 00:00:00,https://news.google.com/./articles/CBMilQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3NvZmlubm92YS1pbnZlc3RtZW50cy1hbm5vdW5jZXMtdGhlLWFkZGl0aW9uLW9mLWluZHVzdHJ5LXZldGVyYW4tbWFoYS1rYXRhYmktcGhkLWFzLWEtcGFydG5lci0zMDA4MzUzNTYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Evotec to buy Just Biotherapeutics for up to $90M,2019-05-23 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXZvdGVjLXRvLWJ1eS1qdXN0LWJpb3RoZXJhcGV1dGljcy1mb3ItdXAtdG8tOTBtLzU1NTQ2NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie brain cancer drug fails late-stage study in another oncology ...,2019-05-17 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLWJyYWluLWNhbmNlci1kcnVnLWZhaWxzLWxhdGUtc3RhZ2Utc3R1ZHkvNTU1MDIzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
How to go fast to IND: 3 tips to combine speed with quality,2019-05-17 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL2hvdy10by1nby1mYXN0LXRvLWluZC0zLXRpcHMtdG8tY29tYmluZS1zcGVlZC13aXRoLXF1YWxpdHkvNTU0Nzg3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Why does the cost of prescription drugs keep rising?,2019-05-01 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDUvd2h5LWRvZXMtdGhlLWNvc3Qtb2YtcHJlc2NyaXB0aW9uLWRydWdzLWtlZXAtcmlzaW5nL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Newron faces delay to would-be schizophrenia blockbuster ...,2019-05-28 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL25ld3Jvbi1mYWNlcy1kZWxheS10by13b3VsZC1iZS1zY2hpem9waHJlbmlhLWJsb2NrYnVzdGVy0gEA?hl=en-US&gl=US&ceid=US%3Aen
"FDA approves Pfizer's Vyndaqel, Vyndamax for cardiomyopathy in ...",2019-05-06 00:00:00,https://news.google.com/./articles/CBMic2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDUvZmRhLWFwcHJvdmVzLXBmaXplcnMtdnluZGFxZWwtdnluZGFtYXgtZm9yLWNhcmRpb215b3BhdGh5LWluLXJhcmUtcHJvdGVpbi1kaXNvcmRlci_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"With new cancer drugs, the challenge is finding where cost, value ...",2019-05-15 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDUvd2l0aC1uZXctY2FuY2VyLWRydWdzLXRoZS1jaGFsbGVuZ2UtaXMtZmluZGluZy13aGVyZS1jb3N0LXZhbHVlLW1lZXQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Putting Drug Delivery into Patients' Hands,2019-06-01 00:00:00,https://news.google.com/./articles/CBMiQ2h0dHBzOi8vd3d3LnBoYXJtdGVjaC5jb20vdmlldy9wdXR0aW5nLWRydWctZGVsaXZlcnktcGF0aWVudHMtaGFuZHPSAQA?hl=en-US&gl=US&ceid=US%3Aen
Paul Whitehouse and Bob Mortimer accidentally checked into a sex ...,2019-06-24 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tb3J0aW1lci1hbmQtd2hpdGVob3VzZS1zdGF5ZWQtaW4tYS1zZXgtaG90ZWwtMTUyNzMwODY1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Roger Daltrey insists Keith Moon biopic will be antithesis of 'Bohemian Rhapsody',2019-06-15 00:00:00,https://news.google.com/./articles/CBMifWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9yb2dlci1kYWx0cmV5LWluc2lzdHMta2VpdGgtbW9vbi1iaW9waWMtd2lsbC1iZS1hbnRpdGhlc2lzLW9mLWJvaGVtaWFuLXJoYXBzb2R5LTE4NDk0Mzk0MC5odG1s0gGFAWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL3JvZ2VyLWRhbHRyZXktaW5zaXN0cy1rZWl0aC1tb29uLWJpb3BpYy13aWxsLWJlLWFudGl0aGVzaXMtb2YtYm9oZW1pYW4tcmhhcHNvZHktMTg0OTQzOTQwLmh0bWw?hl=en-US&gl=US&ceid=US%3Aen
"Goldman Sachs Changes Airline Reservations: Downgrades Spirit, Upgrades United",2019-06-06 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9nb2xkbWFuLXNhY2hzLWNoYW5nZXMtYWlybGluZS1yZXNlcnZhdGlvbnMtMTkzNDMwMDM1Lmh0bWzSAWBodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9nb2xkbWFuLXNhY2hzLWNoYW5nZXMtYWlybGluZS1yZXNlcnZhdGlvbnMtMTkzNDMwMDM1Lmh0bWw?hl=en-US&gl=US&ceid=US%3Aen
"BridgeBio takes crown for biggest biotech IPO of 2019, as fellow ...",2019-06-27 00:00:00,https://news.google.com/./articles/CBMikAFodHRwczovL2VuZHB0cy5jb20vYnJpZGdlYmlvLXRha2VzLXRoZS1jcm93bi1mb3ItYmlnZ2VzdC1wdWJsaWMtYmlvdGVjaC1kZWJ1dC1vZi0yMDE5LWFzLWZlbGxvdy11bmljb3JuLWFkYXB0aXZlLXJhaXNlcy1vZmZlcmluZy1zaXplLWFuZC1wcmljZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"From BIO meeting, Merck CEO backs capitalism, rebuts industry's ...",2019-06-05 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvLTIwMTktbWVyY2sta2VuLWZyYXppZXItY2FwaXRhbGlzbS1mcmVlLXRyYWRlLWRydWctaW5kdXN0cnkvNTU2MjU3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
CMS approves Louisiana's 'Netflix model' using Gilead hepatitis C ...,2019-06-26 00:00:00,https://news.google.com/./articles/CBMicmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY21zLWFwcHJvdmVzLWxvdWlzaWFuYXMtbmV0ZmxpeC1tb2RlbC13aXRoLWdpbGVhZC1mb3ItaGVwYXRpdGlzLWMtZHJ1Z3MvNTU3NzA4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Drug development innovations that work: Precision medicine (Part 3 ...,2019-06-07 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL2RydWctZGV2ZWxvcG1lbnQtaW5ub3ZhdGlvbnMtdGhhdC13b3JrLXByZWNpc2lvbi1tZWRpY2luZS1wYXJ0LTMtaW4tYS1zZXIvNTU2MTg3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Unblinded: Kevin Gorman on Neurocrine's rise, fall and future",2019-06-18 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdW5ibGluZGVkLW5ldXJvY3JpbmUtY2VvLWtldmluLWdvcm1hbi1iaW90ZWNoLWluZHVzdHJ5LW1hdHVyaXR5LzU1NTM5Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA's Woodcock defends accelerated approvals and talks of culture ...,2019-06-05 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvLTIwMTktZmRhLXdvb2Rjb2NrLWFjY2VsZXJhdGVkLWFwcHJvdmFsLWJpb3NpbWlsYXJzLWNsaW5pY2FsLXRyaWFscy81NTYxNjEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Teva faces potential cash crisis amid lawsuit risks, flatlining sales",2019-06-20 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS1mYWNlcy1wb3RlbnRpYWwtY2FzaC1jcmlzaXMtYW1pZC1sYXdzdWl0LXJpc2tzLWZsYXRsaW5pbmctc2FsZXMvNTU3MTk3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Merck racks up another FDA approval for Keytruda cancer drug,2019-06-18 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stcmFja3MtdXAtYW5vdGhlci1mZGEtYXBwcm92YWwtZm9yLWtleXRydWRhLWNhbmNlci1kcnVnLzU1NzExMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FLUID Study Rethinks Treat-and-Extend in Neovascular AMD,2019-06-11 00:00:00,https://news.google.com/./articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85MTQxMDDSAQA?hl=en-US&gl=US&ceid=US%3Aen
The Falsified Medicines Directive – truly an opportunity for pharma ...,2019-06-21 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9zcG90bGlnaHQvZnV0dXJlLW9mLWdlbmVyaWNzL2ZhbHNpZmllZC1tZWRpY2luZXMtZGlyZWN0aXZlLW9wcG9ydHVuaXR5LXBoYXJtYS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
How Brent Saunders' Allergan experiment failed - STAT,2019-06-26 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE5LzA2LzI2L2hvdy1icmVudC1zYXVuZGVycy1hbGxlcmdhbi1leHBlcmltZW50LWZhaWxlZC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
The road ahead for FDA's Pre-Cert program,2019-06-12 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDYvdGhlLXJvYWQtYWhlYWQtZm9yLWZkYXMtcHJlLWNlcnQtcHJvZ3JhbS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Regent Investment Management L,2019-07-15 00:00:00,https://news.google.com/./articles/CBMixQFodHRwczovL3d3dy5ndXJ1Zm9jdXMuY29tL25ld3MvOTA5MDkzL3JlZ2VudC1pbnZlc3RtZW50LW1hbmFnZW1lbnQtbGxjLWJ1eXMtYm9laW5nLWNvLWhvcml6b24tdGhlcmFwZXV0aWNzLXBsYy1kdXBvbnQtZGUtbmVtb3Vycy1pbmMtc2VsbHMtbG93ZXMtaW5jLWlzaGFyZXMtaW5jLW1zY2ktYnJhemlsLW1hcnZlbGwtdGVjaG5vbG9neS1ncm91cNIBAA?hl=en-US&gl=US&ceid=US%3Aen
"Amneal to restructure, slashing 2019 earnings estimate",2019-07-10 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1uZWFsLXRvLXJlc3RydWN0dXJlLXNsYXNoaW5nLTIwMTktZWFybmluZ3MtZXN0aW1hdGUvNTU4NDgwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Industry Shift: With Four Departures This Year, Who Is The Longest-Tenured Automotive CEO?",2019-07-08 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbmR1c3RyeS1zaGlmdC1mb3VyLWRlcGFydHVyZXMtbG9uZ2VzdC0xOTA0MjQ3NTkuaHRtbNIBXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2luZHVzdHJ5LXNoaWZ0LWZvdXItZGVwYXJ0dXJlcy1sb25nZXN0LTE5MDQyNDc1OS5odG1s?hl=en-US&gl=US&ceid=US%3Aen
Biohaven blames Apotex for FDA rejection of ALS drug,2019-07-22 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvaGF2ZW4tYmxhbWVzLWFwb3RleC1mb3ItZmRhLXJlamVjdGlvbi1vZi1hbHMtZHJ1Zy81NTkyMjgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"3 Gilead execs, including R&D head, to leave as leadership shake ...",2019-07-17 00:00:00,https://news.google.com/./articles/CBMic2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvMy1naWxlYWQtZXhlY3MtaW5jbHVkaW5nLXJkLWhlYWQtdG8tbGVhdmUtYXMtbGVhZGVyc2hpcC1zaGFrZS11cC1jb250aW51LzU1ODk0Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"FTC probing J&J on Remicade, as biosimilar market remains muted",2019-07-30 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZnRjLXByb2JlLWpvaG5zb24tcmVtaWNhZGUtYmlvc2ltaWxhci1tYXJrZXQtY29tcGV0aXRpb24vNTU5ODE3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA warns Indian drug manufacturer Strides about document ...,2019-07-17 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXdhcm5zLWluZGlhbi1kcnVnLW1hbnVmYWN0dXJlci1zdHJpZGVzLWFib3V0LWRvY3VtZW50LXNocmVkZGluZy81NTg5NTkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Amgen, Allergan launch first US biosimilars of Roche's Herceptin ...",2019-07-19 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tYWxsZXJnYW4tbGF1bmNoLWZpcnN0LXVzLWJpb3NpbWlsYXJzLW9mLXJvY2hlcy1oZXJjZXB0aW4tYW5kLWF2YXN0aS81NTkxMzAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Patient-centric or site-centric clinical trials: Can you have both?,2019-07-25 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3BhdGllbnQtY2VudHJpYy1vci1zaXRlLWNlbnRyaWMtY2xpbmljYWwtdHJpYWxzLWNhbi15b3UtaGF2ZS1ib3RoLzU1OTE1NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Trump to roll out drug pricing executive order,2019-07-05 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE5LzA3LzA1L3RydW1wLWV4ZWN1dGl2ZS1vcmRlci1mYXZvcmVkLW5hdGlvbi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
PE firm to buy Cambrex for $2.4B amid flurry of CDMO acquisitions,2019-08-07 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGUtZmlybS10by1idXktY2FtYnJleC1mb3ItMjRiLWFtaWQtZmx1cnJ5LW9mLWNkbW8tYWNxdWlzaXRpb25zLzU2MDQyNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Four Of The Best Class 8 Truck Manufacturers For The Money,2019-08-09 00:00:00,https://news.google.com/./articles/CBMiRWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9mb3VyLWJlc3QtY2xhc3MtOC10cnVjay0xOTQzNTA3NTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen
"Drug co-invented by Martin Shkreli fails, pressuring his former biotech",2019-08-22 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHJ1Zy1jby1pbnZlbnRlZC1ieS1tYXJ0aW4tc2hrcmVsaS1mYWlscy1wcmVzc3VyaW5nLWhpcy1mb3JtZXItYmlvdGVjaC81NjE0ODgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Nabriva wins FDA's favor on pneumonia antibiotic,2019-08-20 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmFicml2YS13aW5zLWZkYXMtZmF2b3Itb24tcG5ldW1vbmlhLWFudGliaW90aWMvNTYxMjgzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Novartis replaced AveXis chief scientist, R&D head amid Zolgensma ...",2019-08-14 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtcmVwbGFjZXMtYXZleGlzLWNoaWVmLXNjaWVudGlzdC1yZXNlYXJjaC1oZWFkLXpvbGdlbnNtYS81NjA5MDcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Regenxbio inks viral vector rights deal with Pfizer,2019-08-01 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVnZW54YmlvLWlua3MtdmlyYWwtdmVjdG9yLXJpZ2h0cy1kZWFsLXdpdGgtcGZpemVyLzU2MDA0Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Zogenix buys Modis for $250M, building out rare disease pipeline",2019-08-26 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvem9nZW5peC1idXlzLW1vZGlzLWZvci0yNTBtLWJ1aWxkaW5nLW91dC1yYXJlLWRpc2Vhc2UtcGlwZWxpbmUvNTYxNjgxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Amgen, maker of Enbrel, to pick up Celgene's Otezla for $13.4B. Will ...",2019-08-26 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLW1ha2VyLWVuYnJlbC10by1waWNrLXVwLWNlbGdlbmUtcy1vdGV6bGEtZm9yLTEzLTRiLXdpbGwtZnRjLWhpdC1iYWNr0gEA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer/Mylan: Pending Clash Of Quality Systems Could Determine ...,2019-08-04 00:00:00,https://news.google.com/./articles/CBMiggFodHRwczovL3BpbmsucGhhcm1haW50ZWxsaWdlbmNlLmluZm9ybWEuY29tL1BTMTQwNjIyL1BmaXplck15bGFuLVBlbmRpbmctQ2xhc2gtT2YtUXVhbGl0eS1TeXN0ZW1zLUNvdWxkLURldGVybWluZS1GYXRlLU9mLU5ldy1GaXJt0gEA?hl=en-US&gl=US&ceid=US%3Aen
Envista Holdings Opens Above IPO Price,2019-09-18 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9lbnZpc3RhLWhvbGRpbmdzLW9wZW5zLWFib3ZlLWlwby0xNDUzMjgzMTUuaHRtbNIBVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2VudmlzdGEtaG9sZGluZ3Mtb3BlbnMtYWJvdmUtaXBvLTE0NTMyODMxNS5odG1s?hl=en-US&gl=US&ceid=US%3Aen
"With third pharma deal, IFM's unorthodox approach paying off",2019-09-05 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWZtLW5vdmFydGlzLXRoaXJkLXBoYXJtYS1kZWFsLXN0aW5nLWlubmF0ZS1pbW11bmUvNTYyMjM5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Vertex to buy preclinical biotech for $950M, searching a Type 1 ...",2019-09-03 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LXRvLWJ1eS1wcmVjbGluaWNhbC1iaW90ZWNoLWZvci05NTBtLXNlYXJjaGluZy1hLXR5cGUtMS1kaWFiZXRlcy1jdS81NjIxMjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"3 Akcea execs, including CEO, leave in a 'disconcerting surprise'",2019-09-23 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvMy1ha2NlYS1leGVjcy1pbmNsdWRpbmctY2VvLWxlYXZlLWluLWEtZGlzY29uY2VydGluZy1zdXJwcmlzZS81NjM1MDUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
4 Money Apps That Will Eliminate Cash,2019-09-09 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy80LW1vbmV5LWFwcHMtZWxpbWluYXRlLWNhc2gtMTUzOTQ5NTM1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Lundbeck buys into migraine, acquiring Alder for $2B",2019-09-16 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbHVuZGJlY2stYnV5cy1pbnRvLW1pZ3JhaW5lLWFjcXVpcmluZy1hbGRlci1mb3ItMmIvNTYyOTg3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Amazon Seeks To Take Over Site Of The Old Pontiac Silverdome,2019-09-19 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWF6b24tc2Vla3Mtb3Zlci1vbGQtcG9udGlhYy0xNjEwMzM5MTguaHRtbNIBU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2FtYXpvbi1zZWVrcy1vdmVyLW9sZC1wb250aWFjLTE2MTAzMzkxOC5odG1s?hl=en-US&gl=US&ceid=US%3Aen
What could help biotech close out 2019 stronger? Analysts pick 3 ...,2019-09-04 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2hhdC1jb3VsZC1oZWxwLWJpb3RlY2gtY2xvc2Utb3V0LTIwMTktc3Ryb25nZXItYW5hbHlzdHMtcGljay0zLWV2ZW50cy10by81NjIyMjQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Who joins Purdue on pharma's top 10 settlements list? Merck, GSK ...",2019-09-12 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL21lcmNrLWdzay1wZml6ZXItai1qLWFtb25nLXRvcC0xMC11LXMtcGhhcm1hLXNldHRsZW1lbnRzLWFsbC10aW1l0gEA?hl=en-US&gl=US&ceid=US%3Aen
Alexion suffers another Soliris patent setback,2019-09-06 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi1zb2xpcmlzLXBhdGVudC1zZXRiYWNrLWV1cm9wZS81NjIzOTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
This Day In Market History: Nintendo Is Founded,2019-09-23 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9kYXktbWFya2V0LWhpc3RvcnktbmludGVuZG8tZm91bmRlZC0xMTE1MDAxNjUuaHRtbNIBWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2RheS1tYXJrZXQtaGlzdG9yeS1uaW50ZW5kby1mb3VuZGVkLTExMTUwMDE2NS5odG1s?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer's Read to step down as chairman, handing role to CEO Bourla",2019-09-27 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLWNoYWlybWFuLWlhbi1yZWFkLXJldGlyZS1hbGJlcnQtYm91cmxhLzU2Mzg3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
BioMarin talks down worries on gene therapy data differences,2019-09-10 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvbWFyaW4tZXhwbGFpbnMtaGVtb3BoaWxpYS1nZW5lLXRoZXJhcHktZGlmZmVyZW5jZXMtc3Rlcm9pZHMtdmFscm94LzU2MjYyNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"ICER's blasted pharma pricing for years, but now drugmakers are ...",2019-09-10 00:00:00,https://news.google.com/./articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL3BoYXJtYS9pY2VyLXMtYmxhc3RlZC1waGFybWEtcy1wcmljaW5nLWZvci15ZWFycy1idXQtbm93LWRydWdtYWtlcnMtYXJlLXJvbGxpbmctdXAtdGhlaXItc2xlZXZlcy10b9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Private equity firm to buy Sanofi's oldest plant in India,2019-09-12 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLXNlbGwtb2xkZXN0LXBsYW50LWluZGlhLXByaXZhdGUtZXF1aXR5LWFkdmVudC16ZW50aXZhLzU2MjgwNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Torrent recall, Dr Reddy's distribution halt add to cracks in global ...",2019-09-23 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy90b3JyZW50LWFuZC1kci1yZWRkeS1zLWFjdGlvbnMtYWRkLXRvLWNyYWNrcy1nbG9iYWwtZHJ1Zy1zdXBwbHnSAQA?hl=en-US&gl=US&ceid=US%3Aen
GW Pharmaceuticals' cannabis-derived epilepsy drug wins ...,2019-09-24 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDkvZ3ctcGhhcm1hY2V1dGljYWxzLWNhbm5hYmlzLWRlcml2ZWQtZXBpbGVwc3ktZHJ1Zy13aW5zLWV1cm9wZWFuLWFwcHJvdmFsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
ECTRIMS: Novartis' Mayzent delays wheelchair use by 4-plus years ...,2019-09-12 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2VjdHJpbXMtbm92YXJ0aXMtbWF5emVudC1kZWxheXMtd2hlZWxjaGFpci11c2UtYnktNC1wbHVzLXllYXJzLWZvci1zcG1zLXBhdGllbnRz0gEA?hl=en-US&gl=US&ceid=US%3Aen
Reports: Purdue has reached partial settlement in opioid lawsuit,2019-09-11 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDkvcmVwb3J0cy1wdXJkdWUtaGFzLXJlYWNoZWQtcGFydGlhbC1zZXR0bGVtZW50LWluLW9waW9pZC1sYXdzdWl0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Apellis to Stop Developing APL-2 for Lupus Nephritis After Phase 2...,2019-10-21 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vbHVwdXNuZXdzdG9kYXkuY29tL25ld3MvYXBlbGxpcy10by1zdG9wLWRldmVsb3BpbmctYXBsLTItZm9yLWx1cHVzLW5lcGhyaXRpcy1hZnRlci1waGFzZS0yLXRyaWFsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
UCB goes to Ra for a complementary approach,2019-10-10 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvZGVhbHMvdWNiLWdvZXMtcmEtY29tcGxlbWVudGFyeS1hcHByb2FjaNIBJmh0dHA6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTUxNjIvYW1w?hl=en-US&gl=US&ceid=US%3Aen
From Medical CBD To Cannavore Edibles: 6 Cannabis Companies Make Investment Pitches,2019-10-26 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tZWRpY2FsLWNiZC1jYW5uYXZvcmUtZWRpYmxlcy02LTIxMjIzMzI3Ni5odG1s0gFVaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvbWVkaWNhbC1jYmQtY2FubmF2b3JlLWVkaWJsZXMtNi0yMTIyMzMyNzYuaHRtbA?hl=en-US&gl=US&ceid=US%3Aen
Nordstrom Enters New York City As Barneys Is Sold,2019-10-28 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9ub3Jkc3Ryb20tZW50ZXJzLXlvcmstY2l0eS1iYXJuZXlzLTE0MTkyODU1NS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen
'An Invaluable Resource': Snoop Dogg Becomes Seedo Brand Ambassador,2019-10-23 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnZhbHVhYmxlLXNub29wLWRvZ2ctYmVjb21lcy1zZWVkby0xNzAyMTQ2NDUuaHRtbNIBWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2ludmFsdWFibGUtc25vb3AtZG9nZy1iZWNvbWVzLXNlZWRvLTE3MDIxNDY0NS5odG1s?hl=en-US&gl=US&ceid=US%3Aen
Aspen admits 1800% U.K. price hike was wrong—and it'll pay $10M ...,2019-10-03 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FzcGVuLWFkbWl0cy13cm9uZ2RvaW5nLW92ZXItMS04MDAtcHJpY2UtaGlrZS11LWstdG8tcGF5LW5ocy1wczht0gEA?hl=en-US&gl=US&ceid=US%3Aen
Reckitt inks $700M deal to clear states' probes into Suboxone ...,2019-10-24 00:00:00,https://news.google.com/./articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JlY2tpdHQtYmVuY2tpc2VyLWFncmVzcy10by1pbmstNzAwbS1kZWFsLXRvLWNsZWFyLXN0YXRlcy1wcm9iZXMtaW50by1zdWJveG9uZS1tYXJrZXRpbmfSAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis' Zolgensma starts strong as about 100 infants are treated ...,2019-10-22 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtem9sZ2Vuc21hLXNtYS1nZW5lLXRoZXJhcHktc3Ryb25nLWxhdW5jaC81NjU1NDYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Assessing provider (and patient) motivation,2019-10-23 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL2Fzc2Vzc2luZy1wcm92aWRlci1hbmQtcGF0aWVudC1tb3RpdmF0aW9uLzU2NTQ3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Merck to lay off 500 US-based commercial employees,2019-10-18 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stNTAwLXBoYXJtYS1sYXlvZmZzLVVTLXNhbGVzLXdvcmtmb3JjZS1yZWR1Y3Rpb25zLzU2NTM0Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Strides Plans Injectables Re-entry As Mylan Non-Compete Nears End,2019-10-07 00:00:00,https://news.google.com/./articles/CBMid2h0dHBzOi8vc2NyaXAucGhhcm1haW50ZWxsaWdlbmNlLmluZm9ybWEuY29tL1NDMTI1OTc3L1N0cmlkZXMtUGxhbnMtSW5qZWN0YWJsZXMtUmUtZW50cnktQXMtTXlsYW4tTm9uLUNvbXBldGUtTmVhcnMtRW5k0gEA?hl=en-US&gl=US&ceid=US%3Aen
A new breed of pharma manufacturing | pharmaphorum,2019-10-10 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9yLWQvdmlld3MtYW5hbHlzaXMtci1kL2EtbmV3LWJyZWVkLW9mLXBoYXJtYS1tYW51ZmFjdHVyaW5n0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novartis downplays late-stage asthma drug failures,2019-10-22 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtZmV2aXBpcHJhbnQtYXN0aG1hLXBoYXNlLTMtemVhbC1zdHVkeS1mYWlsdXJlcy81NjU1Njkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Bayer 2019: Fighting back – PharmaLive,2019-10-15 00:00:00,https://news.google.com/./articles/CBMiNGh0dHBzOi8vd3d3LnBoYXJtYWxpdmUuY29tL2JheWVyLTIwMTktZmlnaHRpbmctYmFjay_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA approves Vertex's triple combo therapy for cystic fibrosis 5 ...,2019-10-22 00:00:00,https://news.google.com/./articles/CBMieWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMTAvZmRhLWFwcHJvdmVzLXZlcnRleHMtdHJpcGxlLWNvbWJvLXRoZXJhcHktZm9yLWN5c3RpYy1maWJyb3Npcy01LW1vbnRocy1haGVhZC1vZi1zY2hlZHVsZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Helen Brooke Taussig: An Often Overlooked Advocate for Drug Safety,2019-10-11 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LnJhcHMub3JnL25ld3MtYW5kLWFydGljbGVzL25ld3MtYXJ0aWNsZXMvMjAxOS8xMC9oZWxlbi1icm9va2UtdGF1c3NpZy1hbi1vZnRlbi1vdmVybG9va2VkLWFkdm9jYXRl0gEA?hl=en-US&gl=US&ceid=US%3Aen
American Outdoor Brands Investors React Positively To Smith ...,2019-11-14 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWVyaWNhbi1vdXRkb29yLWJyYW5kcy1pbnZlc3RvcnMtcmVhY3QtMTgzNTQwNzI2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Stock Picks & Analyst Ratings from Citigroup,2019-11-10 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL3JhdGluZ3MvYnktaXNzdWVyL2NpdGlncm91cC1zdG9jay1yZWNvbW1lbmRhdGlvbnMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Aveo's cancer drug runs into a skeptical FDA,2019-11-04 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXZlby1jYW5jZXItZHJ1Zy10aXZvemFuaWItc2tlcHRpY2FsLWZkYS81NjY1NDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot ...,2019-11-04 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2RhaWljaGktc2Fua3lvLWV4aXRzLXUtcy1wYWluLW1hcmtldC1hbWlkLW9uY29sb2d5LXBpdm90LW9waW9pZC1zY3J1dGluedIBAA?hl=en-US&gl=US&ceid=US%3Aen
Payer perceptions of real world evidence in the rare disease space,2019-11-22 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3BheWVyLXBlcmNlcHRpb25zLW9mLXJlYWwtd29ybGQtZXZpZGVuY2UtaW4tdGhlLXJhcmUtZGlzZWFzZS1zcGFjZS81Njc1NjUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novartis' Cosentyx falls short vs. AbbVie's Humira in head-to-head trial,2019-11-01 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY29zZW50eXgtZmFsbHMtc2hvcnQtdnMtYWJidmllcy1odW1pcmEtaW4taGVhZC10by1oZWFkLXRyaWFsLzU2NjQ0Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Barclays sees 21% upside in J&J in premarket analyst action ...,2019-12-19 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9uZXdzLzM1MjczNzYtYmFyY2xheXMtc2Vlcy0yMS1wZXJjZW50LXVwc2lkZS1pbi1qLWFuZC1qLWluLXByZW1hcmtldC1hbmFseXN0LWFjdGlvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen
Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone,2019-12-27 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9zcGVjdHJ1bS1waGFybWEtYW5hbHlzdC1zYXlzLXNlbGwtMTk1MDQ5MTY4Lmh0bWzSAVdodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9zcGVjdHJ1bS1waGFybWEtYW5hbHlzdC1zYXlzLXNlbGwtMTk1MDQ5MTY4Lmh0bWw?hl=en-US&gl=US&ceid=US%3Aen
Ash 2019 – Sanofi gets a warm reception for Bioverativ asset,2019-12-10 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvYXNoLTIwMTktc2Fub2ZpLWdldHMtd2FybS1yZWNlcHRpb24tYmlvdmVyYXRpdi1hc3NldNIBJmh0dHA6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTUzODkvYW1w?hl=en-US&gl=US&ceid=US%3Aen
'Bachelor' Host Chris Harrison Treats Girlfriend Lauren Zima To An Amazing Birthday,2019-12-02 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LnlhaG9vLmNvbS9lbnRlcnRhaW5tZW50L2JhY2hlbG9yLWhvc3QtY2hyaXMtaGFycmlzb24tdHJlYXRzLTE4MzQwMzYwMS5odG1s0gFeaHR0cHM6Ly93d3cueWFob28uY29tL2FtcGh0bWwvZW50ZXJ0YWlubWVudC9iYWNoZWxvci1ob3N0LWNocmlzLWhhcnJpc29uLXRyZWF0cy0xODM0MDM2MDEuaHRtbA?hl=en-US&gl=US&ceid=US%3Aen
"4 Biotech Neurology Stocks, As Biotechs March On",2019-12-16 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQzMTI4MDAtNC1iaW90ZWNoLW5ldXJvbG9neS1zdG9ja3MtYmlvdGVjaHMtbWFyY2gtb27SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Jazz lines up $1B for lung cancer drug, making oncology focus clear",2019-12-19 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamF6ei1waGFybWFtYXItbHVuZy1jYW5jZXItZHJ1Zy1saWNlbnNpbmcvNTY5NDIwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Meet Chase Namic, Who Shares Insights On How To Make $100k On YouTube",2019-12-18 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tZWV0LWNoYXNlLW5hbWljLXNoYXJlcy1pbnNpZ2h0cy0xMzUxNTAyODMuaHRtbNIBVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL21lZXQtY2hhc2UtbmFtaWMtc2hhcmVzLWluc2lnaHRzLTEzNTE1MDI4My5odG1s?hl=en-US&gl=US&ceid=US%3Aen
A USPTO legal adviser is off controversial Gilead HIV case after ...,2019-12-13 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vZW5kcHRzLmNvbS9hLXVzcHRvLWxlZ2FsLWFkdmlzZXItaXMtb2ZmLWNvbnRyb3ZlcnNpYWwtZ2lsZWFkLWhpdi1jYXNlLWFmdGVyLWFjdGl2aXN0cy1hbGxlZ2UtdHdlZXRzLXNob3ctYmlhcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Homology unveils first data for PKU gene therapy, marking early ...",2019-12-17 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaG9tb2xvZ3ktZmlyc3QtZGF0YS1wa3UtZ2VuZS10aGVyYXB5LzU2OTI3NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"After FDA rejection, Immunomedics tries again with breast cancer drug",2019-12-03 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW1tdW5vbWVkaWNzLXJlc3VibWl0cy1mZGEtYnJlYXN0LWNhbmNlci1kcnVnLXNhY2l0dXp1bWFiLzU2ODM1MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Novartis shutters late-stage asthma program, spelling trouble for ...",2019-12-16 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtZmV2aXBpcHJhbnQtZGlzY29udGludWUtYXN0aG1hLWdvc3NhbWVyLzU2OTE0OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J to buy US biotech Taris and its bladder cancer drug device ...,2019-12-23 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL2pqLXRvLWJ1eS11cy1iaW90ZWNoLXRhcmlzLWFuZC1pdHMtYmxhZGRlci1jYW5jZXItZHJ1Zy1kZXZpY2Uv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA's approval of Ebola vaccine will be felt around the world,2019-12-20 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3dvcmxkLmNvbS9hcnRpY2xlcy80MzE5NjgtZmRhcy1hcHByb3ZhbC1vZi1lYm9sYS12YWNjaW5lLXdpbGwtYmUtZmVsdC1hcm91bmQtdGhlLXdvcmxk0gEA?hl=en-US&gl=US&ceid=US%3Aen
Free session on AI's impact on R&D at Digital Medicine & Medtech ...,2019-12-18 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMTIvZnJlZS1zZXNzaW9uLW9uLWFpcy1pbXBhY3Qtb24tcmQtYXQtZGlnaXRhbC1tZWRpY2luZS1tZWR0ZWNoLXNob3djYXNlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
